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Abstract 
Ku is an abundant, highly conserved DNA binding protein found in both prokaryotes 
and eukaryotes that plays essential roles in the maintenance of genome integrity. In 
eukaryotes, Ku is a heterodimer comprised of two subunits, Ku70 and Ku80, that is best 
characterized for its central role as the initial DNA end binding factor in the “classical” non-
homologous end joining (C-NHEJ) pathway, the main DNA double-strand break (DSB) 
repair pathway in mammals. At the break, Ku directly and indirectly interacts with several C-
NHEJ factors and processing enzymes, serving as the scaffold for the entire DNA repair 
complex. In this work we aim to characterize the role of the Ku70 von Willebrand A-like 
(vWA) domain, a protein-protein interaction domain, in Ku’s role in the response to DSBs. 
In this study we identified a requirement for the Ku70 vWA domain in both NHEJ 
and signaling to the DNA damage response (DDR) pathway to determine cell fate decisions. 
We demonstrate that mutation of residues D192A/D195R in helix 5 resulted in extremely 
low survival after ionizing radiation (IR) treatment and decreased DNA repair efficiency, 
indicating a role for these residues in NHEJ. We also identified a novel phosphorylation 
event at Ku70 S155 in response to DNA damage. Mutation of this residue to alanine has no 
impact on DNA repair, however results in increased survival and decreased activation of 
apoptosis following IR treatment, indicating a defect in the DDR pathway to relay the signal 
of failed repair to the cell death machinery. The expression of a phosphomimetic S155D 
substitution had the opposite phenotype, with very low survival after IR, and the constitutive 
activation of DDR markers and cell cycle arrest even in the absence of any DNA damage. 
We found Ku70 S155 phosphorylation was required to interact with and inhibit the Aurora 
Kinase B after IR, a kinase that promotes cell cycle progression, to induce cell cycle arrest. 
iii 
Overall we propose that the Ku70 vWA domain functions to both facilitate the repair of 
breaks by NHEJ, and to relay the signal of unsuccessful repair to the DDR in order to 
activate cell cycle arrest and apoptosis. 
Keywords
Ku, Ku70, DNA repair, NHEJ, vWA, DSB, DNA damage response, phosphorylation, 
apoptosis, cell cycle arrest, Aurora B 
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Chapter 1 
1 Introduction 
1.1 General introduction 
Structural changes to DNA pose a serious threat to organismal health as the 
maintenance of genomic integrity is required for proper cellular homeostasis and the 
faithful transmission of genetic material to progeny. Unfortunately, it is estimated that 
each cell in the human body is subjected to tens of thousands of genomic insults per day 
(1). These DNA lesions can arise spontaneously from physiological processes, such as 
meiosis, DNA replication errors, or byproducts from metabolism and inflammation (1). 
We are also exposed to numerous environmental damaging agents, including ultraviolet 
radiation, ionizing radiation and carcinogenic chemical compounds (1). If not repaired 
properly, these DNA lesions can be cytotoxic, or even more problematic, can cause 
altered cellular function leading to malignant transformation.  
 In order to combat the threat of DNA damage, organisms have developed a 
complex and sophisticated signaling pathway, collectively termed the DNA damage 
response (DDR). The end goal of this process is DNA repair, coordinated enzymatic 
processes specific to the type of DNA damage, that restore integrity of the DNA. 
Simultaneously, numerous signaling cascades are initiated that induce cell cycle arrest, in 
order to give the cell type to repair the DNA, but also activate cell death if the repair 
cannot be completed. This thesis will examine the role of Ku, an integral component of 
2 
2 
the DNA double strand break (DSB) pathway, non-homologous end joining (NHEJ), in 
both the execution of DNA repair and coordination of cell fate decisions to the DDR. 
1.2 Ku Heterodimer 
1.2.1 General introduction 
Ku was first identified in the early 80’s as an autoantigen targeted by 
autoantibodies in the serum of patients diagnosed with an autoimmune disease known as 
scleroderma polymyositis overlap syndrome (2). The name Ku comes from the first two 
letters of the name of the original patient in whose serum it was identified.  
Autoantibodies directed against Ku were subsequently found in several other 
autoimmune diseases, including systemic lupus erythematosus, Sjorgren’s syndrome, 
polymyositis and scleroderma (3-5). Early studies using serum from Ku-positive patients 
identified Ku as an abundant, mostly nuclear protein (2, 6). Subsequent reports showed 
that Ku had unusual DNA binding properties, binding avidly to the ends of double-
stranded DNA molecules in a sequence-independent manner and to a lesser extent to 
other forms of DNA discontinuities such as hairpins gaps and nicks (6-8). These unusual 
end-binding properties made Ku an appealing candidate for a role in DSB repair and 
V(D)J recombination, which was confirmed when the two Ku subunits (XRCC5, Ku80 
and XRCC6, Ku70) were found to complement the DNA repair defect of several IR-
sensitive cell lines (9-15). It is now well established that while not essential to individual 
life in the short term, Ku function is critical to the maintenance of genomic integrity and 
to the proper cellular and organismal development. A better understanding of Ku’s 
diverse roles at the cellular and organismal level have implications for the study and the 
treatment of other human diseases, such as immune system disorders, cancer and aging.  
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1.2.2 Ku Structure 
Ku is a highly abundant protein found in vivo as a stable heterodimer consisting of 
two subunits, Ku70 and Ku80 (70 and 80 kDa, respectively). Both Ku70 and Ku80 
eukaryotic Ku subunits contain three domains (Figure 1-1A): an N-terminal alpha 
helix/beta barrel von Willebrand A (vWA) domain; a central core domain required for 
DNA binding and dimerization; and a helical C-terminal domain.  
The Ku70/80 crystal structure (Figure 1-1B) shows that the two subunits dimerize 
through the central domain to form a ring capable of accommodating two turns of double-
stranded DNA (approximately 14 base pairs) (16). This ring, consisting of intertwined 
strands of both Ku70 and Ku80, is lined with positively charged residues positioned to 
interact with the sugar phosphate backbone of DNA in a sequence-independent manner. 
Ku binds double-stranded DNA ends with high affinity (Kd~10-9 M), including 5’-3’ or 
3’-5’ overhangs and blunt ends, however has significantly less affinity for circular DNA 
and single-stranded DNA ends (6, 17, 18). Ku has a preferred orientation when loaded 
onto the DNA, placing Ku70 proximal to the DNA end, and Ku80 on the distal side, 
facing away from the end (16). 
The N-terminal vWA domain (also called α/β domain) consists of a six-stranded 
beta-sheet in a Rossman fold. The amino side of the beta-sheet makes contact with the 
DNA groove, although it contributes little to Ku70/80 dimerization or DNA binding. The 
carboxyl end of the fold points away from the break, which makes it available as a 
protein-protein interaction surface (16). This domain, named for its prototype protein, the 
von Willebrand Factor type A, is present in mostly extracellular matrix proteins but also 
several intracellular proteins, where it facilitates protein-protein interactions with a wide  
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Figure 1-1 Representation of Ku structure 
(A) Schematic diagram of domain representation of the Ku70 and Ku80 subunits. The 
subunit domain structure of yeast and human Ku consists of the alpha helix, beta barrel 
N-terminal vWA domain, a central DNA binding core and a C-terminal helical domain 
(CTD). The eukaryotic Ku80 CTD contains the region required for binding DNA-PKCS , 
while the Ku70 CTD is shorter and contains a SAF-A/B, Acinus and PIAS domain 
(SAP). The location of the nuclear localization signals and post translation modifications 
(phosphorylation and acetylation) on the human Ku protein is indicated. Yeast Ku is 
comprised of a similar domain structure to human Ku, except for a truncated C-terminal 
domain in Ku80. Prokaryotes encode for a single Ku subunit that is homologous to the 
eukaryotic core DNA binding domain. (B) The crystal structure of human Ku (PDB: 
IJEY) coloured according to the domain structure. The dimer forms an asymmetrical 
basket structure with a positively charged ring large enough to accommodate two turns of 
the DNA. The Ku80 C-terminus is not included in this crystal structure.  
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variety of ligands (19). Overall, the function of this domain is not well characterized but 
there is emerging evidence that it has an important role in DSB repair and telomere 
regulation. In Saccaromyces cerevisae, mutations in helix 5 of Ku80 abrogated telomere 
silencing, while mutations in helix 5 of Ku70 had a negative impact on DSB repair in 
yeast and mouse cells (20-22). Specific residues in the Ku70 vWA domain were also 
shown to be critically implicated in conferring abasic site processing by Ku in vitro (23, 
24). Additionally, another region of the human Ku70 vWA domain in helix 4 was found 
to regulate DNA damage signaling to apoptosis (22). Consistent with its predicted role as 
a protein-protein interaction surface, the vWA domain has been shown to mediate an 
interaction with both the telomere complex component telomere repeat binding factor 2 
(TRF2) and NHEJ factor aprataxin and PNKP like factor (APLF) (21, 25).  
Both Ku subunits contain a helical C-terminal domain (CTD), however this is the 
most divergent region of the two proteins. The Ku80 CTD is approximately 15 kDa and 
contains a helical and a disordered region. In vertebrates, the extreme Ku80 C-terminus is 
involved in the recruitment of DNA-dependent protein kinase catalytic subunit (DNA-
PKCS) to DNA (26, 27). Lower eukaryotes, such as S. cerevisiae and Aradopsis thaliana, 
encode for a smaller Ku80 protein, missing this DNA-PKCS binding region, which 
correlates with the fact that DNA-PKCS is not present in these organisms. The Ku70 CTD 
is composed of a highly flexible linker region followed by a structured 5 kDa helix-loop-
helix region known as the SAP domain (named after SAF-A/B, Acinus and PIAS motifs) 
(28). The SAP domain has putative DNA binding properties and has been shown to 
increase the overall DNA binding affinity of the heterodimer (29, 30). This C-terminal 
region is also subject to post translational modifications. Multiple C-terminal lysine 
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residues are acetylated to regulate Ku interaction with pro-apoptotic proteins (31, 32). 
Acetylation and sumoylation of Ku70’s C-terminal tail were also implicated in 
modulating its recruitment to DNA damage sites and Ku’s DNA binding affinity, 
respectively (32, 33). The Ku70 SAP domain was also shown to mediate the recruitment 
of homeodomain proteins to DNA ends (34). Furthermore, Ku is primarily a nuclear 
protein, and the CTD in both subunits contains the basic nuclear localization signal motif 
that regulates the heterodimer’s nuclear transport (35). 
It is currently unclear whether Ku subunits can exist alone in a monomeric form, 
but there is strong evidence that Ku is an obligate heterodimer. Cells derived from Ku70 
deficient mice show very low expression of Ku80, and similarly, the expression of Ku70 
is severely reduced in cells derived from Ku80 deficient mice (15, 36, 37). This 
phenomenon is also observed in yeast strains null for either Ku subunit, and in fact, these 
strains are phenotypically identical to the double Ku subunit knockout strain (38). This is 
likely due to the instability of each subunit in the absence of their interacting partner, as 
exogenous re-expression of the missing subunit restores the protein levels of its 
heterodimeric partner (37). Overall, evidence suggests that the individual Ku subunits are 
unstable and require heterodimerization to function.  
The Ku subunits share little primary sequence, but do have a conserved secondary 
structure, indicating that they may be derived from a common ancestor. Ku is an 
evolutionarily conserved protein, found in both the prokaryotic and eukaryotic kingdoms, 
and its overall structure is preserved throughout. As several homologues have been 
identified in bacterial and archaea species, Ku is thought to have prokaryotic origins (39, 
40). For the most part, prokaryotic genomes contain a single copy of a Ku-like protein 
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which also functions in a bacterial NHEJ pathway, but as a homodimer (41). While 
having little DNA or protein sequence similarity to its eukaryotic counterparts, 
prokaryotic Ku homologues display structural homologies to the central core DNA 
binding domain region of both eukaryotic Ku subunits and form homodimers that bind 
double-stranded DNA ends (42). Prokaryotic Ku is much smaller however, only 
approximately 30-40 kDa, lacking both the vWA and C-terminal domains found in 
eukaryotes (39, 40). 
1.3  DNA Repair 
1.3.1 Types of DNA damage and repair 
DNA is subject to a wide variety of chemical modifications as a result of damage 
from both extrinsic and intrinsic agents. In order to resolve this diverse collection of 
modifications, several separate DNA repair pathways have evolved. The simplest DNA 
damaging agent is hydrolysis, which deletes DNA bases by severing the N-glycosidic 
bond between the base and the deoxyribose, as well as the deamination of bases that 
create conversions (eg. uracil to cytosine) (43-45). Other base modifications are produced 
from endogenous reactive molecules like nitric oxide (NO-) and reactive oxygen species 
(ROS) (46, 47). These base damages that do not distort DNA structure are generally 
resolved through the base excision repair (BER) pathway (48).  Larger lesions that do 
distort the DNA structure are repaired by the nucleotide excision repair (NER) pathway 
(49). Examples of these bulky lesions are the pyrimidine dimers formed by UV radiation, 
or DNA intra-strand crosslinks created from drugs such as cisplatin (50). The mismatch 
repair (MMR) pathway is utilized in the correction of DNA polymerase errors like 
insertions, deletions or incorrect base incorporation (51-53). Finally, there are both single 
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strand break (SSB) and double strand break repair (DSBR) pathways that are utilized 
when the DNA damaging agent severs the sugar phosphate backbone of DNA (54).  
The DNA DSB is considered to be the most dangerous and lethal form of DNA 
damage. DSBs can arise from both exogenous sources, such as ionizing radiation (IR), 
chemotherapeutic drugs and endogenous sources, such as meiosis, immune system gene 
rearrangements, stalled replication forks and reactive oxygen species (ROS) (1). All 
organisms are exposed to low levels of environmental IR and to varying amounts 
throughout our lifetime during medical procedures such as X-rays and cancer treatment 
(1). IR is a particularly complex DNA damaging agent due to the wide variety of DNA 
damage it produces. The DNA is initially damaged through the direct deposition of 
energy, but also, the ionization of surrounding water molecules produces ROS, which 
themselves damage the DNA (55). As a consequence, 1 Gy of IR produces approximately 
40 DSBs per cell, but also 1000 single-strand breaks (SSBs), and 2000 base 
modifications (56-58). DSBs generated from IR can often be complex, clustered lesions 
that contain additional single strand overhangs and base damage that require additional 
processing before repair.  There are three main DSB repair pathways in eukaryotes 
(Figure 1-2): the classical NHEJ (C-NHEJ), alternative NHEJ or microhomology-
mediated end joining (A-NHEJ or MMEJ) and homologous recombination (HR) (59-61). 
C-NHEJ and A-NHEJ have the potential to be active in all stages of the cell cycle, 
however HR, is only active in the S and G2 phases because it utilizes the 
complementarity of the sister chromatid to repair the DSB with high accuracy (60, 61). 
C-NHEJ is capable of ligating any two DNA ends, regardless of sequence. Due to this 
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Figure 1-2 Schematics of the double-strand break repair pathways in higher 
eukaryotes.  
(A) Homologous Recombination. After the introduction of a DSB, the ends are 
recognized by the MRN complex (Mre11-Rad50-NBS1), which recruits proteins Sae2, 
Sgs1, Exo1 and Dna2 to facilitate resection of the break in the 5’ direction and leave 3’ 
single-stranded extensions. The 3’ single-stranded overhangs are bound by the proteins 
RPA, Rad51, and Rad54 to form a nucleoprotein filament. The next step, aided by the 
recruitment of Rad52, is the invasion of this filament strand into the DNA of the 
homologous chromosome to form a D-loop structure. A polymerase extends the 3’ 
overhang to create a cross structure known as the Holliday junction, which is later cut to 
resolve the chromosome.  (B) Alternative end joining/microhomology-mediated end 
joining (A-NHEJ/MMEJ). The break is recognized by the MRN complex, PARP1 and 
XRCC1, which promote the nucleolytic degradation of DNA to reveal 5-25 bp regions of 
microhomology between the DNA strands. After the alignment of complementary 
regions, the gaps are filled in by polymerase β, and ligated by either ligase I or ligase III. 
(C) Non homologous end joining (C-NHEJ). (1) The ends are recognized by the Ku 
heterodimer which slides directly onto the break via its DNA binding ring. The PIKK 
member DNA-PKCS binds at the Ku80 C-terminus to create the DNA-PK complex. (2) 
DNA-PK autophosphorylates to create the catalytically active DNA-PK complex. 
Artemis is recruited to DNA-PK and phosphorylated. (3) Several enzymes, including 
polymerases (polymerase µ or λ), nucleases, kinases (polynucleotide kinase) are recruited 
to the break and remove damaged bases or single-strand overhangs to create compatible 
ends for ligation. (4) The ligation complex, consisting of Ligase IV, XRCC4, and XLF 
are recruited by Ku and ligate the two DNA ends. (5) It is unclear how the Ku dimer is 
removed from the ligated break. Possible mechanisms include degradation of Ku by 
proteases and the ubiquitin pathway, or physical nicking of the repaired DNA by 
nucleases to allow Ku to slide off. 
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flexibility, C-NHEJ is the predominant DSB repair pathway in humans and other higher 
eukaryotes (62-64).  
1.3.2 Classical Non Homologous End Joining (C-NHEJ) 
1.3.2.1 Overview 
C-NHEJ can be divided into five main stages: I) recognition of the break by Ku, 
II) Synaptic end bridging, III) DNA end processing to produce compatible ends, IV)
ligation of the break, and finally, V) Ku removal from the restored DNA. The importance 
of Ku to DSB repair has been well documented with reports of Ku deficient cells 
displaying inaccurate end-joining, dramatic radiosensitivity, and chromosomal breakage, 
translocations and aneuploidy (15, 65-69).  
1.3.2.2 DNA end recognition 
The initial step of C-NHEJ is the rapid recognition of the DSB by Ku. Ku’s 
abundance (in humans, approximately 500,000 molecules per cell (6, 16, 70)) and strong 
affinity for DNA allows it to associate with DNA ends within 5 seconds of damage (71). 
Ku binding has a protective role and in Ku-deficient cells, nucleolytic processing occurs 
at DSB ends (72). Once Ku has encircled the DNA via its central ring domain, it directly 
and indirectly interacts with several NHEJ factors, serving as the scaffold for the entire 
NHEJ complex. Some uncertainty remains as to how many Ku molecules are recruited to 
a DNA break. Many DNA damage response factors form distinct foci easily visible at the 
site of DNA damage. However there has been difficulty in observing Ku following DNA 
damage by microscopy, leading to the conclusion that Ku does not accumulate in large 
numbers at a DSB. Furthermore, an in vitro study showed that only one or two Ku 
molecules were able to load onto a chromatin substrate (73). A recently developed 
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method for visualizing Ku foci also demonstrated that on average there are only two Ku 
molecules present at a DSB in vivo, presumably one at each end of the DNA break (74).  
1.3.2.3 Bridging of the DNA ends 
Ku is the DNA binding subunit of the DNA-dependent protein kinase (DNA-PK) 
complex, which comprises Ku and DNA-PK catalytic subunit (DNA-PKCS), a member of 
the phosphoinositide 3-kinase-related kinase (PIKK) family (75). DNA-PKCS activity is 
very important for successful DNA repair, as loss of DNA-PKCS activity through 
mutations or knockout, strongly diminishes C-NHEJ efficiency and, at the organismal 
level, results in profound immunodeficiency (11). The low-resolution electron 
microscopic structure of the DNA-PK complex indicates that Ku70/80 makes several 
contacts with DNA-PKCS, including the N-terminal and C-terminal regions of DNA-PKCS 
(76). At DSBs, DNA-PKCS is recruited by Ku to form the active complex, leading to Ku 
translocation and the eventual activation of DNA-PKCS catalytic activity. This 
translocation allows DNA-PKCS to be positioned at the tip of the break and mediates the 
synaptic joining of the two broken ends and the stabilization of the complex (77). 
Another important consequence of DNA-PK kinase activation are 15 auto-
phosphorylation events on DNA-PKCS (78-82). Ku70 and Ku80 were shown to be 
phosphorylated by DNA-PK in vitro, however the importance of these events in C-NHEJ 
function is unclear, as mutation of these residues does not impact cell survival after 
ionizing radiation (IR) (83). Similarly, DNA-PK phosphorylates several NHEJ factors in 
vitro such as DNA ligase IV, X-ray cross complementing protein 4 (XRCC4), XLF 
(XRCC4 like factor, also known as Cernunnos) and Artemis but again many of these 
were dispensable for NHEJ in vivo (80, 84-86). 
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 There is increasing evidence that, along with DNA-PKCS, Ku itself mediates the 
DNA end bridging and stabilization of the C-NHEJ ligation complex. Several early 
observations lead to the conclusion that Ku functions to bridge DNA ends, including the 
in vitro joining of two radiolabelled DNA ends by recombinant Ku protein and the 
visualization of Ku dependent DNA fragment joining by electron and atomic force 
microscopy (87, 88). More recently, utilizing an experimental system designed to 
visualize DSBs introduced by restriction endonucleases in mammalian cells, it was 
observed that the loss of Ku80 resulted in increased distance between DNA ends (89). 
Despite these observations, there has been little insight into the precise mechanism of Ku 
end bridging. A mutation in helix 5 of the Ku70 vWA domain, noted for its ability to 
impair DSB repair in both yeast and mammalian cells, was found to decrease 
multimerization of Ku proteins, leading to the speculation that this helix mediates DNA 
end bridging through the binding of two Ku70 molecules (20-22). 
1.3.2.4 DNA end processing 
Between the initial break recognition by Ku and the final ligation of the break, 
there is considerable flexibility in the factors involved in repair. For example, IR is 
known to produce a variety of damage to the DNA, occasionally leaving non-ligatable 3′-
phosphate groups, 3′-phosphoglycolates, or 5′-hydroxyl groups. Therefore, a number of 
kinases/phosphatases (polynucleotide kinase/phosphatase (PNKP), nucleases (Werner, 
Mre11, Artemis, ExoI), polymerases (DNA polymerases µ and λ), helicases (RECQ1), 
and phosphodiesterases (tyrosyl-DNA phosphodiesterase 1) may be required to produce 
compatible DNA ends (90). In the case of DSBs induced by Topoisomerase II (TOP2) 
poisons, TOP2 remains covalently linked to via a phosphotyrosyl bond to the 5’ terminus 
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and requires a specific end-processing enzyme, tyrosyl DNA phosphodiesterase 2 
(TDP2), that hydrolyses 5’-phosphotyrosyl bonds at TOP2-associated DSBs (91, 92). In 
many cases, recruitment of these factors to the DNA break is dependent on Ku, with 
some factors directly interacting with Ku (Table 1-1). Interestingly, Ku itself has been 
shown to have some enzymatic activity and may also participate in the processing of 
DNA ends. It was identified as a 5′-dRP/AP lyase that removes abasic sites by nicking 
DNA 3' of the abasic site via a mechanism involving a Schiff-base covalent intermediate. 
Several lysine residues in the Ku70 vWA domain catalyze this reaction, notably 
K160/164, which when mutated to an alanine residues completely inhibit Ku’s ability to 
form a Schiff base (23, 24).  
1.3.2.5 Ligation of the break 
Following end-processing, the two DNA ends are ligated back together. Ku also 
has an important role in the recruitment of the ligase complex, which is comprised of 
DNA ligase IV, XRCC4 and XLF. The complex requires Ku to be recruited to the break 
through a direct interaction with Ku, with DNA ligase IV and XLF interacting with the 
whole heterodimer and XRCC4 interacting with Ku70 specifically (71, 93-96). There is 
still great uncertainty regarding the stepwise recruitment of NHEJ factors following Ku 
binding, although this is not surprising given that different processing enzymes are 
required in different situations. Indeed there is also some evidence that high complexity 
DSBs (containing single-strand overhangs, base oxidation and abasic sites) are repaired 
with slow kinetics and are dependent on DNA-PKCS activity, while low complexity DSBs 
(without surrounding DNA damage) do not require DNA-PKCS binding, and are 
efficiently ligated with only Ku and the ligation complex (97-100).  
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Table 1 Ku protein-protein interactions. 
A list of proteins proposed to directly interact with Ku, classified according to cellular 
process. 
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1.3.2.6 Ku removal from the DNA 
One of the outstanding questions in NHEJ is how Ku is removed from DNA 
following ligation of the DSB. Ku is rapidly recruited to the break, but is only found there 
transiently, as laser micro-irradiation studies found that Ku signal steadily depletes within 
the few hours following the initial damage, presumably being removed as DNA is 
repaired (71, 101). Ku differs from many other DNA binding proteins in that it binds 
DNA ends by encircling them through its ring domain, which would suggest that once the 
two DNA breaks are ligated, Ku is trapped on the linear repaired DNA. Furthermore, the 
crystal and electron microscopy (EM) structures do not indicate an obvious escape 
mechanism given that the vWA and central ring domain conformations of Ku remain 
unchanged whether or not bound to DNA (16, 76). One possible mechanism is that the 
removal of Ku from DNA occurs via a protein degradation pathway. Studies in Xenopus 
laevis have shown that poly-ubiquitination of Ku80 Lysine 48 leads to its degradation by 
the Skp1-Cul1-Fbxl12 (SCF) E3 ubiquitin ligase complex (102). Similarly in human 
cells, Ku80 ubiquitination was found to be dependent on the E3 ubiquitin ligase RING 
finger protein 8 (RNF8) (103). The depletion of RNF8 led to increased Ku80 retention at 
the break and decreased NHEJ efficiency, suggesting that removal of Ku80 by ubiquitin-
mediated degradation is an important step in successful DSB repair (103). Another 
proposed mechanism for Ku removal is the direct nicking of DNA to allow Ku escape. 
Evidence for this has emerged from yeast systems, with the HR complex MRX (Mre11-
Rad50-Xrs2) performing an endonucleolytic incision adjacent to the DNA end, followed 
by digestion of the DNA to allow Ku removal and then restoration of the DNA by MRX 
and Dna2 resection (104-106). Overall, protein degradation and direct DNA nicking are 
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very different possible mechanisms for Ku removal and further work needs to be done to 
resolve this discrepancy. It should be noted that these results were obtained from different 
biological systems and could indicate that there is a divergence in Ku removal 
mechanisms between yeast and higher eukaryotes. 
1.3.3 Competition between repair pathways 
There is much investigation regarding how organisms regulate the DSB repair 
pathway choice and increasing evidence suggests that Ku has an inhibitory effect on the 
other DSB pathways. Ku is one of the first proteins found at DSB regardless of cell cycle 
stage and cells will first attempt to repair DSBs by C-NHEJ if the ends are compatible 
(101, 107-109). HR is the preferred pathway in the S and G2 phases, and the initial end 
binding factors of HR, for example Mre11, antagonize Ku for DNA end binding. The 
binding of HR factors initiates DNA end resection to produce single-stranded DNA, 
which Ku does not have a strong affinity for, and promotes the completion of DSB repair 
by HR (61). In yeast, Ku appears to outcompete HR factors in G1 phase, as the loss of Ku 
results in increased Mre11 recruitment and Exo1 mediated resection (72, 110-113). 
Overexpression of Ku is even able to reduce recruitment of Mre11 in G2, when HR is the 
preferred DSB repair pathway (110). The HR inhibitory effect appears to be specifically 
dependent upon Ku’s DNA end binding function, as deletion of other NHEJ factors, such 
as ligase IV, were not able to increase HR activity to the same extent (110). Another 
study has implicated, not only Ku binding, but the kinase activity of DNA-PKCS in the 
DNA repair pathway choice, as initiated of HR in G2 depended upon DNA-PKCS 
autophosphorylation  events (114). Ku70 also antagonizes HR via the Fanconi Anemia 
(FA) and break-induced replication (BIR) repair pathways. The FA pathway repairs DNA 
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interstrand cross-links (ICLs) in cooperation with the HR pathway during replication 
(115). Cell lines deficient in FA genes display increased sensitivity to DNA damaging 
agents that specifically create DNA cross-links and show a greater dependence on repair 
by NHEJ. The simultaneous deletion of Ku70 however, reverses this sensitivity, and 
repair is completed by HR once again (116). Similarly, BIR is responsible for the repair 
of breaks that occur in S phase following a replication fork collapse (117). This pathway 
is also dependent on HR, and yeast cells null for Mre11 activity are sensitive to agents 
that induce replication stress (118). Several Ku70 mutants were identified that rescue this 
Mre11 loss, again suggesting a competitive interplay between Ku and Mre11 (118, 119). 
A-NHEJ is Ku-independent end joining, and while it is not currently fully 
characterized, it is considered to be a more mutagenic DSB pathway as it occasionally 
utilizes microhomologies far from the DSB which results in extended resection and 
deletions at the repair site (59, 60, 120, 121). Similar to C-NHEJ, this pathway is active 
in all phases of the cell cycle, however it was only identified after the deletion of 
essential C-NHEJ components, suggesting that this pathway is secondary to C-NHEJ (57, 
120, 122). It is still unclear why A-NHEJ may be selected over the less mutagenic C-
NHEJ pathway, however A-NHEJ, similar to HR, often begins with resection to form 
SSBs, which would inhibit Ku binding and promote the binding of A-NHEJ factors, such 
as PARP-1(59, 60, 120, 121).  Ku outcompetes the DNA binding factor PARP-1, and 
deletion of Ku results in increased repair by this pathway (123-125). Furthermore the 
DNA-PK complex has an inhibitory effect on the enzymatic activity of PARP-1 (126). 
Studies have indicated that human somatic cell lines with Ku80 deletions retain DSB 
repair capability, but show a shift towards the A-NHEJ pathway (127). However Ku80-
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expressing cell lines with individual deletions of the other proteins required for C-NHEJ 
have a dramatic decrease in all DSB repair pathways (127). These results suggest that the 
binding of Ku, or the entire DNA-PK complex to DNA has a dominant negative effect on 
the other DSB repair pathways if C-NHEJ cannot be completed.  
The DNA repair pathway choice is largely determined by cell cycle stage, with 
breaks in G1 phase repaired by end joining, and breaks in G2/S phases largely repaired 
by HR. Not surprisingly, members of the cell cycle machinery, namely the cyclin-
dependent kinases (CDKs), have been implicated in regulating the activity of several 
DNA repair factors (128, 129). Several studies have shown, in both yeast and mammalian 
systems, that CDKs phosphorylate the HR factors CtBP-interacting protein (CtIP) and 
Dna2 in order to initiate the switch to recombination at the G1/S transition (130-132). 
There is some evidence that Ku could also be regulated by CDK phosphorylation. Cyclin 
A1/CDK2 was implicated in the regulation of NHEJ following radiation and was 
proposed to be a binding partner of Ku in vertebrates (133). Furthermore, mass 
spectrometry studies revealed potential CDK phosphorylation sites on Ku (134, 135). 
However, the functional significance of Ku phosphorylation by CDKs has yet to be 
elucidated. While several potential CDK1 phosphorylation sites were identified in S. 
cerevisae Ku, mutation of these sites did not elicit a DNA repair defect (136). 
 Recent work has also implicated the factors p53 binding protein 1 (53BP1) and 
breast cancer 1 (BRCA1) as essential regulators in the pathway choice in mammalian 
cells. 53BP1, along with RAP1 interacting factor (Rif1) and Pax transactivation domain-
interacting protein (PTIP), promote NHEJ and negatively regulate resection in G1 phase 
(137, 138). BRCA1, along with CtBP-interacting protein (CtiP), promotes the removal of 
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53BP1 during the switch to HR at the G1/S transition (139). It is currently unclear how 
Ku fits into this mechanism, however there is evidence that Ku associates with BRCA1 
and that this interaction is important for successful NHEJ in G1 (140-142). It is possible 
that this association is essential for the removal of Ku from breaks, with BRCA1 utilizing 
the exonuclease activity of the MRN (Mre11-Rad50-NBS1) complex in a nicking 
mechanism analogous to that proposed for yeast Ku removal. 
1.3.4 Role of Ku in other DNA repair pathways 
In addition to its role in the repair of DSBs by C-NHEJ, Ku has been implicated 
in a number of other DNA repair pathways. Ku has been implicated in base excision 
repair (BER), which repairs DNA base damage, apurinic/apyrimidic (AP) sites and 
single-strand breaks (SSBs) (48). Cells deficient in Ku70 and Ku80 were sensitive to 
reactive oxygen species (ROS) and alkylation damage producing agents that result in 
base lesions and SSBs (143). Additionally, in vitro experiments demonstrated that Ku 
subunits bind AP sites and cell extracts from Ku deficient cells have decreased BER 
activity (143, 144). Furthermore, Ku has been shown to interact with ABH2, an enzyme 
involved DNA alkylation repair, potentially implicating it in this pathway as well (145). 
1.4 Ku at Telomeres 
Telomeres are the linear ends of chromosomes and therefore have the potential to 
be recognized as DSBs and processed by DSB repair pathways. Specific protein 
complexes, such as the shelterin complex in mammals and the Rap1 or CST (Cdc13–
Stn1–Ten1) complexes in yeast have evolved to bind and form protective caps on the 
DNA ends to prevent access by the DNA repair complexes (Figure 1-4) (146, 147). A  
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Figure 1-3 General structure of telomeres 
In most eukaryotes telomeric DNA consists of extended tracts of G-rich repeat arrays. 
The G-rich strand forms a short 3’ single-strand protrusion called the G-overhang, which 
mediates the formation of a complex secondary structure called a t-loop. The t-loop 
structure allows the folding of the end of the chromosome to mask and protect the DNA 
end from degradation.  A. Structure of the yeast telomere. The MRX 
(Mre11/Rad50/Xrs2) and Sir/Rap1 complexes directly bind the telomeric DNA (281). Ku 
could potentially (a) bind the DNA end via its DNA binding domain or (b) bind via a 
protein-protein interaction with telomeric complexes (such as Sir/Rap1). Ku has a role in 
recruiting telomerase, mediated by an interaction with the TLC1 RNA and Ku80. Ku 
interaction with the telomere may be indirect, requiring the heterotetramerization of two 
Ku molecules. B. Structure of the mammalian telomere. The Shelterin 
(TRF1/TRF2/Tin1/Pot1/TPP1) and MRN (Mre11/Rad50/Nbs1) complexes coat the 
telomeric DNA to protect from degradation (282). Again there is controversy whether (a) 
Ku directly binds the telomeric DNA or (b) is retained through a protein interaction with 
components of the Shelterin complex (such as TRF1/TRF2). 
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role for Ku in the maintenance of telomeres in yeast has been long established. 
Foundational to this was the observation that deletion of either Ku subunit in S. cerevisae 
resulted in shortened telomeres and long G-tails compared to wildtype (148-150). The 
requirement of Ku for proper telomere structure and maintenance appears to be separate 
from C-NHEJ, as DNA Ligase IV deficient strains, the ligase essential for completion of 
C-NHEJ, do not show any telomere defects (151). Analysis of telomeres in Ku-deficient 
mice has produced conflicting results regarding telomere length, with reports of telomere 
shortening as well as lengthening (152-154). Despite this, the same mice exhibit 
increased telomere end-to-end fusions and chromosomal aberrations (153, 154). 
Similarly, human cells with deleted Ku80 show telomere loss and abnormal telomere 
structure, overall indicating a clear role for Ku in proper telomere structure maintenance 
in mammals (155).  
Similar to its role in protecting the DNA ends of DSBs in NHEJ, Ku protects 
telomere ends from recombination and degradation events (148-150, 152-154).  
Paradoxically, although Ku promotes the fusion of dysfunctional, or uncapped, telomere 
ends, it has an inhibitory effect on the HR and A-NHEJ pathways and on the 
recombination of normal telomeres. Mouse embryonic fibroblasts (MEFs) deficient in 
Ku70 have normal telomere structure, however they exhibit increased sister telomere 
exchanges mediated by HR and chromosome fusions by the A-NHEJ pathway (156, 157). 
Additionally, Ku deficient S. cerevisiae display increased RAD52 dependent 
recombination of the subtelomeric DNA elements, consistent with its general HR 
inhibitory function (158, 159). While wildtype cells only exhibit long G-tails during late 
S phase, yeast Ku deficient strains possess long G-tails throughout the cell cycle. This 
25 
25 
defect is almost completely suppressed by the deletion of the 5’ to 3’ exonuclease Exo1, 
suggesting that Ku acts to inhibit inappropriate nucleolytic degradation of the C strand by 
nucleases (160).  
Ku also positively regulates telomere length through telomere addition by aiding 
in the recruitment of telomerase. In yeast, Ku has been shown to interact with telomerase 
component 1 (TLC1), the telomerase RNA subunit, via binding of TLC1’s 48nt stem-
loop region (161, 162). Deletion of the binding interface from either the Ku80 vWA 
domain or the TLC1 stem-loop results in decreased telomere length and decreased de 
novo telomere addition, perhaps due to the decreased levels of TLC1 RNA or altered 
localization of the telomerase holoenzyme (161, 163-166). There is no sequence 
conservation between TLC1 and the human telomerase RNA counterpart, hRT, however 
there is evidence that the interaction between the RNA component of human telomerase 
(hRT) and Ku in humans is conserved (167). Another study detected an interaction with 
Ku and telomerase in human cells, however this interaction was reported to occur through 
the catalytic reverse transcriptase protein subunit hTERT (168).  
The phenomenon of the telomere position silencing effect (TPE), observed in 
many eukaryotic species, is the process by which organisms transcriptionally silence 
genes located near the telomere (reviewed in (169, 170)). In S. cerevisiae, Ku, along with 
the silent information regulator (Sir) complex, are essential for TPE, as deletion of either 
Ku subunit results in complete loss of telomeric silencing (171-174). As a consequence of 
this role, Ku is also involved in the nuclear organization of telomeres. Telomeres and 
TPE proteins in S. cerevisiae are found distinctly clustered in foci around the nuclear 
periphery, and the loss of Ku function often results in the random distribution of 
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telomeres throughout the nucleus (174-176). Ku participates in these processes as part of 
multi-protein complexes with various proteins (such as the Sir proteins, Rap1 and Mps3) 
and Ku is particularly essential for their formation in the G1 phase of the cell cycle (176-
178). 
It is still currently unknown how Ku is associated with the telomere in vivo, 
whether it is through direct DNA binding of the end, or is mediated through a protein-
protein interaction with another telomere bound factor. Ku has the ability to directly bind 
telomere DNA in vitro, in both mammals and yeast (179, 180). Furthermore, mutations in 
yeast Ku’s DNA binding domain reduces association with telomeric chromatin and 
renders it unable to protect the telomere end, suggesting that this region is key for 
telomere binding (181). Despite this evidence, there is still some question whether it truly 
slides onto the telomere end via its DNA binding ring. Telomeres in many species form 
higher order loop structures designed to conceal the end from attack by Ku and the DSB 
repair pathways, so further research needs to be done to understand how and when Ku 
would be allowed access to the telomere end.  
Another possibility is that Ku is retained at the telomere through protein-protein 
interaction with other telomere bound factor(s). Ku has been shown to interact with 
TRF1, TRF2 and Rap1 (21, 182-186). These components of the shelterin complex bind 
DNA directly and then mediate the recruitment of other shelterin factors, such as TERF1-
interacting nuclear factor 2 (TIN2) to the TRF proteins in humans and Sir3/4 to Rap1 in 
S. cerevisiae, and therefore could also be involved to recruit Ku at the telomeres (187, 
188). A longstanding model for telomerase recruitment by Ku in yeast, suggested that Ku 
bound to the telomere end through its DNA binding ring and then bound the TLC1 RNA 
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via the yeast Ku80 vWA domain (161). However there is evidence that Ku requires the 
DNA binding domain for both DNA and RNA binding and cannot bind both 
simultaneously (189). These observations suggest that Ku does not recruit telomerase to 
the telomere by binding the telomere directly, and instead favours a model where Ku 
must bind another telomere bound factor to be retained. A combination of DNA binding 
and protein interaction is also possible and has been reported for the shelterin component 
protection of telomeres 1 (POT1), which was shown to bind the G-strand of telomeres, as 
well as form multiple protein interactions (190, 191). Given that Ku has been shown to 
multimerize, it is possible that one Ku molecule interacts with the telomere end then 
multimerizes with another Ku molecule that is bound to telomerase. Although it appears 
that there are similarities in Ku telomere binding between yeast and mammalian systems, 
these organisms have different telomere structure and protein complexes present, so it is 
possible that Ku has different mechanisms for telomere binding and protection. Advances 
in high-resolution microscopy techniques have allowed for direct visualization of 
telomere structures, such as mammalian t-loop formation by TRF2, and could help in 
understanding Ku’s role at the telomere (192). 
1.5 DNA Damage Response 
1.5.1 Overview 
The DNA damage response (DDR) (Figure 1-4) is a carefully orchestrated 
signaling cascade that senses DNA damage and promotes DNA repair to salvage the cell, 
but also carries out cell fate decisions to protect the overall health of the organism (193). 
The early stages of the DDR involve the building of a large multi-protein complex at the 
site of damage, followed by numerous post-translational modifications (including  
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Figure 1-4 Overview of DNA double-strand break (DSB) recognition and DNA 
Damage Response (DDR). 
After the introduction of a double-strand break (DSB), the broken DNA end is rapidly 
recognized by the Ku heterodimer and the MRN complex (Mre11/Rad50/NBS1). Next is 
the recruitment of the PIKK family members DNA-PKcs, bound to Ku, and ATM, which 
both phosphorylate the histone variant H2AX on its C-terminal residue Ser139 (to yield 
γ-H2AX). The MRN complex promotes the activation of ATM molecules, which in turn 
further amplify H2AX phosphorylation and spread the γ-H2AX signal far from the initial 
damage site. Several other factors are phosphorylated by ATM and recruited to the 
damaged site in large numbers, including MDC1, 53BP1, Rif1 and BRCA1. ATM also 
initiates a signaling cascade through the phosphorylation of p53 and Chk1/2 that results 
in broad transcriptional changes to induce cell cycle arrest or activate apoptosis if the 
damage is unable to be repaired (193).  
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phosphorylation, ubiquitination, acetylation, sumolyation, methylation and ribosylation) 
to the proteins and surrounding histones. The resulting chromatin modification and 
reorganization allows access to the DNA for processing and repair to occur (194). 
Simultaneously, the activation of transducer proteins, mainly kinases, activates numerous 
downstream effector molecules to induce broad transcriptional changes throughout the 
cell. This cascade is required to initiate cell cycle checkpoints, and if necessary, 
programmed cell death and senescence, two mechanisms that eliminate cells damaged 
beyond repair. The failure to properly execute the DDR can have devastating 
consequences to the health of an organism, as it can allow DNA damage to persist, 
resulting in genomic instability and perhaps cellular transformation and cancer.  
1.5.2 ATM 
The serine/threonine kinase ATM of the PIKK family of kinases is the chief 
regulator of the DDR (195, 196). ATM has an impressive list of cellular targets including 
proteins involved in DNA repair, cell cycle regulation, and cell death pathways (197). 
One of the critical events in ATM signaling is the phosphorylation of p53, a transcription 
factor that has broad transcriptional control over many cell survival and cell death 
effector proteins (198). Another well-characterized target is the histone H2A variant, 
H2AX, which is phosphorylated on its C-terminal tail at residue serine-139. 
Phosphorylated H2AX (commonly known as ϒ-H2AX) serves as a docking site nearby 
the DSB for repair factors to accumulate and form large foci (199, 200). H2AX 
phosphorylation often propagates kilo- to megabases from the initial damage site, making 
it easily observable by fluorescent microscopy, and is therefore commonly used as a 
marker for DSBs (199, 200). 
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The activation of ATM is dependent on both post-translational modifications and 
protein-protein interactions.  Several proteins are recruited to the DSB foci that are 
required for full ATM activation. Some of the first proteins recruited to the DSB are the 
Mre11-NBS1-Rad50 proteins (forming the MRN complex), which create a bridge 
spanning the DSB and play roles in both repair through HR and DDR signaling. The 
MRN complex activates ATM through an interaction with the NBS1 subunit, and this 
interaction is further stabilized through the activities of neighboring foci proteins, namely 
53BP1 and BRCA1 (195, 196). ATM activation is also mediated by the scaffolding 
protein, MDC1, which binds ϒ-H2AX and ATM, tethering ATM to the chromatin (195, 
196). ATM directs its own positive feedback loop by phosphorylating MDC1 and the 
MRN complex to recruit and activate further ATM molecules, greatly amplifying the 
signaling cascade. Additionally, ATM undergoes several phosphorylation and acetylation 
modifications, including the autophosphorylation of particular residues (most notably, 
serine 1981) that is essential for retention of ATM at DNA and prolonged DDR signaling 
(195, 196).  
1.5.3 Cell cycle checkpoints 
The eukaryotic cell cycle is divided into four phases: gap (G1), synthesis (S), G2 
and mitosis (M). During the G1 phase, the cell increases in size and begins synthesizing 
RNA and proteins. During the S phase, genomic DNA undergoes replication to produce 
an exact copy for the daughter cell. In G2, the cell continues to grow and produce enough 
energy for division into two. Finally, during mitosis, the cell divides chromosomes, 
separates into two daughter cells, and the cell cycle resumes. Cells that are not actively 
cycling through these four phases are said to be in G0, a state that they may remain in 
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transiently, or until their death. Cell cycle progression is largely controlled by the activity 
of cyclins and cyclin dependent kinases (CDKs). Cyclins, small proteins that are 
expressed and degraded in a coordinated matter as the cells transition between phases, 
bind and activate the CDKs to induce phosphorylation of a number of cell cycle 
regulatory proteins. The transition between each phase is tightly regulated and the cell 
must ensure that the integrity of its DNA is not compromised prior to moving onto the 
next phase, termed the G1/S, intra-S, G2/M or mitotic DNA damage checkpoints.  
The G1/S transition (Figure 1-5A) is mediated by the CyclinD/CDK4/6 complex, 
which phosphorylates a number of targets, including the Retinoblastoma protein (Rb), to 
ultimately relieve inhibition on cell cycle promoting E2F transcription factors (201). 
These factors create a positive feedback loop by promoting the activation of the 
CyclinE/CDK2 complex, which phosphorylates more Rb, to activate more E2Fs and 
drives transcription of genes required for the transition (201). The G1/S checkpoint is 
essential for preventing cells from initiating DNA synthesis with damaged DNA. It is 
initiated by the ATM-mediated phosphorylation of p53, the p53 inhibitor Mdm2, and the 
kinase Chk2. Activated p53 upregulates the CDK inhibitor p21, which binds and inhibits 
both the CyclinD/CDK4/6 and CyclinE/CDK2 complexes (201). In parallel, Chk2 
induces the degradation of the phosphatase CDC25a, thereby preventing the removal of 
inhibitory phosphates and maintaining an inactive CDK2 (201). This checkpoint is 
extremely sensitive and can be initiated by a single DSB (202-204). At low doses it 
functions to provide the cell with sufficient time for repair, which is estimated to be about 
6 hours for a 1 Gy dose, as measured by the kinetics of H2AX phosphorylation (202-
204).  
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Figure 1-5 DNA damage checkpoints. 
(A) The transition from the G1 to S phase (boxed) is initiated by Cyclin D/CDK4/6 
complex phosphorylation of the retinoblastoma protein (Rb), allowing the release of the 
bound E2F transcription factors. The E2Fs stimulate a positive feedback loop by 
initiating expression of the CyclinE/CDK2 complex, which phosphorylates more Rb, to 
increase the pool of E2Fs and induce expression of genes necessary for S phase. The 
G1/S DNA damage checkpoint is accomplished by two parallel mechanisms. (i) ATM 
phosphorylates Mdm2 to allow the release of the transcription factor p53, and also 
phosphorylates p53 to stimulate its transcriptional activity (activator phosphates in 
green). p53 induces the expression of the cell cycle inhibitor p21 which binds and 
inactivates both the CyclinD/CDK4/6 and CyclinE/CDK2 complexes. (ii) ATM 
phosphorylates to activate the kinase Chk2, which subsequently phosphorylates the 
phosphatase Cdc25a to trigger its degradation (inhibitory phosphates in red). Cdc25a is 
required to remove inhibitory phosphates from the CyclinE/CDK2 complex, and so its 
degradation keeps CyclinE/CDK2 in its inactive form. (B) The transition from the G2 to 
M phase (boxed) is triggerered by the activity of the CyclinB/CDK1 complex. Wee1 and 
Myt1 kinase dependent inhibitory phosphorylation keep this complex inactive, but 
activity of the Cdc25a phosphatase removes this inhibition to induce G2/M transition. 
The G2/M DNA damage checkpoint is achieved through two mechanisms similar to that 
of the G1/S checkpoint. (i) ATM dependent upregulation of p21 to directly bind and 
inhibit the CyclinB/CDK1 complex. (ii) ATM and Chk2 dependent degradation of the 
cdc25a phosphatase to prevent removal of inhibitory phosphates from the CyclinB/CDK1 
complex.  
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Mitotic entry at the G2/M transition (Figure 1-5B) is driven by the activities of the 
CyclinB/CDK1 complex. Prior to entry, the CyclinB/CDK1 complex is kept inactive by 
Wee1 and Myt1 kinase mediated phosphorylation, but this inhibition is relieved by the 
activities of the Cdc25 phosphatase. The G2/M checkpoint is initiated again through the 
ATM dependent activation of p53 and Chk kinases. Similar to the G1/S transition, p21 is 
upregulated to bind and inhibit the CyclinB/CDK1 complex, while Chk2 inactivates 
Cdc25 to prevent the removal of inhibitory phosphates (205, 206). This checkpoint is 
required to transiently arrest the cells to repair breaks occurring in G2 phase and prevent 
the entry into mitosis with DNA damage. This process occurs rapidly, however, it does 
not completely block progression, as there are several reports of cells still entering 
mitosis in the presense of 10-20 DSBs (207-209). 
Once the damage is repaired, cell cycle checkpoints are terminated and normal 
cycling can resume. Although the mechanisms governing the resolution of damage 
checkpoints are less well understood, it is known that the action of phosphatases play a 
large role (210, 211). Examples of phosphatases demonstrated to counteract the DDR 
activator kinases include Wip1, PP1, PP2A, PP4 and PP6, which remove the phosphates 
on substrates such as ATM, checkpoint kinases, H2AX and DNA repair proteins, 
rendering them inactive (212-216). The signaling pathways that drive the shift in balance 
towards phosphatase over kinase activity remain to be established.  
1.5.4 Senescence 
Senescence can be defined as irreversible growth arrest to prevent the 
proliferation of damaged cells (217). Senescent cells can be distinguished from other 
non-dividing cells, such as quiescent and terminally differentiated cells, by 
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morphological changes and the expression of several biomarkers. These include the 
expression of cell cycle inhibitors, the absence of proliferation markers, constitutive 
heterochromatin foci, and upregulation of the β-galactosidase enzyme (217). Initiation is 
marked by the activation of p53, leading to the upregulation of several CDK inhibitors, 
namely p16 (also known as INK4A), p15 (INK4B), p21 (WAF1) and p27, and promoting 
the hypophosphorylation of the tumor suppressor Rb (198, 217, 218).  
It is unclear what mechanisms induce senescence as opposed to transient cell 
cycle arrest, as they are initiated by the same mechanisms, such as the p53-p21 and p16-
Rb pathways (217, 218). It is possible that the quick repair of DNA damage shuts down 
signaling, whereas slow or incomplete repair results in prolonged signaling and an 
eventual senescence phenotype. There is evidence that fibroblasts that have fully 
activated the p16-Rb pathway are unable to resume growth, even after the inactivation of 
p16, Rb and p53, indicating there is a point of no return in senescence activation, 
however this point remains to be elucidated (219). 
1.5.5 Apoptosis 
The most drastic response to overwhelming DNA damage is the initiation of 
programmed cell death, termed apoptosis. Apoptosis is a tightly regulated cascade, 
triggered by either external (extrinsic pathway) or internal (intrinsic pathway) stimuli, 
that converges upon a family of cysteine proteases (caspases) to cleave a broad range of 
intracellular proteins and induce cell death (218, 220). Morphologically, this process 
results in cellular shrinkage, chromatin condensation and fragmentation, membrane 
blebbing and the formation of apoptotic bodies (220).  
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The intrinsic apoptotic pathway mediates cell death in response to cellular 
stresses, including DNA damage. The transcription factor p53 is a main regulator of this 
process, and is activated following damage to transcriptionally upregulate genes encoding 
apoptotic effectors (198, 220). Main targets of p53 in include the Bcl-2 family of 
proteins, comprised of multidomain and BH3 domain-only members that regulate the 
mitochondrial membrane permeability. Upon stimulus of the intrinsic pathway, p53 
upregulates the pro-apoptotic Bcl-2 member, Bax, which induces mitochondrial 
membrane permeability and allows the release of cytochrome c. This triggers the 
activation of the intiator caspase, caspase 3, that in turn, cleaves to activate the effector 
caspase, caspase 9, which is responsible for cleaving proteins involved in cell growth and 
maintenance and ultimately causing cell death (218, 220). 
There are additional p53-independent signaling cascades that are activated by 
DNA damage and contribute to apoptosis. The JNK kinases (JNK1 and JNK2) are stress-
induced kinases that execute its pro-apoptotic functions primarily through the activation 
of the c-Jun, AP-1, and activating transcription factor 2 (ATF2) transcription factors 
(221). Similarly, the mitogen activated protein kinase (MAPK) family member p38 is 
often induced after DNA damage and upregulates the activities of ATF2, ATF3, cAMP 
response element-binding protein (CREB) and C/EBP homologous protein (CHOP) 
transcription factors (222). These transcription factors will subsequently regulate the 
expression of vast array of proteins, including those of the Bcl-2 family, to promote cell 
death (221, 222).  
1.5.6 Ku in the DDR 
There is some evidence that Ku is involved in the modulation of ATM activity 
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following DNA damage. Ku appears to prevent ATM-dependent ATR activation, perhaps 
acting as a signaling block to the HR pathway (223). Furthermore, Ku80 null cells were 
shown to have increased S phase inhibition after DNA damage due to increased ATM 
activity (224). We identified a specific residue in Ku70’s vWA domain, serine 155, that 
when mutated to alanine results in decreased DNA damage signaling and apoptotic 
activation after IR, despite having no impact on Ku’s ability to function in C-NHEJ (22). 
These results suggest that in addition to its essential role in DNA repair, modification of 
Ku also signals to the ATM dependent DDR cascade to regulate cell fate after DNA 
damage. This is not entirely surprising as several other DNA repair factors (ex. Mre11), 
have functions in both DNA repair as well as the DNA damage signaling cascade (225). 
It is possible that Ku also has a dual role in the DNA damage response, first promoting 
the repair by NHEJ, as well as relaying signals as to the completion, or lack thereof, of 
DNA repair. 
 In addition to its impact on upstream DDR signaling, a number of studies have 
implicated Ku70 as a direct inhibitor of apoptosis, through the binding and inhibition of 
the pro-apoptotic factor Bax (226, 227). This interaction is proposed to be modulated by 
various mechanisms, including protein-protein interactions and post-translational 
modification of Ku. Some examples of protein interactions include the binding of Ku70 
to NBS1 and a cleavage product of cyclin E, both of which were suggested to inhibit the 
binding of Ku70 to Bax and promote apoptosis (228, 229). The acetylation of Ku70 is 
also suggested to negatively regulate the Ku70-Bax interaction. Ku70 is acetylated in the 
C-terminal linker domain on eight lysine residues between K539 and K556 and alanine 
substitution of these residues decreased Bax-dependent apoptotic activation (31). This 
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acetylation is mediated by CREB-binding protein (CBP) and P300/CBP-associated factor 
(PCAF) while deacetylation is controlled by histone deacetylase (HDAC) and sirtuin 
(SIRT) deacetylase enzymes (31, 230, 231). There is some evidence that Ku may have 
deubiquitination activity, as it has been proposed to promote the deubuquitination of Bax, 
and another anti-apoptotic regulator of Bax, Mcl-1 (226, 232). Overall, there are several 
unanswered questions regarding the interaction with Ku70 and Bax. Many studies have 
suggested that this interaction occurs in the absence of Ku80, despite the fact that there is 
little evidence that the Ku subunits exist as monomers. Furthermore, Ku is predominantly 
a nuclear protein but Bax is largely cytoplasmic in its inactive form and then translocates 
to the mitochondria during apoptotic activation (233). The regulatory mechanisms that 
would allow a subset of Ku70 monomers to remain in the cytoplasm bound to Bax 
remain to be elucidated.   
1.5.7 Aurora Kinases 
The Aurora kinases are a family of serine/threonine kinases with a well-
established role in promoting cell cycle progression (234). Mammalian genomes encode 
for three members, Aurora A, B and C, which differ in their size, function and subcellular 
localization. All members can be divided into three general domains: a well conserved 
central catalytic domain, C-terminal region containing a D-box motif required for 
degradation, and a diverse N-terminal region largely utilized as a regulatory domain 
(234). Aurora A and B are most similar in their structure and ubiquitous expression 
pattern, however their cellular roles vary due to their differing localization. Aurora A 
promotes mitotic entry and spindle assembly, while Aurora B is involved in the spindle 
assembly checkpoint, kinetochore attachment, chromatin modification and cytokinesis 
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(234). Although their roles in mitosis are well described, increasing evidence suggests 
that the both Aurora A and B also participate in the G1/S and G2/M transitions (235, 
236). These proteins are often found upregulated in cancers and have subsequently 
become the target of several small molecule inhibitors to utilize in cancer treatment (237, 
238).  
The regulation of aurora kinases is tightly controlled by a number of different 
mechanisms. Ultimately, the activation is achieved through the autophosphorylation of a 
threonine residue in the activation loop of the catalytic domain. However, many 
activating cofactors are involved that bind either the catalytic domain or the N-terminal 
regulatory region and allow for the specific activation of kinase activity at the correct cell 
cycle phase and subcellular localization (239). Aurora B is the catalytic member of the 
mitotic chromosomal passenger complex (CPC) and requires the binding of the other 
regulatory complex members (INCENP, Survivin and Borealin/Dasra B) for full 
activation and localization to the centromere (240). Protein binding either induces 
conformational changes in Aurora to promote catalytic activation, or the regulatory 
subunits promote Aurora B clustering and subsequent autoactivation. Cofactors also bind 
and inhibit Aurora activity, such as the PP1 and PP2A phosphatases, that remove 
activating phosphatases to render it inactive (241, 242).  
Not surprisingly, as kinases that promote cell cycle progression, Aurora kinases 
are found inhibited after the introduction of DNA damage (243, 244). Emerging evidence 
suggests that this regulation is due to interactions with DDR and DNA repair factors. 
Aurora B has been shown to interact with, and be inhibited by, the A-NHEJ factor PARP-
1, while the HR factor BRCA2 has been demonstrated to promote Aurora B degradation 
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(244, 245). There are also indications of a reciprocal regulation of DDR factors by 
Aurora kinases. Aurora B has been shown to phosphorylate ATM, while Aurora A 
regulates BRCA1 and p53. Overall, given the strong interest in targeting Aurora kinases 
for cancer treatment, a clearer understanding of how Aurora kinases are regulated after 
DNA damage is required.  
1.6 Ku in Disease 
1.6.1 Immune system disorders 
The vertebrate immune system utilizes Ku and C-NHEJ to repair physiological 
DSBs generated to create immune system genetic diversity. Recombination of the V, D, 
and J segments of immunoglobulins (Ig) in lymphoid cells and class switch 
recombination of the T-cell receptor genes in mature T cells allows for the recognition of 
a wide variety antigens, which results in an adaptive immune response (246). The exons 
of the Ig genes are flanked by recombination-signal sequences that are recognized by the 
recombination-activating gene (RAG) complex to produce a blunt ended DSB at the 
signal sequence and a closed hairpin at the coding sequence. This structure is then 
processed and resolved by the C-NHEJ machinery (246).  
 Ku70 and Ku80 knockout mice display many immune system abnormalities 
including B cell developmental arrest, T cell arrest, and failed lymphocyte differentiation 
following γ-irradiation (67, 247-249). Humans and mice suffering from genetic defects in 
V(D)J recombination present with a severe combined immunodeficiency (SCID) 
phenotype resulting in severe infections and poor prognosis. There are several 
characterized human disorders with various degree of SCID phenotype that have been 
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linked to mutations in NHEJ factors, such as DNA Ligase IV, Artemis, and XLF, as well 
as the other DSB repair pathway and DDR factors (250-253). Interestingly, only a few 
individuals have been reported to have genetic defects in the DNA-PK complex, 
however, all presented mutations occurred in the DNA-PKCS subunit, and thus far, no 
disorder linked to Ku mutations has been identified (254, 255). It is currently unknown 
whether mutations in Ku are better tolerated in humans, or in the contrary, whether 
deleterious Ku mutations are lethal in humans. 
1.6.2 Aging 
Aging is the progressive degeneration that occurs at the cellular and organismal 
level. One of the observed phenotypes of Ku deficient mice is increased aging and 
senescence (249, 256-258). Mice deficient in one Ku subunit have one-third the lifespan 
of their wildtype counterparts, partially in due to an early onset of the phenotypic 
symptoms of aging (259). There is evidence that C-NHEJ declines during the aging 
process, with lower efficiency observed in aging rodents, and in Alzheimer’s patients, so 
the loss of NHEJ in Ku deficient mice could be contributing to the aging process (260-
262). Furthermore, as previously described, Ku deficient mice and cells exhibit shortened 
telomeres as well as other telomere abnormalities. Shortened telomeres have been linked 
to increased aging and senescence, due to increased genomic instability leading to cell 
cycle arrest, so this could also be contributing to the aging phenotype observed in Ku-
deficient mice (263, 264). 
1.6.3 Cancer 
A common characteristic amongst human tumors is genomic instability (265). 
Cells defective in DSB repair are predisposed to chromosome translocations and gene 
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amplifications, potentially leading to the activation of oncogenes and tumourigenesis. 
Through its role in C-NHEJ, Ku functions as a cancer caretaker gene, promoting genomic 
integrity and preventing tumourigenesis. Ku knockout mice show increased chromosomal 
breakage, translocations and aneuploidy (249, 256, 258, 259). These mice display slightly 
increased cancer incidence as compared to controls, however this is mostly restricted to 
lymphomas (249, 256, 258, 259). Together with a p53 deficiency that impairs control of 
proliferation, Ku80 deficient mice show early onset tumour formation and further 
increased incidence of T and B cell lymphomas (68). This suggests that Ku mutations can 
be oncogenic when accompanied by a mutation in a tumor suppressor gene.  
The expression of Ku has been frequently found deregulated in tumour samples 
and its expression level has been proposed as a marker of predicting patient response to 
radiation therapy and survival (266-271). The exploitation of genetic defects in DNA 
repair and DDR factors have long been employed in cancer treatment (272). As 
previously mentioned, Ku and DNA-PKCS deficient cell lines are sensitive to radiation 
and chemotherapeutic drugs, and therefore would make them potential druggable targets 
in cancer treatment. There are a few examples of strategies to target Ku specifically, 
including a subunit dimerization interference using a peptide, downregulation by RNAi 
and small molecule inhibition (273-276). The therapeutic potential of targeting the 
Ku70/Bax interaction to activate apoptosis in cancer has been explored through creation 
of Bax inhibiting peptides derived from the Ku70 sequence and promoting Ku70 
acetylation in vivo through deacetylase inhibitors (277-279). A more commonly 
employed strategy to target the DNA-PK complex however, is to modulate the kinase 
activity of DNA-PKCS with small molecular inhibitors, as DNA-PKCS expression is 
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frequently found upregulated in tumours (280).  
1.7 Scope of thesis 
The cellular response to DSBs is a tightly controlled process with the ultimate 
goal of repairing the DNA damage, but also protecting the overall health of the organism. 
Amongst proteins involved in the DDR, there are several examples of DNA repair 
proteins performing dual roles in both repair and maintaining the signaling cascade. For 
example, the MRN complex has a mechanistic role in the HR DSB repair pathway, but 
also is integral for the activation and propagation of ATM signaling. We have identified a 
similar role Ku, which has a well-established role as the DNA binding component of the 
NHEJ repair pathway, and for which we now propose a novel role for Ku in the signaling 
to DDR in the case of unsuccessful DNA repair.  
The focus of this work is the Ku70 vWA domain, a conserved protein-protein 
interaction domain, for which the function in DNA repair has remained uncertain. We 
begin by investigating the requirement for different regions of the Ku70 vWA domain in 
response to IR (Chapter 2). We show that helix 5, particularly the residues D192/D195, 
are integral for Ku’s DNA repair function. Mutation of these residues severely 
compromises cell survival in response to IR and dramatically decreases DNA repair 
efficiency. In contrast, the loop region between helix 4 and 5, particularly the residue 
S155, is required for activation of the DDR after IR. Substitution of this residue to 
alanine surprisingly increased survival in response to IR. Further analysis indicated that 
mutation of this residue conferred decreased activation of DDR signaling markers and 
apoptosis, indicating that mutation of this residue was preventing the DDR from 
signaling to the apoptotic machinery. Overall, this chapter established an important role 
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for the Ku70 vWA domain in the response to DSBs. 
Next, we went on to further characterize the role of S155 in the DDR (Chapter 3). 
We hypothesized that this residue was a phosphorylation site and used mass spectrometry 
analyses to observe phosphorylation after IR. Expression of a phosphomimetic 
substitution at this site, S155D, induced constitutive activation of DDR and cell cycle 
arrest at both the G1/S and G2/M checkpoints. Through a general screen of interacting 
factors, we identified the region surrounding S155 as contributing to the binding and 
inhibition of the cell cycle kinase Aurora B. In wild type cells, we determined that Ku 
does not bind Aurora B constitutively, but after IR, they complex to inhibit Aurora B 
activity and induce cell cycle arrest. Altogether, we have characterized a novel 
phosphorylation event in the Ku70 vWA domain that relays DNA repair signals to the 
DDR to carry out cell fate decisions.  
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Chapter 2  
 
2 Ku regulates DNA repair and the DNA damage 
response through the Ku70 vWA domain 
2.1 Introduction 
One of the most dangerous forms of DNA damage is the DNA double-strand break 
(DSB), which can lead to aberrant genomic rearrangement if not repaired properly (1, 2). 
In eukaryotic cells, DSBs trigger signaling pathways that induce cell cycle checkpoints 
and alter gene transcription allowing DNA integrity to be re-established through the 
action of repair complexes (3-6). 
The DNA damage response (DDR) pathway is initiated by a phosphorylation cascade 
that triggers chromatin modifications which enhance accessibility of the broken DNA to 
repair factors and promote the subsequent accumulation of DDR factors into foci at the 
site of damage (4, 7). The Mre11-Rad50-NBS1 (MRN) complex immediately binds the 
DSB, independently of other factors (8), functioning to recruit the serine/threonine (S/T) 
phosphoinositide-3-kinase (PI3K) family member ATM (Ataxia Telangiectasia Mutated), 
an essential regulator of the DNA damage response that is responsible for many 
phosphorylation events at the site of DNA damage (9, 10). An important signal 
amplification step involves the ATM phosphorylation of the histone variant H2AX to 
create a platform to which other DDR proteins are able to bind (11). ATM activates 
signaling cascades that trigger the activation of cell cycle checkpoints leading to cell 
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cycle arrest through phosphorylation of several substrates including p53, MDC1, BRCA1, 
Chk1 and Chk2. ATM also contributes to the establishment of apoptotic pathways (9).  
Two main pathways function to repair DSBs, homologous recombination (HR) which 
uses a homologous chromosome or sister chromatid as template to repair the broken 
DNA, and non-homologous end-joining (NHEJ), which simply re-ligates the two broken 
ends together (2). In mammals, NHEJ is the predominant DSB repair pathway, 
functioning throughout the cell cycle, and exclusive to the G1 and S phases (12, 13). 
NHEJ also mediates the rejoining of programmed breaks generated in V(D)J 
recombination during B and T cell maturation (12, 13). NHEJ can be subdivided into two 
sub-pathways, the core or “classical” NHEJ pathway (C-NHEJ) which represents the 
main end-joining activity in the cell, and “alternative” NHEJ activities (A-NHEJ) 
consisting of microhomology-mediated repair that function as backup pathway(s) to join 
DSBs (2, 12, 14).  
The C-NHEJ complex in higher eukaryotic cells consists of DNA-dependent protein 
kinase (DNA-PK), composed of the Ku heterodimer and DNA-PK catalytic subunit 
(DNA-PKcs), Artemis, a DNA processing enzyme, a DNA ligase complex, 
XRCC4/DNA ligase IV and a recently identified factor called Cernunnos-XLF (12, 13, 
15). Other accessory factors, including polynucleotide kinase (PNK) and DNA 
polymerases µ and λ have been implicated in some aspects of C-NHEJ (12, 13).  
Ku is the DNA-binding component of the C-NHEJ repair machinery. Upon 
recognition and binding to the broken DNA end Ku recruits DNA-PKcs to form the 
active protein kinase complex DNA-PK (12, 13). DNA-PKcs is a large (p450) S/T kinase 
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that is a member of the PI3K kinase group that includes ATM, ATM-related (ATR) and 
mammalian target of rapamycin (mTOR) (16-18). The importance of DNA-PK in 
maintaining genomic integrity is underscored by the profound immunodeficiency, 
radiosensitivity and prevalence of tumours in mice lacking any of the 3 subunits (19-22). 
However, DNA-PKcs knockout mice display milder defects than Ku-/- mice, suggesting 
that Ku has additional functions independent of DNA-PKcs (22, 23). Besides DNA end 
recognition, Ku appears to protect broken DNA from aberrant nucleolytic processing 
(24). Ku has also been shown to bind to telomeres and to function in telomere 
maintenance, notably by anchoring telomeres to the nuclear periphery, contributing to 
telomeric silencing and preventing telomere shortening (24, 25) . 
In addition to its main function in DNA repair, several reports have suggested that 
DNA-PK may also be involved in signaling to regulate specific aspects of the DDR. 
DNA-PK participates in replication protein-A2 (RP-A2) and nuclear factor-κB (NF-κB) 
phosphorylation in response to DNA damage and also contributes to the modification of 
histone H2AX (reviewed in (17, 26)). Roles for Ku in signaling to the apoptotic 
machinery have also been documented (17).  
Aside from a recently identified end-processing activity (27), much of Ku’s function 
appears to be mediated by protein-protein interactions with other factors. A number of 
proteins interact with Ku, including C-NHEJ core proteins and factors implicated in the 
DDR, in telomere maintenance, transcription and replication (26, 28). Within the 
mammalian C-NHEJ complex, interaction of Ku with XRCC4/DNA ligase IV is required 
to recruit the complex to DNA and to stimulate the ligase activity (29, 30). Yeast Ku also 
interacts with factors of the RSC complex that mediates ATP-dependent chromatin 
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remodelling in yeast (31). Interaction with DNA repair and damage-response factors 
Mre11, Werner and PARP have also been documented (26, 28).  
Ku is a heterodimer of two proteins, Ku70 and Ku80 that form a complex that is 
conserved throughout evolution both structurally and functionally (24, 28, 32, 33). Ku 
homologs are found from bacteria to man (33). The two subunits of Ku in eukaryotes 
feature three structurally similar domains: an amino-terminal α/β domain, a central β-
barrel domain and a α-helical carboxy-terminal arm that come together in the 
heterodimer to form a quasi-symmetrical ring structure that envelopes up to two helical 
turns of DNA end as seen in the crystal structure (32). The Ku70 carboxy-terminal 
domain sequence shows similarities with SAP domains that are involved in DNA binding 
(32, 34), whereas the Ku80 C-terminal domain, forms a globular structure with similarity 
to protein domains involved in protein-protein interactions (35, 36). The amino-terminal 
domains of Ku70 and Ku80 (α/β domains (32)) share similarity with von Willebrand 
factor A (vWA), a domain that mediates protein-protein interactions (32, 33, 37). The 
vWA domains of Ku fall into the “ancient conserved vWA proteins” that comprises a 
group of evolutionarily conserved intracellular proteins (37). However, while Ku 
interacts with many proteins, few have been mapped to the vWA domains (13, 24, 26, 
28). Site directed mutagenesis of the Saccharomyces cerevisiae YKU80 and YKU70 genes 
identified that α-helices on the surface of the vWA domain confer different Ku functions 
(38). The Yku80 α-helix 5 is critical for telomeric functions, while Yku70 α-helix 5 is 
required for C-NHEJ. This likely results from differences in the orientation of the two 
vWA domains, the Ku70 vWA domain facing outwards in close proximity to the DNA 
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end, whereas the Ku80 vWA domain faces inwards, thus facilitating telomeric functions 
(32, 38).  
In mammals, very little is known about the precise function of the Ku70/Ku80 N-
terminal vWA domains. In this study, we introduced point mutations in various regions 
of the Ku70 vWA domain with the intent of identifying structural determinants that direct 
Ku function in response to DNA damage (Fig. 1). Mutation of Ku70 vWA α-helix 5 
residues (D192A/D195R) resulted in a sharp decrease in survival. These substitutions, 
previously shown to confer a DNA repair defect in yeast (38), markedly impaired the 
DNA repair function of Ku in mouse embryonic fibroblasts (MEFs), suggesting that the 
function of these residues is conserved between yeast and mammals. Unexpectedly, the 
mutagenesis of residues adjacent to α-helix 4 (S155A/D156A) resulted in increased 
survival following ionizing radiation (IR) treatment. C-NHEJ appeared unaffected, but a 
marked decrease in the activation of apoptosis and alterations in the DNA damage 
signaling response as well as in the transcriptional profile of gene expression following 
DNA damage were identified. In particular, this mutation affected an activating 
transcription factor 2 (ATF2)-dependent transcriptional pathway that modulates several 
genes implicated in the activation of apoptosis. The D192A/D195R survival defect was 
rescued by introducing the S155A/D156A substitution, inferring that separate regions of 
the Ku70 vWA domain confer two different Ku functions in response to DNA damage. 
Further, S155 was identified as the critical residue regulating cell survival. Thus, 
importantly, the defects resulting from these mutations suggest that the N-terminal vWA 
domain of Ku70 is implicated in the activation of apoptotic pathways by linking signals 
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of DNA repair completion (or lack thereof) to the signaling machinery that controls the 
activation of cell death pathways. 
2.2 Material and Methods 
2.2.1 Plasmid expression constructs 
Ku70 human cDNA was cloned from the BamHI site in pEGFP Ku70 (39) into the 
HpaI site of pMSCVpuro retroviral vector (Clontech). Ku70 point mutations were 
introduced by site directed mutagenesis using Pfu polymerase (Stratagene) with primers 
bearing the targeted point mutations (primers are listed in Table S3 in the supplemental 
material). All mutations were confirmed by sequencing. pGL3-Promoter and pRL-SV40 
plasmids are from Promega. 
2.2.2 Cell culture treatments 
Ku70-/- MEFs were obtained from S. Matsuyama (Case Western, Cleveland (40)). All 
cells were cultured in high glucose Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) at 37°C in 5% CO2.  
pMSCV vectors containing wild-type and mutant Ku70, as well as the empty 
pMSCVpuro vector were transfected via calcium phosphate into the Phoenix Ampho 
retroviral packaging cell line. The media-containing virus was collected 48 hours later 
and used to infect Ku70-/- MEFs. Twenty-four hours post infection the media was 
replaced with 2.5µg/ml puromycin containing media to select and maintain cells infected 
with the pMSCV vector. Cells were maintained as a pool for all subsequent experiments.  
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For irradiation experiments, cells were plated the night before at 50-70% confluency. 
Irradiations were performed with a Faxitron RX-650 at a dose rate of 1.42 Gy/min. 
2.2.3 Extracts and western blot analyses 
Whole cell extracts were prepared as described (41). Nuclear Extracts were prepared 
as described (42). For Western blot analysis, extracts were resolved by SDS PAGE 
(either 8% or 10%), transferred onto a PVDF membrane and hybridized with the 
following antibodies:, Ku70 (N3H10, Neomarkers), Ku80 (M-20, Santa Cruz), β-actin (I-
19, Santa Cruz), GADD153/CHOP (F-168, Santa Cruz), ATF3 (C-19, Santa Cruz), 
PCNA (clone PC-10, Millipore), 69/71 phospho ATF2 (Cell Signaling), ATF2 (N-96, 
Santa Cruz).  
2.2.4 Clonogenic survival assays 
Cells were plated in triplicate at single cell density, irradiated 6 hours later at various 
doses of IR and then incubated for 7 days. The plates were washed with PBS and stained 
with 0.5% crystal violet in 20% methanol. Colonies were counted and survival was 
assessed by calculating the ratio of colony number on the irradiated plates over the 
unirradiated controls.  
2.2.5 Caspase assays 
Cell extracts were prepared in Lysis buffer (1mM KCl, 10mM HEPES (pH 7.4), 
1.5mM MgCl2, 1mM DTT, 1mM PMSF, 5µg/ml leupeptin, 2µg/ml aprotinin, and 10% 
glycerol). Caspase activity was measured in caspase assay buffer (25 mM HEPES, pH 
7.4, 10 mM DTT, 10% sucrose, 0.1% CHAPS containing 10 µM caspase-3 substrate, N-
acetyl-Asp-Glu-Val-Asp-(7-amino-4trifluoromethyl-coumarin) (DEVD-AFC, BIOMOL 
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International)). The fluorescence produced by DEVD-AFC cleavage was measured on a 
SpectraMax M5 fluorimeter (excitation 400 nm, emission 505 nm) over a 2 h interval. 
Caspase activity was calculated as the ratio of the fluorescence output in treated samples 
relative to corresponding untreated controls.  
2.2.6 Pulsed-field gel electrophoresis 
One day prior to irradiation, 3.5 million cells were seeded onto a 10 cm plate. 
Following 40 Gy of IR or mock treatment, cells were harvested into agarose plugs using 
the Bio-Rad CHEF Genomic DNA Plug Kit. Agarose plugs were run on a 0.8% gel using 
the Bio-Rad CHEF-DR II system (200-500s switch time, 120° angle, 3V/cm, 48 hours). 
The gels were stained with ethidium bromide, images captured using a BioRad 
ChemiDoc and ImageLab software and staining was quantified using ImageJ. The 
fraction released (fraction of activity released, FAR) corresponding to unrepaired DNA 
was calculated by calculating the ratio of the DNA migrating below the plug over the 
total DNA loaded (DNA remaining in the plug and fraction entering the gel). 
2.2.7 Plasmid repair luciferase assays 
The pGL3-Promoter luciferase reporter plasmid was digested with Bgl II, which cuts 
between the promoter and the luciferase coding region. pMSCV infected MEFs were 
transfected with 750 ng of linearized PGL3-Promoter and 5 ng of pRL-SV40 in 12 well 
plates using Fugene6 (Roche) following the manufacturer’s instructions. Forty-eight 
hours post transfection the cells were harvested in 0.3 ml 1x passive lysis buffer 
(Promega) and luciferase assays were performed with 30 µl of extract with the Promega 
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Dual-Luciferase Reporter Assay System (50 µl of both LAR II and Stop & Glo® 
reagents) using an Orion II luminometer (Titertek-Berthold).  
2.2.8 Immunofluorescence 
One day prior to irradiation, cells were seeded at 60-80% confluence on 10 mm 
glass coverslips. At the given time points post irradiation, cells were washed in cold PBS 
and fixed in 3% paraformaldehyde. Cells were permeabilized in 0.5% Triton-X and 
blocked in 5% FBS, followed by incubation with the primary antibodies, either phospho-
serine 139 H2AX antibody (20E3, Cell Signaling) or ATF2 (C-19, Santa Cruz), or 69/71 
phospho ATF2 (Cell Signaling). Slides were then incubated with an anti-rabbit Alexa 497 
secondary antibody (Invitrogen). Coverslips were mounted onto glass slides using 
ProLong Gold containing DAPI (Invitrogen). Cell pictures were taken with an Olympus 
BX51 microscope at 40x magnification and the Image-Pro Plus software (Media 
Cybernetics, Inc.). For g-H2AX and phospho-ATF2, pixel density was measured with 
ImageJ software and used as a measure of foci content per picture. DAPI nuclei staining 
were used for cell counting and the pixel density was averaged per cell for approximately 
500 cells. For quantification of ATF2 foci, all pictures were set to an equal contrast 
threshold on ImageJ and cells were scored positive if containing at least one focus.   
2.2.9 Reverse transcriptase (RT-qPCR) 
Total RNA was isolated using the Qiagen RNeasy RNA Extraction kit. RNA (2 µg) 
was reverse transcribed with the Superscript II cDNA kit (Invitrogen). Quantitative PCR 
was performed using Bio-Rad MyiQ single-colour real-time PCR detection and Bio-Rad 
IQ SYBR green mix. Primers are listed in Table S3 in the supplemental material. Relative 
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quantification of specific gene expression was determined by the ΔΔC(t) method, with 
the target gene C(t) values normalized to that of the beta-2-microglobulin control. Change 
of gene expression in irradiated samples was calculated relative to the unirradiated 
controls.  
2.2.10 Sequence alignments 
Sequences were obtained from the NCBI database and aligned using MUSCLE 
software (43). Percent identity calculations were performed using Jalview software. 
2.2.11 Statistical analyses 
Differences between two groups were compared using an unpaired two-tailed t-
test and analysis of variance (ANOVA) was used when comparing multiple groups. 
Results were considered significant when P<0.05. 
 
2.3 Results 
2.3.1 Identification of Ku70 mutations that impair survival in 
response to IR 
In order to investigate the contribution of the Ku70 vWA domain in Ku70’s function 
in the response to DSBs, several point mutations were produced in the human Ku70 vWA 
domain. These mutations targeted residues located on the solvent exposed surface of the 
protein and showing various degrees of conservation across Ku70 homologs (Figure 2-1). 
For instance, residues in Ku70 α-helix 5 previously involved in DNA repair in yeast are 
fairly well conserved (Figure 2-1A) (38). In contrast, α-helix 3 is much less conserved 
(Figure 2-1A). We produced five different Ku70 mutations: two mutations in α-helix 3,  
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Figure 2-1 Generation of Ku70 vWA domain mutants 
(A) Sequence alignment of the Ku70 N-terminal vWA domain (α-helices 3 to 5) from a 
selection of Ku70 eukaryotic homologs. The position of the vWA domain α-helices is 
indicated at the top. Conservation between species of the residues within α-helices 3 to 5 
is highlighted according to percent identity (PID) (light grey >40%, dark grey >60%, and 
black >80% PID). The residues mutated in this study are boxed and the substitutions 
introduced are indicated below the alignments.  (B)  Space-filling representations of the 
human Ku dimer structure bound to DNA (32) (PDB ID: IJEY depicted in PyMol). Top, 
front view of the Ku dimer (facing the DNA end). The Ku70 vWA domain E145/W148, 
S155/D156 and D192/D195 residues are highlighted in black and their position is 
indicated. DNA is represented as a black helix.  Below, side view of the Ku dimer (DNA 
end to the left). The position of the Ku70 vWa domain K114/L117 and K129/D133 
residues is shown. 
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one in α-helix 4, one in α-helix 5, and one in a loop region bordering α-helix 4 
(S155A/D156A) (Figure 2-1B). At each location, we substituted 2 amino acids to 
maximize the likelihood of disrupting a protein interacting surface. Wild-type human 
Ku70 as well as the various mutant human Ku70 cDNAs were stably introduced into 
Ku70-/- immortalized MEFs via a murine stem cell virus construct. To determine whether 
the mutations interfered with Ku’s function in response to IR, we measured the 
radiosensitivity of MEFs expressing wild-type or mutant Ku70 at various doses of IR 
(between 2 and 10 Gy) using a clonogenic assay. Cells lacking Ku70 are severely 
deficient in DSB repair and therefore have very low survival following treatment with IR 
(44). Consistent with previous reports (44, 45), the re-expression of human Ku70 in the 
Ku70-/- MEFs restored wild-type MEF survival in response to IR (Figure 2-2A). Western 
blot analyses indicated that the level of Ku70 restored was similar to that in wild-type 
cells (Supplementary Figure 2-1). Also, we verified that the expression of Ku80, which is 
reduced to undetectable levels in the absence of the Ku70 subunit was re-established 
upon expression of the human Ku70 construct (Figure 2-2D and 2-3D).  
MEFs expressing α-helix 3 and α-helix 4 Ku70 mutant constructs produced survival 
curves not significantly different from wild-type, therefore suggesting that these 
substitutions do not interfere with Ku’s role in response to IR (Supplementary Figure 2- 
2). An α-helix 5 mutation (D192A/D195R) was designed based on the previously 
identified DNA repair defect associated with the mutation of the corresponding residues in 
yeast Ku70 (38). The Ku70 D192A/D195R expressing cells showed a dramatic decrease 
in survival following IR treatment, displaying a survival curve that more closely  
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Figure 2-2 Analysis of cell survival properties of Ku70−/− MEFs expressing Ku70 
bearing substitutions in the N-terminal vWA domain.  
 (A)  Re-expression of human wild-type Ku70 via retroviral infection restores wild-type 
survival levels of MEFs following ionizing radiation. Clonogenic survival of MEFs wild-
type (Ku70+/+), Ku70-deficient (Ku70-/-) or Ku70-/- expressing empty vector (pMSCV) or 
Ku70 cDNA (Ku70 pMSCV) was tested at the IR doses indicated. Results are the means 
of three separate experiments performed in triplicate with error bars representing the 
standard deviation (SD). Error bars are included for all data points but may not be visible 
when smaller than symbol size.  (B)  Ku70-/- MEFs expressing Ku70 mutant bearing 
substitutions D192A/D195R exhibit radiation sensitivity. Clonogenic assay was done as 
in A with Ku70-/- MEFs expressing Ku70 wild-type (WT), Ku70 with substitutions 
(D192A/D195R) or empty vector (pMSCV).  (C)  MEFs expressing Ku70 with 
S155A/D156A substitutions show increased survival following IR. Clonogenic assay 
results are presented as in A. Error bars represent the SD.  (D)  Representative western 
blot analysis of Ku70-/- MEFs or Ku70-/- MEFs expressing wild-type Ku70 (WT) and 
Ku70 S155A/D156A. The blot was analyzed with antibodies to Ku80, Ku70 and PCNA, 
as indicated. The star (*) indicates the position of a non-specific band migrating above 
Ku80.  
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matched that of the Ku70-/- cells than that of wild-type (Figure 2-2B). For example at 4 
Gy, 34% of Ku70 wild-type expressing MEFs formed colonies, versus 4.5% of cells 
expressing empty vector and 10% of Ku70 D192A/D195. At 6 Gy, 20% of wild-type 
cells survived versus 4% in Ku70 D192A/D195R and 1.5% in cells expressing empty 
vector. This suggests that these residues may be functionally conserved between yeast 
and human. Intriguingly, a Ku70 mutant bearing alanine substitutions of residues S155 
and D156 located in a loop region between α-helices 4 and 5 consistently conferred a 40-
50% increase in survival compared to wild-type (at 4 Gy, 60% versus 33% and at 6 Gy, 
30% versus 19%, Figure 2-2C). This was unexpected, and as the expression of this 
mutant was similar to that of Ku70 wild-type (Figure 2-2D), suggested that the mutation 
enhanced viability in response to IR.  
2.3.2 S155A/D156A does not affect DNA repair efficiency 
Since Ku’s prominent documented function is to recruit DNA repair factors to DSBs 
and promote C-NHEJ, we first considered the possibility that the increase in survival 
conferred by the Ku S155A/D156A mutant was due to an improved capacity for DNA 
repair. To test this possibility, we employed pulsed-field gel electrophoresis (PFGE) to 
analyze DNA repair. The analysis was performed with samples processed immediately 
following IR, to measure the total amount of genomic DNA breakage, 2 hours later, when 
DNA repair is on-going and then 6 hours after IR treatment, at which time most DNA 
breaks are already repaired (46, 47). Comparison of Ku70 wild-type and Ku70 
S155A/D156A mutant cells revealed no significant differences in their abilities to repair 
genomic DNA damaged by IR (Figure 2-3A). To confirm this result, an in vivo plasmid 
repair assay was employed, which measures the cell’s ability to recircularize a transfected 
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Figure 2-3 The Ku70 S155A/D156A mutation does not affect DNA repair.  
(A) The S155A/D156A mutation does not interfere with the repair of IR induced 
genomic DNA damage. PFGE analysis of genomic DNA from Ku70-/- MEFs expressing 
Ku70 wild-type (WT), Ku70 S155A/D156A or empty pMSCV either untreated (control) 
or immediately after IR (0h), 2h or 6h following IR treatment. For all samples, FAR 
(fraction of activity released) was averaged from 3 independent experiments with error 
bar representing SEM.  (B)  The Ku S155A/D156A mutation does not interfere with the 
repair of extrachromosomal DNA breaks. Ku70-/- MEFs expressing Ku70 wild-type 
(WT) mutant S155A/D156A or empty vector (pMSCV) were transfected with a 
linearized pGL3-Promoter plasmid and control pRL-SV40 plasmid and assayed for 
luciferase activity 48 hours later. Data represents the average firefly luciferase values 
normalized to the renilla luciferase for 3 separate experiments with error bars 
representing SD (*P <0.01).  (C)  Ku70 S155A/D156A mutation rescues the IR 
sensitivity conferred by the D192A/D195R substitution. Clonogenic survival assay of 
Ku70-/- MEFs expressing Ku70 wild-type (WT), Ku70 bearing the substitutions 
D192A/D195R or the double mutant D192A/D195R, S155A/D156A. Results are 
averaged from 3 experiments and the error bars represent the SD.  (D)  Western blot 
analysis of Ku70-/- MEFs with empty vector (pMSCV) or Ku70-/- MEFs expressing wild-
type Ku70 (WT) and Ku70 mutants as indicated. The blot was analyzed with antibodies 
to Ku80, Ku70 and actin.  (E)  Ku70 S155A/D156A substitutions do not rescue the DNA 
repair defect conferred by the Ku70 D192A/D195R mutation. PFGE analysis was done as 
in A with genomic DNA from Ku70-/- MEFs expressing Ku70 wild-type (WT), 
D192A/D195R, the double mutant D192A/D195R, S155A/D156A or empty pMSCV 
either untreated (control) or immediately after IR (0h), and 6h following IR treatment. 
FAR was averaged from 3 independent experiments with error bar representing SEM (*P 
<0.05).  
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linearized luciferase expression plasmid by measuring luciferase activity. Ku wild-
typeand Ku70 S155A/D156A cells showed no significant difference in their ability to 
repair restriction enzyme cut extra-chromosomal plasmid DNA (Figure 2-3B), suggesting 
that the mutated residues did not enhance the DNA repair function of Ku. To substantiate 
the potential for the Ku S155A/D156A mutation to increase survival independent of 
DNA repair, we tested whether this mutation could rescue the survival defect conferred 
by a Ku repair mutation. To this end, we introduced the D192A/D195R substitution in α-
helix 5 in the Ku70 S155A/D156A construct. The survival of cells expressing the double 
mutant Ku70 S155A/D156A, D192A/D195R was completely rescued (Figure 2-3C), 
suggesting that mutation of the S155/D156 residues can compensate for the defects 
imparted by a DNA repair deficiency. To confirm this result, we analyzed DNA repair in 
cells expressing Ku70 D192A/D195R versus the double mutant Ku70 S155A/D156A, 
D192A/D195R using PFGE (Figure 2-3E). As expected, Ku70 D192A/D195R expressing 
cells displayed a marked repair defect not statistically different than that of the Ku70-
deficient cells. A similar repair defect was observed in cells expressing the Ku70 
S155A/D156A, D192A/D195R substitutions, providing evidence that S155A/D156A 
substitutions do not affect Ku’s function in DNA end-joining and confer a survival 
advantage that is independent of DNA repair.   
2.3.3 Ku70 S155A/D156 mutant cells display decreased activation 
of apoptosis 
Since the S155A/D156A mutation did not affect DNA repair, it suggested the 
possibility that it may interfere with DNA damage response pathways and prevent the 
execution of apoptosis. To determine whether apoptosis was affected in Ku70 
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S155A/D156A expressing cells, we tested the endpoint of apoptosis, using a caspase-3 
assay. While wild-type Ku70 MEFs showed a strong caspase-3 activity at 48 and 72 
hours post-IR, the mutant cells displayed significantly lower caspase-3 activity, and 
therefore decreased apoptotic activation (Figure 2-4A). We then compared the ability of 
Ku70 wild-type and Ku70 S155A/D156A expressing cells to form γ-H2AX foci, an early 
marker of the DNA damage response (46). Ku70 S155A/D156A cells showed no 
significant difference in basal foci levels in absence of IR treatment, whereas, Ku70-/- 
cells had increased γ-H2AX foci levels indicative of unrepaired endogenous DSBs. Early 
foci formation 1 hour following IR treatment was again similar in Ku70 wild-type and 
S155A/D156A-expressing cells, suggesting that the mutation did not interfere with the 
initial phosphorylation events. However Ku70 S155A/D156A cells displayed persistent 
foci 24 hours following IR compared to Ku70 wild-type cells (Figure 2-4B) suggesting 
an abnormally prolonged DNA damage response. Altogether, these results suggested that 
the mutation interfered with the activation of apoptosis and resulted in a persistent DNA 
damage response.  
2.3.4 Ku70 S155A/D156A mutant cells display altered 
transcriptional regulation in response to DNA damage 
DNA damage-induced apoptosis is largely regulated at the transcriptional level (48, 
49), so we thought to investigate whether Ku S155A/D156A could interfere with the 
transcriptional regulation of genes involved in the IR-induced apoptotic response. In 
order to examine global gene expression differences between S155A/D156A and wild-
type Ku70 expressing MEFs following IR, Affymetrix GeneChip analysis was performed 
using RNA prepared from unirradiated control cells and from cells at 8 hours and 24  
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Figure 2-4 Ku70 S155A/D156A expressing cells exhibit DNA damage signaling 
defects.   
(A) Analysis of IR-induced apoptosis in Ku70 S155A/D156A expressing cells.  Irradiated 
or mock-treated Ku70-/- MEFs expressing Ku70 wild-type (WT) or Ku70 S155A/D156A 
were assayed for caspase-3 activity at the times indicated. Fold activation of caspase-3 
activity is shown relative to the unirradiated control, averaged over 4 experiments with 
error bars representing the SEM (**P <0.01, * P <0.05).  (B) S155A/D156A Ku70 
mutant cells display prolonged H2AX serine 139 phosphorylation (γ-H2AX) 24 hours 
post-IR. Cells as in A were irradiated with 4 Gy of IR or mock treated, fixed at the time 
points indicated, and subjected to analysis with a γ-H2AX antibody and DAPI. Foci were 
quantified based on pixel intensity and averaged over the number of cells present (a.u., 
arbitrary units). Data represents the average of 4 separate experiments, each assessing 
approximately 500 cells, and error bars represent SEM (*P  <0.05).  
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hours post-IR treatment. We noticed that the change of expression of several genes 
induced or repressed by IR was reduced in Ku S155A/D156A expressing cells 
(Supplementary Table 2-1). Genes found differentially regulated in WT and S155A/
D156A cells included the Inhibitor of differentiation (Id) genes (Id1, Id2, Id3), Activating 
Transcription Factor 3 (ATF3) and Growth arrest and DNA damage-inducible gene 153 
(GADD153), also known as DNA-damage-inducible transcript 3 (Ddit3) and C/EBP-
homologous protein (CHOP), which have previously been characterized as participating 
in the regulation of apoptosis (50-53). Id1 was shown to be downregulated by ATF3 
during stress (53, 54), whereas GADD153/CHOP was found to be upregulated by ATF3 
to induce cell death programs in response to stress (55, 56). Change of expression of 
these genes was confirmed using quantitative RT-PCR analysis. Downregulation of Id1 
and Id2 expression in response to IR was found severely inhibited in Ku70 S155A/
D156A cells while Id3 also showed a decreased inhibition, albeit less pronounced (Figure 
2-5A). The induction of GADD153/CHOP was also affected 24 hours post-IR in cells 
expressing Ku70 S155A/D156A (Figure 2-5B). Western blot analysis further confirmed 
the reduction in GADD153/CHOP protein expression in Ku70 S155A/D156A mutant 
cells compared to wild-type (Figure 2-5C). Since ATF3 activation would be expected to 
precede that of its target genes Id1 and GADD153/CHOP, we tested ATF3 protein levels 
in Ku70 wild-type and S155A/D156A mutant cells by western blot at earlier time points 
following IR treatment. A marked decrease in ATF3 induction in cells expressing Ku70 
S155A/D156A was detected 2 and 8 hours after IR treatment and was still noticeable at 
16 hours post-IR, confirming that Ku70 S155A/D156A interferes with and/or delays 
ATF3 activation (Figure 2-5D). Altogether, these results  
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Figure 2-5 S155A/D156A Ku70 expressing cells show altered expression of ATF3, 
GADD153/CHOP and Id1, Id2, and Id3 in response to IR.   
(A)  RT-PCR analysis of Id family genes Id1, Id2, and Id3. RNA samples from Ku70 
S155A/D156A (Mt) and Ku70 wild-type (WT) expressing MEFs, 24 hours following 6 
Gy of irradiation or unirradiated control cells were analyzed by RT-qPCR with primers 
for the indicated Id genes (Id1, Id2, Id3). Fold change of gene expression relative to that 
of unirradiated control samples is shown with error bars indicating SEM. For all samples, 
P <0.05 between WT and Mt.  (B)  RT-PCR analysis of pro-apoptotic GADD153/CHOP 
expression. RNA samples were processed as in A and RT-qPCR was performed using 
primers specific for GADD153/CHOP (P <0.05).  (C)  Western blot analysis of 
GADD153/CHOP protein levels in Ku70 S155A/D156A (Mt) and Ku70 wild-type (WT) 
MEFs following IR. Representative western blot analysis of cells irradiated at 6 Gy or 
mock treated (control) and extracts taken at the time points indicated. The membrane was 
hybridized with the indicated antibodies. (D)  Western blot analysis of ATF3 expression. 
Cells were treated and harvested as in C at the times indicated and the blot was 
hybridized with ATF3 and actin antibodies. Both panels are from the same blot, but a 
longer exposure is shown for ATF3 in the left panel (no IR, 2h) due to weaker ATF3 
signal intensity. 
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suggest that the Ku70 S155A/D156A mutation impairs a signaling pathway that affects 
ATF3 and its target genes in response to IR. ATF3 itself is regulated by ATF2, a 
transcription factor of the same family (57, 58). Interestingly, we identified additional 
genes known to be regulated by ATF2 and whose expression is altered by stress or DNA 
damage that were differentially expressed in Ku wild-type and S155A/D156A cells in 
response to IR (Supplementary Table 2-2). This suggested that the Ku70 S155/D156 
residues could function to modulate the activation of an ATF2-dependent pathway in 
response to IR.  
2.3.5 Ku70 S155A/D156A inhibits ATF2 phosphorylation and foci 
formation 
ATF2 expression is not altered in response to IR, but ATF2 is rapidly recruited to IR-
induced foci that co-localize with γ-H2AX (59). Foci formation by ATF2 is dependent on 
phosphorylation of C-terminal residues (490, 498) (59). In addition, the activation of 
ATF2 transcriptional activity in response to DNA damage and other forms of stress is 
dependent on the phosphorylation of two residues in the N-terminal region (Thr69/71) 
(57). Thus, to determine whether the Ku70 S155A/D156A mutation interfered with ATF2 
activation in response to IR, we first analyzed ATF2 foci formation in Ku70-/- pMSCV 
MEFs and cells re-expressing Ku70 wild-type and the Ku70 S155A/D156A mutant. 
While all 3 cell lines displayed equivalent background level of ATF2 foci in untreated 
cells, IR-induced ATF2 foci formation was much stronger in Ku deficient cells than in 
cells re-expressing Ku70 wild-type (Figure 2-6A). Foci formation was reduced in cells 
expressing Ku70 S155A/D156A compared to wild-type at both 1 and 4 hours after IR 
treatment. Next, to determine whether Ku also modulated ATF2 phosphorylation at the  
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Figure 2-6 Deficient ATF2 activation in response to DNA damage in Ku70 
S155/D156 expressing cells. 
(A)  Representative images of ATF2 foci formation in response to IR in Ku70-/- MEFs 
expressing wild-type Ku70 (WT), Ku70 S155A/D156A and empty vector (pMSCV). 
Cells fixed either untreated (no IR) or 1h after IR (6 Gy) were stained with an ATF2 
antibody and DAPI. Below, quantification of foci formation was done for unirradiated 
cells (control) or cells processed 1h or 4h after IR treatment as described in Materials and 
Methods and the results were averaged from 4 experiments (about 250 
cells/experiments), with error bars representing SEM (*P<0.05).  (B)  Cells were 
analyzed as in A with a phospho-ATF2 (69/71) antibody. Representative images are 
shown at the top, with quantification of phospho-ATF2 staining intensity from 3 separate 
experiments shown below (a.u., arbitrary units of signal intensity).  (C)  Western blot 
analysis of phospho-ATF2 (69/71) in Ku70-/- MEFs expressing wild-type Ku70 (WT) and 
Ku70 S155A/D156A (Mt). Cells were left untreated (no IR) or subjected to 10 Gy and 
collected at the time points indicated to prepare nuclear extracts. Western blot analysis 
was done with a phospho-ATF2 69/71 antibody (p69/71) or with an ATF2 antibody to 
determine total ATF2 protein expression and actin as indicated. 
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N-terminal sites (Thr69/71) that activate ATF2 transcriptional function, we analyzed 
phospho-ATF2 at the 69/71 residues using immunocytochemistry. IR-induced phospho-
69/71 ATF2 staining appeared mostly diffuse, but exhibited small foci (Figure 2-6B). 
Similar to ATF2 foci formation, phospho 69/71 was enhanced in Ku-/- cells compared to 
Ku70 wild-type MEFs, and reduced in Ku70 S155A/D156A at both time points tested. 
To confirm the difference in phosphorylation at the ATF2 69/71 site between Ku70 wild-
type and S155A/D156A mutant MEFs, we analyzed phospho-ATF2 by western blotting. 
Consistent with the immunofluorescence result, a noticeable reduction in ATF2 
phosphorylation was observed at all times points between 1 and 4 hours post-IR in Ku70 
S155A/D156A MEFs compared to wild-type, suggesting that substitutions at S155/D156 
impaired ATF2 69/71 phosphorylation (Figure 2-6C). Together, these results suggest that 
Ku functions to repress ATF2 activation in response to DNA damage and that the 
S155A/D156A mutation further enhances this repression. 
2.3.6 Increased survival in response to IR is dependent on the 
mutation of S155 
The Ku70 S155/D156 residues are present in a loop region between α-helix 4 and α-
helix 5 of the Ku70 vWA domain (32). The effect of the mutation could be due either to 
the disruption of a key phosphorylation event on Ser155, or could simply be disrupting a 
protein-protein interaction surface. To address the latter possibility, we produced a Ku70 
mutant containing alanine substitutions across the entire loop (aa 155 to 160), reasoning 
that extending the mutated surface could amplify the effect observed with the 
S155A/D156A mutation. Analysis of IR survival curves revealed no significant 
difference in survival between MEFs expressing the Ku70 155-160A mutant and those 
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expressing the S155A/D156A mutant, suggesting that S155A/D156A alone conferred 
maximal increased resistance to IR (Figure 2-7A). We next tested the effect of the single 
S155A and D156A substitutions on cell survival in response to IR. Ku70 D156A 
expression resulted in a survival profile not significantly different than wild-type Ku70. 
The Ku70 S155A however, conferred enhanced survival that was similar to that of the 
155-160 mutant and the double S155/6 mutation (Figure 2-7B). This suggests that the 
DNA damage signaling events that modulate cell survival in response to IR are solely 
dependent on Ku70 S155.  
As this residues is a serine, it suggested the possibility that S155 might be targeted for 
phosphorylation to modulate DNA damage signaling, and that the S to A substitution 
prevented this crucial modification. To test this possibility, we generated an aspartic acid 
mutant, S155D, to assess the effect of a phosphomimetic substitution on cell survival in 
response to IR. Cells expressing Ku70 S155D appeared fragile and susceptible to cell 
death. Also, while we confirmed expression of Ku70 S155D (Figure 2-7D), the protein 
levels appeared to decline quickly in the first few passages following drug selection, and 
only about 65% of MEFs were found expressing this mutant, versus over 90% for Ku70 
WT and other mutants (Supplementary Table 2-2). Clonogenic assays revealed that the 
Ku70 S155D mutation conferred a pronounced hypersensitivity to IR, as cells expressing 
Ku70 S155D displayed even greater radiosensitivity than the Ku-deficient cells (Figure 
2-7C). To determine the effect of the S155D substitution on ATF2 phosphorylation, we 
compared ATF2 69/71 phosphorylation in cells expressing Ku70 S155D, Ku70 S155A, 
wild-type Ku70 and Ku70-/- pMSCV MEFs. In control unirradiated cells, both Ku70-
deficient MEFs and S155D showed strong background levels of phospho-ATF2 in  
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Figure 2-7 Ku70 S155A substitution is required and sufficient to confer increased 
survival following IR.  
(A)  Clonogenic assay of Ku70-/- MEFs expressing Ku70 with 155-160 alanine 
substitutions (155-160A) and S155A/D156A in comparison Ku70-/- expressing wild-type 
Ku70 (WT). Survival is expressed as the number of colonies present at each IR dose 
relative to the unirradiated control, averaged over 3 experiments and with error bars 
representing the SD (**P<0.01, *P<0.05).  (B)  Clonogenic assay comparing survival of 
MEFs expressing Ku70 wild-type (WT) and Ku70 D156A and S155A substitutions. 
Survival is expressed as in A. (*P<0.01).  (C)  Clonogenic assay of MEFs expressing 
Ku70 wild-type (WT), Ku70 S155A and empty pMSCV vector (KO) in comparison to 
Ku70 bearing the phosphomimetic S155D substitution. Survival is expressed as in A. 
WT, S155A and pMSCV are significantly different from each other at all time points 
(P<0.05), but the stars indicating significance are omitted for clarity. Significance is 
indicated for S155D compared to pMSCV (*P<0.001).  (D)  Western blot analysis of Ku 
subunits expression in Ku70-/- MEFs expressing empty vector (pMSCV), wild-type Ku70 
(WT), or Ku70 mutants as indicated.  (E)  Western blot analysis of phospho-ATF2 
(69/71) in Ku70-/- MEFs expressing wild-type Ku70 (WT), Ku70 S155A and Ku70 
S155D or empty vector (pMSCV). Cells were either left untreated (no IR) or subjected to 
10 Gy and collected 2 hours later. Western blot analysis was done with a phospho-ATF2 
69/71 antibody (p69/71), an ATF2 antibody to determine total ATF2 protein expression 
and actin as indicated. 
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comparison to Ku70 wild-type and S155A (Figure 2-7E). In response to IR, as expected, 
phospho-ATF2 was enhanced in Ku-deficient cells and reduced in Ku70 S155A 
compared to Ku70 wild-type. As well, Ku70 S155D expressing cells displayed increased 
levels of phospho-ATF2 in comparison to Ku70 wild-type. Thus, these results are 
consistent with a phosphomimetic effect of the Asp substitution and support the notion 
that Ku70 S155 phosphorylation in response to IR is an important event that activates 
apoptotic pathways in response to DNA damage.   
2.4 Discussion 
This study identifies a novel function for Ku in regulating signaling pathways leading 
to apoptosis in response to DNA damage. This regulation occurs through a previously 
uncharacterized region near α-helix 4 in the Ku70 vWA domain. Amino acid 
substitutions in this region, while not affecting DNA repair, compromise the activation of 
apoptosis, and alter the transcriptional profile of genes regulated by an ATF2/ATF3 
pathway. 
Previous studies have shown the involvement of the Ku70 vWA domain in C-NHEJ. 
A recent study demonstrated that Ku has a 5’ lyase activity that is conferred by specific 
residues in the Ku70 vWA, supporting a direct role for Ku in end-processing (27). This 
activity was found to be dependent on an N-terminal “active site” (aa 4-34) and on three 
lysine residues within the Ku70 N-terminal domain. In yeast, Ku70 α-helix 5 was found 
to convey crucial C-NHEJ functions (38). We show here that substitutions in the 
corresponding human Ku70 α-helix 5 residues (D192A/D195R) caused a survival defect 
in MEFs, consistent with an C-NHEJ defect. α-helix 5 is an exposed α-helix facing 
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towards the DNA terminus that is well conserved from yeast to man (Figure 1)(38). 
While the underlying cause of this DNA repair defect is still unknown, this implies that 
the function of this Ku region is evolutionarily conserved. Mutations in α-helices 3 and 4 
did not cause any obvious defects. Our results are consistent with previous findings in 
yeast showing that α-helix 4 mutations do not affect C-NHEJ (38). Additionally, it 
should be pointed out that α-helix 3 is positioned away from the DNA and therefore may 
be less likely to function in DNA repair process (32, 38).  
In contrast to the aforementioned involvement of vWA regions in C-NHEJ, the Ku70 
S155A/D156A mutation is fully functional for DNA repair, suggesting that these residues 
are not involved in the interaction of Ku with C-NHEJ factors. In particular, it also 
indicates that these substitutions do not interfere with the overall DNA-PK kinase activity 
which is known to be required for C-NHEJ and defects in which result in IR sensitivity 
(13, 60). Since the DNA-PKcs region of interaction with Ku lies in the Ku80 C-terminal 
domain, it is unlikely to be affected by a Ku70 N-terminal substitution. However, the 
possibility remains that S155A/D156A could interfere with phosphorylation of specific 
targets by DNA-PK.  
The increased survival of the MEFs expressing Ku70 S155A/D156A correlated with 
a marked decrease in apoptosis as measured by caspase-3 activation. In contrast to wild-
type cells, persistent γ-H2AX foci were present 24h following IR, suggestive of the 
presence of residual unrepaired DNA breaks. Since Ku70 S155A/D156A does not confer 
any repair defects, the persistence of γ-H2AX foci suggests defects in DNA damage 
signaling. γ-H2AX foci present at 24 hours may indicate DSBs that were unable to be 
98 
98 
repaired and would normally trigger apoptotic pathway activation to eliminate the 
damaged cells. We postulate that in Ku wild-type cells, the activation of apoptotic 
pathways allows the return of γ-H2AX foci to background levels, whereas defects in 
signaling to apoptosis in Ku70 S155A/D156A delays or impedes foci disappearance in 
these cells.  
Since Ku70 S155A/D156A resulted in apoptotic defects, we first investigated 
whether it could affect p53, since this factor is a major regulator of apoptotic pathways in 
response to DNA damage (49). Analysis of p53 response to IR revealed that p53 
expression is not induced in either Ku wild-type or Ku70 S155A/D156A cells 
(Supplementary Figure 2-3), suggesting that the immortalization of the Ku Ku70-/- MEFs 
disrupted p53 regulation, an event that frequently occurs in the process of MEFs 
immortalization (61). However, p53 was efficiently phosphorylated at Ser 15 (Ser 18 in 
mouse) in response to IR, suggesting that the ATM-dependent signaling which is 
responsible for p53 phosphorylation at this site is intact in these cells (62). Importantly, 
no difference in the efficiency of phosphorylation was observed between wild-type and 
Ku70 S155A/D156A cells, suggesting that the effect of Ku on signaling to apoptosis does 
not affect p53 response nor appears to be p53 dependent (Supplementary Figure 2-3). 
The altered expression of several genes involved in an ATF2/ATF3 signaling 
pathway in Ku70 S155A/D156A cells led us to speculate that Ku functions to regulate 
this signaling pathway in response to IR. ATF3 is a basic-region leucine zipper (bZIP) 
transcription factor member of the ATF/CREB superfamily that is rapidly upregulated by 
a variety of stress signals including DNA damage (51, 58, 63, 64). ATF3 can function 
both to activate and repress transcription, depending on its dimerization partner and the 
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promoter context. Several studies have demonstrated a crucial role for ATF3 activity in 
inducing apoptosis and the suppression of tumorigenesis (51, 65, 66). Furthermore, ATF3 
is directly involved in down-regulating Id1 expression, while contributing to 
GADD153/CHOP transcriptional activation (53, 55). While Id1 has been shown to be 
directly regulated by ATF3, Id2 and Id3 expression is not well characterized but there is 
evidence that they are regulated coordinately (52, 67). Id proteins function as dominant-
negative antagonists of the basic helix-loop-helix (bHLH) family of transcription factors 
and play roles in development, tumorigenesis and cell cycle by promoting cell survival 
and proliferation (52, 67). Overexpression of Id proteins correlates with tumorigenesis 
and downregulation of Id1 expression sensitizes cells to apoptotic agents (52, 67-69). 
Finally, previous studies have shown that Id1 is downregulated in response to stress and 
DNA damage in an ATF3-dependent manner (53, 54). Consistent with these studies, our 
RT-PCR analyses showed a strong downregulation of Id1 following IR treatment, 
concurrent with that of Id2 and Id3. In Ku70 S155A/D156A cells, this repression was 
substantially lessened, correlating with reduced activation of ATF3. Thus, the combined 
IR-induced regulation of these transcription factors converge towards the regulation of 
apoptosis and their dysregulation in Ku70 S155A/D156A cells is consistent with the 
reduced activation of apoptosis observed in response to DNA damage. 
ATF3 activation is mediated by several factors and pathways depending on the 
activating stimulus (51, 56). DNA damage activation of ATF3 has been suggested to 
depend on an ATM-NBS1 pathway, and ATF2 (58). Recent studies have implicated 
ATF2 in the DDR (59, 70). In response to DNA damage, ATF2 transcriptional activity is 
activated by phosphorylation at N-terminal residues T69/71 by p38 and Jun-N-terminal 
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Kinase (JNK) in an ATM-dependent manner (58, 71, 72). In addition, ATF2 is 
phosphorylated at C-terminal S490/498 by ATM, resulting in its accumulation at IR-
induced foci that co-localize with γ-H2AX and the MRN complex (59). Mutation of these 
residues results in loss of ATF2 foci formation, defective DNA damage response and 
confer increased sensitivity to IR and tumour susceptibility in mice (59, 70).  
Analysis of ATF2 IR-induced foci formation and T69/71 phosphorylation showed 
that both were affected by Ku expression and Ku70 S155A/D156A mutation. Previously, 
it was determined that while mutation of ATF2 S490/498 prevented foci formation, 
T69/71 phosphorylation was dispensable for ATF2 localization into foci, and 
phosphorylation at both sites were suggested to be independent events (59, 71). The 
relationship between these two phosphorylation events is still unclear as ATM is required 
for ATF2 T69/71 phosphorylation (58), but whether T69/71 phosphorylation is an 
independent event, or is contingent on S490/498 modification has not been determined. 
We found that phospho T69/71-ATF2 is localized into IR-induced foci. This infers the 
existence of an ATF2 population that is phosphorylated at both N-terminal and C-
terminal motifs suggesting that phosphorylation at both sites is not exclusive and that 
transcriptionally active ATF2 is present at DNA breaks. Thus, our results suggest that Ku 
functions to modulate both events whether or not they are independent of one another.  
The deregulation of several genes directly or indirectly dependent on ATF2 
transcriptional activity in Ku70 S155A/D156A cells suggests that this mutation can 
interfere with the transcriptional activity of ATF2 mediated by T69/71 phosphorylation. 
Phosphorylation of T69/71 is induced in Ku70-/- cells compared to wild-type, suggesting 
that Ku plays an inhibitory role on ATF2 transcriptional activation in response to IR. 
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Since ATF2 T69/71 phosphorylation initiates signaling cascades leading to the activation 
of apoptosis, one potential explanation is that Ku-mediated inhibition of ATF2 activation 
is linked to Ku’s ability to activate DNA repair. Ku-mediated assembly of a functional C-
NHEJ complex and/or completion of DNA repair could prevent ATF2 activation. In the 
case of overwhelming DSBs, Ku may be present at the break, however, may not be able 
to assemble a functional repair complex because of the limiting availability of other C-
NHEJ factors, thus allowing ATF2 phosphorylation and the establishment of a signaling 
pathway leading to the activation of apoptosis. The increased repression of ATF2 
phosphorylation by Ku70 S155A suggests that this mutation disrupts an event that 
normally allows ATF2 activation when DNA repair is not completed. As ATF2 
phosphorylation and activation in response to DNA damage is ATM dependent (58, 59), 
the Ku70 vWA region may function to link Ku to ATM signaling and modulate an ATM-
dependent pathway.  
We demonstrated that S155 is the essential residue implicated in this regulation of 
cell survival. As serine/threonine kinases are an integral part of the DNA damage 
response signaling pathway, the S155A mutation could be preventing an important post-
translational signaling event in the regulation of apoptosis. However, S155 has not been 
previously identified as a DNA-PK phosphorylation site on Ku70 (73), nor is it located in 
any canonical kinase phosphorylation motif (as determined using NetworKIN) (74). 
Interestingly, a recent proteomics study analyzing site-specific phosphorylation after IR 
treatment identified a new DNA damage-related phosphorylation motif, SXXQ, which 
was overrepresented amongst phospho-sites regulated within 1 hour following IR 
treatment (75). Peptides with this motif were found to follow a profile of phosphorylation 
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similar to that of SQ motifs, suggesting that this site could be targeted by ATM or DNA-
PK. S155 is located in a SXXQ motif (SDVQ – Figure 2-1), thus making these two 
kinases prime candidates for a phosphorylation event at this site. Future experiments will 
have to determine whether ATM or DNA-PK can phosphorylate this site and whether 
phosphorylation of S155 is indeed responsible for the modulation of cell survival through 
regulation of ATF2-dependent pathway.  
The idea that S155 is a phosphorylation site is supported by our experimental results 
showing that that the survival advantage conferred by the S155A substitution is 
completely overturned by the S155D mutation. This suggests that this phosphomimetic 
substitution provides for a constitutive activation of apoptosis irrespective of DNA repair. 
Somewhat surprisingly, cells expressing Ku70 S155D displayed an even more 
pronounced hypersensitivity to IR than cells lacking Ku. ATF2 phosphorylation appeared 
similar in Ku-deficient and S155D within the limit of sensitivity of the western blot 
analysis. Thus, it is possible that Ku70 phosphorylation at S155 not only potentiates 
ATF2 phosphorylation but also has additional effects that contribute to further activation 
of downstream apoptotic pathways.   
The apoptotic pathway regulated by Ku identified in this study seems independent 
from the control of Bax by Ku70 described in previous studies (76). First, the Bax-Ku70 
interaction that has been described relies on the acetylation of several residues in the 
Ku70 C-terminal domain, thus in a region that is quite distinct from S155 in the N-
terminal domain (77). Second, Bax regulation by Ku70 hinges on the modulation of an 
interaction between Bax and Ku that has been suggested to occur in the cytoplasm (40), 
while the regulation that we have uncovered here involves the interplay between proteins 
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that form DNA-induced foci at DNA breaks. However, further investigations will be 
needed to determine whether Ku70 S155 modulates the activation of apoptosis through 
other pathways and in particular, whether Ku-Bax interaction is affected by this 
regulation.  
Finally, it is interesting to consider the positioning of the α-helix 5 residues (D192, 
D195) which mutation confers a DNA repair defect in yeast and that we have confirmed 
here severely impair viability, and the loop region adjacent to α-helix 4 where the S155 is 
located. Both are facing outwards, towards the DNA break (Figure 2-1B), in proximity to 
one another, suggesting the potential for interactions or cross-talk between the two 
regions. Because of its presence at the DNA break and its primary function in C-NHEJ, 
Ku is well positioned to act as a “sensor” of DNA repair. Therefore, the proximity of α-
helix 5, which appears essential for DNA repair, to the S155 residues suggests that Ku 
could function to relay signals from the repair machinery to nearby regulators of 
signaling pathways that control apoptosis.  
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2.6 Supplementary materials 
Supplementary Figure 2-1 Retroviral mediated re-expression of Ku70 in Ku70 
deficient MEFs restores WT protein level 
Western blot analysis of Ku70 protein level in normal WT MEFs, Ku70 -/- MEFs or 
Ku70 -/- MEFs that have stable integration of human Ku70 cDNA mediated through the 
pMSCV retroviral system.  
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Supplementary Figure 2-2 Ku70 vWA mutations that do not alter survival after IR 
(A) Several vWa alanine mutations have no effect on Ku70’s function in response to IR. 
MEFs expressing Ku70 wild-type or Ku70 with the Ku70 mutants bearing substitutions at 
the amino acids indicated were irradiated and processed by clonogenic assay. Survival is 
expressed as the number of colonies present at each IR dose relative to the unirradiated 
control, averaged over 3 experiments and with error bars representing the SD. (B) 
Western blot analysis of Ku70 and Ku80 expression in Ku70-/- MEFs re-expressing 
Ku70 with the indicated substitutions. 
111 
111 
Supplementary Table 2-1 List of genes differentially regulated after IR in 
S155A/D156A Ku70 expressing MEFs relative to WT Ku70. 
Samples from control and IR-treated (8h and 24h) MEFs were subjected to microarray 
analysis using a GeneChip Mouse Gene 1.0 ST Array (Affymetrics, Santa Clara, CA). 
Gene Chips were processed at the London Regional Genomics Centre (Robarts Research 
Institute, London, ON; http://www.lrgc.ca). Fold induction/repression of expression with 
respect to unirradiated controls was calculated for each gene and cell line. The fold 
difference in gene expression change between Ku70 wild-type relative to S155A/D156A 
expressing MEFs is shown for those genes with a 1.4 fold or greater difference at either 
the 8h or 24h time point. The data shown for the 8h time point is an average of two 
replicates, while the data shown for the 24h time point is the result of a single 
experiment.  
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Gene 8h	  WT:MUT 24h	  WT:MUT8h	  WT:MUTGene 24h	  WT:MUT Gene 8h	  WT:MUT 24h	  WT:MUT
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Emp2 1.851322 Syk 1.7073638 1.40014645 Pawr 1.5773272 1.63090913
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Lck 1.822613 Ifrg15 1.6830456 Prkar2b 1.5696642 1.45887399
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Crebl2 1.8204641 1.48618771 Gabre 1.6663143 1.60901173 Ccdc15 1.5594109
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Abca8b 1.8091591 1.77865379 Ucp2 1.6553069 -­‐1.4602673 Gnpda1 1.5567131
Manea 1.8089528 1.48560589 Chic1 1.6534133 Tbcel 1.555061
Jmy 1.8053534 Chmp2b 1.653137 Snx32 1.552689
N4bp2l1 1.8049026 Herpud2 1.6523057 Ahcyl2 1.5525451
Adam12 1.8001194 Id3 1.6511606 1.46457371 Trib1 1.5384128
Chd2 1.7937267 Mtrr 1.6466074 1.59264985 Ier5l 1.5316894 1.50676698
Flcn 1.7909338 Mapkapk3 1.6461378 1.46947343 Kdsr 1.5315071
Ltbp2 1.7905111 Atad5 1.6448174 Nbr1 1.5310058
Pdzrn3 1.7881917 1.46929767 Cxx1c 1.6401412 1.43671172 Tnrc6c 1.5282717
Gaa 1.778258 Zc3h6 1.6348365 1.49781831 Armcx1 1.5270307
Snx30 1.7745176 1.40473952 Zmym6 1.6345893 1.42376192 Slc23a3 1.5265664 1.48729289
Ank2 1.7739278 1.74855875 Hbp1 1.6327409 Pon2 1.5231683
Ptgs2 1.7718354 Srrt 1.6303987 Adh7 1.5224364
Plk2 1.7701335 1.52447539 Wbp1 1.6298901 -­‐1.415566 Mfap1a 1.5217243
Fhod1 1.7696444 Usp53 1.6286135 Atad2b 1.5206588 1.43555531
Recql4 1.7689527 1.48256428 Lmbrd1 1.6279505 Fam178a 1.5192538
Pycr1 1.7682591 1.48911203 Pip4k2c 1.6273531 Trpm7 1.5180277
Hpcal1 1.7678159 1.46282945 Mcoln1 1.6230606 Diap2 1.5152733 1.42091663
Sft2d2 1.762365 1.45749417 Stx3 1.6196043 1.59749504 Gem 1.5141896
Fyn 1.7564347 1.5736287 Gga2 1.6180539 1.40142053 Clcn7 1.5132979
Dnm3os 1.7560198 1.63043417 Tmem140 1.6180375 Rab39b 1.5109985 1.48356497
Xpot 1.753066 1.51032446 Prnp 1.6175543 Phf3 1.5099878
Fam50a 1.7525657 Npy1r 1.6164847 Rab11fip1 1.5097985
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Kctd17 1.5084522 Cfp 1.4139547 Tom1l2 -­‐1.6045891 1.44938259
Rnaset2a 1.5076496 Hspa1a 1.4134225 Elovl3 -­‐1.6252544 1.99057739
Pex1 1.5053057 1.52917586 Tom1 1.4121067 Atp6v1h -­‐1.6356868 1.5266622
Gpr174 1.5044154 1.54601296 Prkg2 1.4080633 Mgst3 -­‐1.6517545
Gtf2a1 1.5036435 Chaf1b 1.4064953 Marcks -­‐1.6628105 1.84515731
Atp6v1b2 1.4988765 Stambpl1 1.4064801 Col1a1 -­‐1.6640281 1.62336255
Kctd11 1.4966708 Pfkfb2 1.4049028 1.48405674 Gnpda2 -­‐1.6650639
Adamtsl4 1.4964988 1.45204123 Zfyve1 1.4039952 Idua -­‐1.6676651 1.48600963
Zc3h6 1.4939777 -­‐1.9389697 Wwtr1 1.4005728 Dab2 -­‐1.6834219 1.57361035
Itpr2 1.493064 1.5963841 Zfyve26 1.4001212 Ypel2 -­‐1.6915289 1.54727112
Arl5b 1.4862402 Gtlf3b -­‐1.407985 Phospho2 -­‐1.699858
Phf20l1 1.4826609 Zbtb34 -­‐1.408413 Vaultrc5 -­‐1.7089014
Ccl9 1.4802112 Fuca2 -­‐1.410325 1.66129296 Slc25a44 -­‐1.7254237 1.73818215
Cebpg 1.4800289 1.4554497 Fdft1 -­‐1.41511 1.71930121 F3 -­‐1.7347191 1.44880528
Tmem194 1.4796213 Nsl1 -­‐1.423584 1.56897416 Helq -­‐1.7572803 1.56087793
Wdr7 1.4764016 1.40290202 Bag4 -­‐1.432748 1.53878605 Nhlrc3 -­‐1.7578207 1.62414217
Mfap1a 1.4748779 Cd59a -­‐1.434654 Cd248 -­‐1.7607058 1.90026662
Zbtb24 1.4743597 1.41659601 Sh3bgrl2 -­‐1.44526 1.47207129 St3gal5 -­‐1.7623064 1.49131409
Rnf214 1.4739105 Zxdc -­‐1.45311 Lcn2 -­‐1.765672 1.41532747
Extl1 1.4732526 1.5735995 Fam33a -­‐1.462599 1.40060564 Cp -­‐1.7675866
Strbp 1.4684626 1.48605154 Fam171a2 -­‐1.467632 Galc -­‐1.7676586 1.43521665
Ankle1 1.4670578 Fam175b -­‐1.468052 Tmem68 -­‐1.7800826 1.70021597
Mafg 1.4624167 Ahi1 -­‐1.471704 1.62662905 Acss2 -­‐1.7874627
Vcpip1 1.4617343 Mxd3 -­‐1.47245 Rragb -­‐1.7878325 1.86651919
Samd8 1.4610175 1.40378536 Klhdc1 -­‐1.480162 1.47968148 Napb -­‐1.791784 2.10983143
Adamts9 1.4583605 1.47489082 Taf4b -­‐1.481357 1.49090007 Soat1 -­‐1.7977704
Slc3a1 1.4579581 1.40230701 Dbt -­‐1.489391 1.47642871 Lss -­‐1.8280634 1.46001437
Rnf145 1.4548605 1.40823223 H2-­‐Q6 -­‐1.490049 Tceal1 -­‐1.8488098
Cdt1 1.4503372 Lpar1 -­‐1.49507 1.56514538 Elovl4 -­‐1.8545102 1.58677832
Nfx1 1.4493831 Zfp30 -­‐1.497653 1.44982344 Pla2g12a -­‐1.8695517 1.44630792
Psmd3 1.4487677 Thap6 -­‐1.499752 1.42272694 Slc25a1 -­‐1.8788746 1.56032003
Epc2 1.4485547 Cd274 -­‐1.500081 1.63709957 Cpeb4 -­‐1.8811509 1.57718606
Cdh11 1.4463381 Necab3 -­‐1.503617 Nfxl1 -­‐1.8818451
Lrrc15 1.4455486 1.73231704 Osbpl8 -­‐1.507525 1.50306935 Zscan4c -­‐1.8838396
Cmklr1 1.4453161 Sema3a -­‐1.510492 -­‐1.4169811 Pcyt2 -­‐1.8851732 1.5336036
Gclm 1.4428535 Snrpd2 -­‐1.511373 Abcc4 -­‐1.8871846 1.51993276
Zfyve27 1.4425209 Aldh3b1 -­‐1.515173 Sqle -­‐1.9184307 -­‐1.67106105
Lrpprc 1.4394058 Dhtkd1 -­‐1.517589 1.43467441 Pde5a -­‐1.9254491 1.47501292
Slc25a36 1.4363899 Dmxl2 -­‐1.519363 Vcl -­‐1.9363655 -­‐1.43402451
Tom1 1.4354822 Samd9l -­‐1.521593 Slc38a4 -­‐1.9444142 1.49623692
Wdr76 1.4348115 Plec1 -­‐1.532722 Mvk -­‐1.9457642 1.58697369
Plekhm3 1.4347774 Dap -­‐1.534666 -­‐1.477496 Zbtb10 -­‐1.9583813 1.80621337
Sos2 1.4338364 Sirt1 -­‐1.542143 Acat2 -­‐1.973115 1.46131124
Mafg 1.4305492 Wnt10b -­‐1.547559 -­‐1.4413662 Nxn -­‐1.9754234 1.47388768
Hsdl1 1.4300619 Zc3h8 -­‐1.548371 Pgr15l -­‐1.9896853 2.03752985
Tmem206 1.429989 Neto2 -­‐1.555185 Fads2 -­‐1.989967 -­‐1.60581872
Adh1 1.4272128 Lin54 -­‐1.567111 Prkca -­‐2.0061759 -­‐1.46089205
Avl9 1.4261379 Atp6v1a -­‐1.570635 Utp14a -­‐2.0133472 1.76271345
Zfp422-­‐rs1 1.4246906 Psca -­‐1.570887 Tubb6 -­‐2.0219033
Ssfa2 1.4237975 Wnt10a -­‐1.575599 Pgd -­‐2.0287838 1.50664876
Rragd 1.4199409 1.48761848 Impact -­‐1.578538 1.40814151 Nqo1 -­‐2.0444974 -­‐1.66362682
Parvg 1.4191975 Aoc2 -­‐1.5795 1.54009213 Col1a2 -­‐2.1126376 1.93115753
Mid2 1.4184922 Atg12 -­‐1.581043 Mvd -­‐2.1305326
Qsox2 1.4169895 Rnf146 -­‐1.582225 Aspn -­‐2.1322411 4.32184981
Kif21b 1.4163825 Zfp346 -­‐1.585801 Csprs -­‐2.1352281
Zfc3h1 1.4163468 Tpm1 -­‐1.58908 -­‐1.5677594 Mtap1a -­‐2.1716436 -­‐1.57415996
Fam13b 1.4144871 Tcn2 -­‐1.589205 1.45227314 Gnpnat1 -­‐2.1853354 1.53632549
Brca2 1.4142639 Hsd17b1 -­‐1.601239 Fam135a -­‐2.1886646 1.44703985
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Ehd2 -­‐2.198438 -­‐1.4310684 Thbd 1.57758372 Mfsd7c 1.59639171
Gnpnat1 -­‐2.2427114 1.59901817 Fam59b 1.5577031 Sfmbt1 1.46812573
Nsdhl -­‐2.2681434 1.85714563 V1rb4 1.55313017 Errfi1 1.46644845
Cdkn2b -­‐2.3181381 1.72873896 Zfp772 1.54561075 Taf1b 1.46061889
Figf -­‐2.3378437 -­‐2.2676749 Gas5 1.53413439 Armcx3 1.45633319
Cnn2 -­‐2.406833 -­‐1.6980701 Gm5081 1.53201016 Ccl25 1.45094145
Hmgcs1 -­‐2.4936242 2.01395713 Pim3 1.53006309 Zbtb26 1.44200967
Elovl6 -­‐2.5645781 2.13365248 Cftr 1.50134217 Zfp52 1.43849797
Kirrel3 -­‐2.7847759 2.00441949 Zfp715 1.4848643 Zfp113 1.43517177
Phyhd1 -­‐2.8151805 1.86917757 Acvr2a 1.47278634 Lrrc8d 1.43182828
Mrgprf -­‐2.8627782 -­‐2.436233 Akap10 1.47200656 H2-­‐gs10 1.4310383
Fabp5 -­‐2.8785812 2.34144448 Tmem56 1.87443102 Marcksl1 1.42322118
Lonrf3 -­‐2.9056867 2.56711674 Dnajc28 1.79032135 C2cd2l 1.41497937
Fabp5 -­‐2.9136574 2.31190941 Slc7a3 1.761308 Creg1 1.4138431
Arap2 -­‐2.930112 2.36875016 Plb1 1.73891601 Cldn12 1.4045209
Ldlr -­‐2.9911491 1.75481201 Tmem144 1.66376254 Zfp84 1.40376018
Dhcr24 -­‐3.0019595 -­‐2.2866797 Dusp4 1.64606874 Pmvk -­‐1.40292587
Mest -­‐3.5311891 2.06437933 Mknk1 1.61237653 Ranbp6 -­‐1.48558738
Ccl2 -­‐4.2690591 Bbs4 1.60533845 Kctd13 -­‐1.59967382
Gm10661 1.99061696 Prr5l 1.6002238
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Supplementary Table 2-2 List of ATF2 dependent genes differentially regulated 
after IR in S155A/D156A Ku70 expressing MEFs relative to WT Ku70. 
Samples from control and IR-treated (8h and 24h) MEFs were subjected to microarray 
analysis using a GeneChip Mouse Gene 1.0 ST Array (Affymetrics, Santa Clara, CA). 
Gene Chips were processed at the London Regional Genomics Centre (Robarts Research 
Institute, London, ON; http://www.lrgc.ca). Shown is the list of genes previously 
identified as regulated by either ATF3 or ATF2 that were found differentially expressed 
in Ku70 wild-type and Ku70 S155A/D156A cells following IR exposure. Fold 
induction/repression of expression with respect to unirradiated controls is shown for each 
gene and the difference in gene expression between Ku70 wild-type and S155A/D156A 
mutants is shown in brackets. 
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Supplementary Table 2-2 Ku70 vWA mutant expression 
Immunofluorescence analysis of Ku70 expression in untreated Ku70-/- MEFs expressing 
either the WT or mutant Ku70 constructs. Cells were marked positive if showing a Ku70 
expression level above that seen in Ku70-/- + pMSCV cells (Ku70 positive) and were 
also stained with DAPI for total cell count numbers (Total). Expression level is calculated 
as a percent of Ku70 positive cells relative to the total cell count (%). 
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Supplementary Figure 2-3 S155A/D156A Ku70 expression does not inhibit 
phosphorylation of p53 at serine 15. 
Western blot analysis of total p53 and p53 phosphorylated at residue serine 15 (pSer15) 
in wild type (WT) or S155A/D156A (A) Ku70 expressing MEFs that were either mock 
treated or exposed to 4 Gy of IR and collected after the indicated time points.  
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Supplementary Table 2-4 Primers used in this study 
(A) Primers used for site-directed mutagenesis of Ku70. (B) Primers used for RT-PCR 
analyses. 
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Chapter 3 
3 Ku70 phosphorylation mediates Aurora B inhibition and 
activation of the DNA damage response 
3.1 Introduction 
Double-strand breaks (DSBs) are the most dangerous form of DNA damage, as 
improperly repaired, they can result in genetic alterations, leading to genomic instability, 
a hallmark of cancer. Eukaryotic cells employ DNA damage checkpoint surveillance 
mechanisms to allow the damaged cell time to repair its DNA, or eliminate cells damaged 
beyond repair through apoptosis and senescence (1, 2). 
The DNA damage response (DDR) pathway is initiated by sensor proteins that 
accumulate in foci at the site of damage (1, 3). This accumulation of DDR proteins 
activates a phosphorylation cascade as well as modifies surrounding chromatin to allow 
access of the DNA repair factors. The initial sensors include the Mre11-Rad50-NBS1 
(MRN) complex, 53BP1, as well as the serine/threonine (S/T) phosphoinositide-3-kinase 
(PI3K) family members ATM (Ataxia Telangiectasia Mutated), and ATR (Ataxia 
Telangiectasia and Rad3-related). The PI3K-like kinases are the main regulators of the 
DDR and orchestrate many phosphorylation events at the site of DNA damage that 
promote DNA repair (3). The consequences of DNA damage involve temporary cell 
cycle arrest to allow for DNA repair and activation of senescence or apoptotic pathways 
if repair cannot be completed (2, 4). Cellular senescence, although not cytotoxic, is the 
irreversible exit from the cell cycle, while apoptosis is a form of programmed cell death. 
Both prevent the proliferation of potentially genomically unstable cells, thereby 
eliminating the chance of neoplastic transformation (2, 4). 
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Aurora kinases (Aurora-A, -B and -C) are a family of serine/threonine kinases 
that play essential roles in cell cycle progression (5). Aurora B coordinates the mitotic 
process, functioning to regulate many aspects of mitosis including chromosome-
microtubule interactions, spindle assembly, sister chromatid and centromeric cohesion 
and cytokinesis (5). Aurora B’s activities, however, are not restricted to mitosis, as it is 
expressed throughout the cell cycle and there is evidence that it also contributes to G1/S 
and G2/M checkpoint regulation (6, 7). As a mitotic kinase, Aurora B kinase activity is 
tightly regulated during cell cycle checkpoints and deregulation of its activity can have 
devastating consequences. Ectopic expression of both Aurora A and B results in 
chromosomal abnormalities and cellular transformation, and overexpression of Aurora 
kinases is observed in a number of different cancers (5, 8-10). Consequently Aurora 
kinases were identified as possible druggable targets and a number of Aurora kinases 
inhibitors have been developed for anti-cancer therapy (8, 11). Aurora B inhibitors were 
shown to prevent cytokinesis and cause cell growth inhibition and cell cycle arrest (12-
14). While Aurora B has been implicated in the cellular response to DNA damaging 
agents (15, 16), a thorough understanding of the regulation of Aurora kinase activity 
following genotoxic stress is lacking. 
DSBs are repaired by one of three pathways: homologous recombination (HR), 
which occurs primarily in the G2 and M phases, micro-homology mediated end joining 
(MMEJ), a backup pathway, and non-homologous end joining (NHEJ), the predominant 
repair pathway in higher eukaryotes, which occurs in the G1 and S phases (17, 18). Ku 
has a well-characterized role as the DNA binding component of NHEJ (19). Ku is a 
heterodimer composed of subunits Ku70 and Ku80 (70 and 86 kDa, respectively) which 
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share structural similarity and are conserved from bacteria to man. Each subunit contains 
an N terminal α/ß von Willebrand A (vWA) like domain, central ß-barrel domain and a 
divergent C terminal helical region (20). The Ku dimer forms an asymmetrical ring lined 
with positively charged and hydrophobic residues that can accommodate the double-
stranded DNA backbone independent of sequence (21). Following the introduction of a 
DSB, Ku rapidly binds the broken end and forms a complex with the PI3K-like kinase 
DNA-PKcs to recruit other NHEJ repair factors and facilitate repair of the break (22). Ku 
also has important functions in telomere maintenance and protection, and Ku-deficiency 
leads to telomere defects (23, 24).  
There is increasing evidence that the Ku N-terminal regions play important roles 
in NHEJ as well as in telomere maintenance and apoptotic signaling. Ku70 residues 
D192/D195 in Helix 5 of the vWA domain are essential for NHEJ and cell survival 
following DNA damage (25-27). Other lysine residues nearby, K160 and K164, have 
been shown to confer lyase activity and are involved in DNA processing during NHEJ 
(28, 29). The Ku70 and Ku80 N-terminal domains have structural similarities with the 
von Willebrand A (vWA) domain, an ancient, evolutionarily conserved domain that is 
found in several extracellular and intracellular proteins, where it mediates protein-protein 
interactions (30). Indeed Ku forms numerous protein interactions during NHEJ and other 
processes, and some of these map to the vWA domain (19). Examples include the NHEJ 
factor Aprataxin and PNKP-like Factor (APLF), which binds to the Ku80 vWA domain, 
and the Telomere Repeat Binding Factor 2 (TRF2), which interacts with the Ku70 vWA 
domain (26, 31).   
Our previous investigation focused on identifying key residues in the Ku70 vWA 
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domain involved in the cellular response to DNA damage (25). We demonstrated that 
mutation of Ku70 serine 155 to alanine increased survival and decreased apoptotic 
activation following DNA damage, relative to wild-type (WT) Ku70 despite having no 
impact on DNA repair efficiency. Furthermore, this mutation prevented the activation of 
a DDR, dependent upon Activating Transcription Factor 2 (ATF2). Since this residue was 
a serine, a common site for phosphorylation in the DDR, we hypothesized that this 
mutation was preventing a phosphorylation event. Indeed, a phosphomimetic substitution 
of S155 to aspartic acid (S155D) constitutively activated ATF2 and conferred a severe 
hypersensitivity to IR.  
In the present study, we demonstrate that Ku70 S155 is indeed phosphorylated 
after IR, and show that constitutive expression of the phosphomimetic mutant Ku70 
S155D induces a DDR marked by a constitutive activation of ATM and cell cycle arrest 
at both the G1/S and G2/M checkpoints. Additionally, we show that Ku70 S155D 
interacts with the Aurora B kinase and mediates the inhibition of its kinase activity. The 
interaction of WT Ku70 and Aurora B was detected following IR treatment, but not in 
absence of DNA damage. We therefore propose that Ku70 is phosphorylated after IR at 
serine 155 and this mediates the interaction and inhibition of Aurora B, resulting in 
activation of the DDR and cell cycle arrest. 
3.2 Materials and methods 
3.2.1 Plasmid Expression Constructs 
Ku70 WT, S155D and S155A pMSCVpuro constructs were previously described 
(25). Ku70 WT, S155D vWA-FLAG pMSCVpuro constructs were produced by 
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subcloning the XhoI and EcoRV fragment (aa 1-250) of full length Ku70 into the 
pMSCVpuro vector, and then inserting a FLAG tag by oligonucleotide annealing (Sigma-
Aldrich, Oakville, ON).  
3.2.2 Cell Culture and Treatments 
Immortalized Ku70-/- MEFs were obtained from S. Matsuyama (Case Western, 
Cleveland). IMR-90 cells were obtained from ATCC. All cells were cultured in high 
glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) at 37°C in 5% CO2. Ku70-/- MEFs stably re-expressing Ku70 WT 
and mutants were generated as previously described (25). To assess proliferation rates, 
the Ku expressing MEFs were seeded in triplicate in 6-well dishes. At each time point 
cells were trypsinized, counted using a hemocytometer, and the mean number of cells 
was determined. Percent growth was obtained by dividing the number of cells at each 
time point by the number of cells at day 1. For irradiation experiments, cells were plated 
the night before at 50-70% confluency. Irradiations were performed with a Faxitron RX-
650 at a dose rate of 1.42 Gy/min. For ATM inhibitor treatments, MEFs were incubated 
with 10 µM of KU-55933 (Selleck Chemicals, Houston, TX) for 1 hour prior to 4 Gy of 
irradiation. For Aurora B inhibitor treatments, MEFs were incubated with 20 µM of 
AZD-1152 (Sigma-Aldrich) for 48 hours. 
3.2.3 Extracts, Immunoprecipitation, and Western blot analyses 
Nuclear Extracts were prepared as described previously (70). For co-
immunopreciptation experiments, extracts were adjusted to 0.15% NP-40 and 100 mM 
KCl, and incubated overnight at 4°C with Ku70 antibody (N3H10, Santa Cruz, Santa 
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Cruz, CA). Immunoprecipitates were isolated with Pierce Protein G magnetic beads 
(ThermoFisher Scientific, Rockford, IL). For Western blot analysis, extracts were 
resolved by SDS-PAGE, transferred onto a PVDF (Polyvinylidene fluoride) membrane 
and hybridized with the following antibodies: β-actin (I-19, Santa Cruz), Ku70 (N3H10, 
Santa Cruz), p21 (C-19, Santa Cruz), phospho-serine 1981 ATM (Pierce, ThermoFisher 
Scientific), ATM (Pierce, ThermoFisher Scientific), phospho-serine 10 Histone H3 (Cell 
Signaling, Danvers, MA), Aurora B (H-75, Santa Cruz), FLAG (Sigma-Aldrich). The 
blots were developed using the Clarity Western ECL substrate (Bio-rad, Hercules, CA) 
and imaged on the Molecular Imager® ChemiDocTM XRS system (Bio-Rad). 
Quantifications were performed using Image Lab software (Bio-Rad). 
3.2.4 Aurora B Kinase Assay 
Immunoprecipitation was performed as described above with the Aurora B 
antibody (H-75, Santa Cruz). Immunoprecipitates were resuspended in kinase buffer (20 
mM Tris-HCl, 20 mM KCl, 20 mM MgCl2, 0.4 µM ATP, 0.4 mM DTT) and incubated 
with 1 µg of purified Histone H3.1 (Cell Signaling) for 1 hour at 37°C. Phosphorylation 
was detected by western blot with a phospho-H3S10 antibody (Cell Signaling). 
3.2.5 β-Galactosidase Senescence Assay 
IMR-90 Cells were plated on 35mm dishes or on glass coverslips in 24-well 
dishes. Cells were washed three times with Phosphate Buffer Saline (PBS) and fixed with 
4% paraformaldehyde for 15min at 4°C. The staining solution (40mM citric acid/Na 
phosphate buffer, 5mM K4[Fe(CN)6] 3H2O, 5mM K3[Fe(CN)6], 150mM NaCl, 2mM 
MgCl2, 1mg ml-1 X-Gal (Bioshop Canada Inc, Burlington, ON) in DMSO, pH 6.0)  was 
added to each dish and incubated for 12-16h at 37°C. Cells were viewed by bright field 
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microscopy. Pictures were taken and blue cells cells were counted as a percentage of total 
cells. 
3.2.6 Reverse Transcriptase PCR (RT-qPCR) 
Total RNA was isolated using the Qiagen RNeasy RNA extraction kit. RNA (2 
µg) was reverse transcribed with the Superscript II cDNA kit (Invitrogen, ThermoFisher 
Scientific). Quantitative PCR was performed using Bio-Rad MyiQ single-color real-time 
PCR detection and the Bio-Rad IQ SYBR green mix. The relative quantification of 
specific gene expression was determined by the ΔΔCT method, with the target gene 
threshold cycle (CT) values normalized to that of the beta-2-microglobulin control. 
Primers are listed in Figure E4. 
3.2.7 Cell Cycle Analysis by Fluorescence Activated Cell Sorter 
(FACS) 
Cells were incubated with 10 µM EdU for 1 hour then collected by trypsinization 
at a final concentration of 1 × 107 cells/ml. The samples were processed using the EdU 
Click-It Alexa 647 Flow cytometry kit (Invitrogen) then stained in 0.1% Triton X-100 
(Sigma-Aldrich), 0.2 mg/mL DNase-RNase A (Sigma-Aldrich), and 20 ug/mL of 
propidium iodide (Sigma-Aldrich). Cell cycle FACS was performed on a Calibur II (BD 
Biosciences, Mississauga, ON) and 50,000 gated events were measured per sample. Cell 
cycle modeling and statistics were performed on FlowJo software. All procedures were 
performed at the London Regional Flow Cytometry Facility. 
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3.2.8 Immunofluorescence 
Cells were seeded at 60-80% confluence on 10 mm glass coverslips, washed in 
cold PBS and fixed in 3% paraformaldehyde. Cells were permeabilized in 0.5% Triton-X 
and blocked in 5% FBS, followed by incubation with primary antibodies: phospho-serine 
139 H2AX antibody (Abcam, Cambridge, UK), phospho-serine 1981 ATM (Pierce), 
Histone H3 phospho-serine 10 (Cell Signaling), 53BP1 (Pierce) and then with AlexaFluor 
488/555/647 secondary antibodies (Invitrogen). All coverslips were mounted onto glass 
slides using ProLong Gold containing DAPI (Invitrogen). Cell pictures were taken with 
an Olympus BX51 microscope at 40x magnification using the Image-Pro Plus software
(Media Cybernetics, Inc., Bethesda, MD). For γ-H2AX, 53BP1 and phospho-H3S10 
analyses, cells were scored for the presence of foci, with DAPI nuclei staining used for 
total cell count. Foci-containing cells were quantified as a percentage of total cells, and 
approximately 500 cells were counted for each experimental condition per experiment.  
The in situ proximity ligation assay (PLA) was performed with the Duolink 
(Olink Biosciences, Uppsala, Sweden) kit as per manufacturer instructions with minor 
modifications. MEFs were plated at 50-70% confluency onto 10 mM glass coverslips 
containing a hydrophobic wax boundary. Coverslips were fixed and permeabilized as 
described above and incubated overnight with Ku70 (Santa Cruz) and Aurora B (Santa 
Cruz) primary antibodies. Immunofluorescence images were obtained as described 
above. DAPI nuclei staining was used for total cell count and PLA signal was quantified 
by pixel density measurement in Image J software. The pixel density of the PLA was 
normalized to total cell count to obtain a mean PLA signal per cell. These measurements 
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were then normalized to the background signal obtained in Ku70-/- MEFs control 
samples.  
3.2.9 Mass spectrometry and Protein Identification 
For phosphorylation identification, 70% confluent MEFs were mock-treated or 
treated with 40 Gy of IR and incubated for 30 minutes. 10 mg of nuclear extracts were 
adjusted to 100 mM KCl, 2% NP-40 and immunoprecipitated as described above with a 
Ku70 antibody (Santa Cruz). Immunoprecipitates were boiled in 1X SDS loading buffer 
(2% SDS, 2mM DTT, 5% Glycerol, 40 mM Tris-HCl, 0.01% bromophenol blue), run on 
an SDS-PAGE gel and stained with Coomasssie Blue G-250 (Protea Biosciences, 
Morgantown, WV).  
For peptide pull-down and protein identification, 4 mg of untreated or 10 Gy-
treated MEF extracts were incubated for 2 hours with one of the following N-terminal 
biotin-conjugated peptides (Genscript, Piscataway, NJ): biotin-
EVLWVCANLFADVQFKMSH, biotin-EVLWVCANLFDDVQFKMSH. 10 µg of 
peptide was pre-coupled to 40 µl of Steptavidin beads (Invitrogen) for 30 min at room 
temperature. Pre-coupled beads and extracts were incubated for 2 hours at 4°C. Beads 
were washed in (Tris buffer saline, 0.1% Tween20), boiled in 1X SDS loading buffer and 
run on SDS-PAGE gel. Gels were stained with the Silver Stain Plus Kit (Bio-Rad) as per 
manufacturer instruction.  
In-gel digestion was performed using a MassPREP automated digester station 
(PerkinElmer, Waltham, MA). Gel pieces were Coomassie de-stained using 50 mM 
ammonium bicarbonate and 50% acetonitrile or silver de-stained using a 50 mM sodium 
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thiosulphate 5 hydrate and 15 mM potassium ferricyanide solution, which was followed 
by protein reduction using 10 mM dithiotreitol (DTT), alkylation using 55 mM 
iodoacetamide (IAA), and tryptic or chymotryptic digestion. Peptides were extracted 
using a solution of 1% formic acid and 2% acetonitrile and lyophilized. Prior to mass 
spectrometric analysis, dried peptide samples were re-dissolved in a 10% acetonitrile and 
0.1% TFA (trifluoroacetic acid) solution. 
Mass Spectrometry data were obtained using an AB Sciex 5800 TOF/TOF 
System, MALDI TOF TOF (Framingham, MA, USA). Data acquisition and data 
processing were respectively done using a TOF TOF Series Explorer and Data Explorer 
(AB Sciex).  The instrument is equipped with a 349 nm OptiBeam On-Axis laser. The 
laser pulse rate is 400 Hz. Reflectron positive mode was used.  Reflectron mode was 
externally calibrated at 50 ppm mass tolerance and internally at 10 ppm.  Each mass 
spectrum was collected as a sum of 400 shots. MALDI matrix, α–cyano–4–
hydroxycinnamic acid (CHCA), was prepared as 5 mg/mL in 6mM ammonium phosphate 
monobasic, 50% acetonitrile, 0.1 % trifluoroacetic acid and mixed with the sample at 1:1 
ratio (v/v). All procedures were performed at the London Regional Proteomics Centre 
(LRPC).  
3.2.10 Statistical Analyses 
Differences between multiple groups was determined an analysis of variance 
(ANOVA) and differences between two groups was determined by an unpaired two tail t-
test. Results were considered significant when P< 0.05. 
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3.3 Results 
3.3.1 Ku70 S155 is phosphorylated in response to DNA damage 
We previously established a retroviral system using a murine stem cell virus 
construct (pMSCV) to stably re-express WT Ku70 and Ku70 mutants in immortalized 
Ku70-deficient mouse embryonic fibroblasts (Ku70-/- MEFs). Using this system, we 
determined that MEFs expressing Ku70 S155 amino acid substitutions exhibited altered 
survival following IR treatment (25). A mutant Ku bearing a Ku70 S155 substitution to 
alanine (Ku70 S155A) enhanced survival following IR treatment, causing a DNA damage 
signaling defect and compromising the activation of apoptosis in response to DNA 
damage. In contrast, substitution to a phosphomimetic residue (S155D) conferred 
hypersensitivity to IR treatment. These analyses suggested that S155 is a phosphorylation 
site that is targeted for phosphorylation in response to DNA damage. To determine 
whether this site is phosphorylated following DNA damage, we conducted Mass 
Spectrometry (MS) analyses on Ku70 immunoprecipitated from nuclear extracts obtained 
from WT Ku70-expressing MEFs either untreated, or 30 minutes following a 40 Gy IR 
treatment.  Chymotryptic digestion of immunoprecipitated Ku peptides revealed a peak 
corresponding to a peptide doubly phosphorylated at positions S155 and S162 in the 
irradiated sample, but not in the unirradiated control samples (Supplementary Figure 3- 
1B). To confirm these results, we repeated the analysis with extracts obtained from Ku70 
S155A-expressing MEFs. In this case, only a mono-phosphorylated peptide was 
observed, consistent with the mutation preventing phosphorylation at S155 and being 
solely phosphorylated at S162 (Supplementary Figure 3-1C). Thus, we repeated the 
procedure with MEFs expressing a Ku70 mutant bearing an alanine substitution at 
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position S162. Again, only one peak corresponding to the mono-phosphorylated peptide 
was observed, suggesting that this peptide was now only phosphorylated at the S155 
position (Supplementary Figure 3-1D). Neither control samples obtained from Ku70 
S155A or S162A expressing MEFs contained a peak corresponding to a peptide with 
phosphorylated S155. Overall these results suggest that Ku70 is phosphorylated at S155 
after IR. 
3.3.2 Ku70 S155D induces cell cycle arrest 
While the expression of the Ku70 S155D mutant in Ku70-/- MEFs led to a strong 
hypersensitivity to IR (25), we also noted that Ku70 S155D-expressing MEFs 
proliferated abnormally under standard culturing conditions. Growth rate analysis in the 
absence of any DNA damaging agent showed that expression of Ku70 S155D conferred a 
marked defect in proliferation, as these cells exhibited a 5.7-fold decrease in percent 
growth compared to Ku70-/- MEFs re-expressing Ku WT by the fifth day of culture, and 
were even 3.6-fold slower than Ku70-/- MEFs, which have been previously reported to 
have proliferation defects (32) (Figure 3-1A). In contrast, the Ku70 S155A expressing 
MEFs proliferated faster than the WT counterparts, achieving a 1.8-fold increase over 
Ku70 WT MEFs by the fifth day of culture. In order to further analyze this proliferation 
defect, we compared the cell cycle profile of Ku70 WT, S155D, S155A cells and Ku70-/-
MEFs (Figure 3-1B). Fluorescence activated cell sorting (FACS) analysis of Ku70 
S155D-expressing MEFs showed that 46% of cells were in G1 phase, higher than the 
approximately 30% seen in the other three cell lines. Similarly, 27% of Ku70 S155D-
expressing MEFs were in the G2 phase, higher than the approximately 8% seen in the 
WT, S155A and Ku70-/- cells (Figure 3-1B). Altogether this indicates that the Ku70  
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Figure 3-1 Expression of Ku70 S155D triggers cell cycle arrest 
(A) Ku70 S155 mutants confer altered cell proliferation. Growth rates of Ku70-/- MEFs 
expressing Ku70 WT, S155A, S155D or empty vector were assessed for 5 days. Data 
represents percent growth relative to Day 1 of three independent experiments with error 
bars indicating SEM (*P<0.05, all cell lines compared to WT).  (B)  Ku70 S155D cells 
arrest in G1 and G2. FACS analysis of DNA content and EdU incorporation in 
asynchronous Ku70-/- MEFs expressing Ku70 WT, S155A, S155D or empty vector 
(Ku70-/-) stained with propidium iodide and Anti-Edu Alexa 647. Average percentage 
was determined by FlowJo cell cycle analysis in three separate experiments with error 
bars indicating SEM (*P<0.01 S155D compared to all other cell lines).  
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serine 155 residue regulates cellular proliferation and the expression of the 
phosphomimetic S155D mutation induces cell cycle arrest at both the G1/S and G2/M 
checkpoints. 
In order to analyze the global transcriptional changes that resulted in cell cycle 
arrest, an Affymetrix GeneChip was performed using RNA from Ku70-/-MEFs expressing 
Ku70 WT and S155D. Several genes were either up- or downregulated in the Ku70 
S155D-expressing MEFs relative to WT control (Supplementary Table 3-1), and 
subsequently, some were validated by RT-qPCR (Figure 3-2A). Cyclin D and CDK6, two 
proteins that form a complex to promote the progression through the G1/S checkpoint 
and Cyclin B, whose expression increases during the G2/M transition (33), were found 
5.1-, 13.7-, and 7.2-fold downregulated, respectively, in Ku70 S155D-expressing MEFs. 
Similarly, expression of Protein phosphatase 1 (PP1), a serine/threonine phosphatase, 
involved in the dephosphorylation of several targets during the DDR to resolve DNA 
damage checkpoints (34), was 28.8-fold downregulated in Ku70 S155D-expressing 
MEFs. Finally, the X-linked inhibitor of apoptosis-associated factor 1 (XAF-1), which 
regulates apoptosis and G2/M arrest (35, 36), was upregulated by 5.1-fold in Ku70 
S155D MEFs. We also assessed the protein levels of p21, an inhibitor of cyclin D and B-
CDK complexes which is upregulated in a p53 dependent manner following DNA 
damage and activates the G1 and G2 cell cycle checkpoints (37, 38). Western blot 
analysis showed that while Ku70 WT MEFs required IR treatment to induce expression 
of p21, Ku70 S155D cells displayed a marked upregulation of p21 in the absence of any 
treatment (Figure 3-2B). Conversely, the Ku70 S155A MEFs failed to upregulate p21 
levels, even after IR treatment (Figure 3-2C). Overall, consistent with the observation  
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Figure 3-2 Ku70 S155D-expressing MEFs display altered expression of cell cycle-
related factors.  
(A) RT-PCR analysis of Cyclin D, Cyclin B, CDK6, PP1 and XAF-1 gene expression. 
RNA samples from WT or S155D Ku70-expressing MEFs were analyzed by RT-qPCR 
using primer sets specific for the indicated genes. The fold change in gene expression of 
Ku70 S155D relative to Ku70 WT MEFs is shown, with error bars indicating SEM 
(**P<0.01, *P<0.05). (B) Comparison of p21 expression in Ku70 WT and mutant MEFs. 
Representative western blot analysis of p21 in Ku70 WT and S155D expressing MEFs 
without IR (above) and p21 induction at the time points indicated after 10 Gy of IR in 
Ku70 WT and S155A MEFs (below). Similar amount of extracts were loaded on both 
gels (30 µg). Due to the strong expression of p21 in the Ku70 S155D MEFs, the western 
blot on the left required only a 30-second exposure, compared to a 10-minute exposure 
for the western blot on the right required to obtain a similar intensity of p21 signal in 
response to DNA damage. Exposure time for the actin signal is similar for both western 
blots. 
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that the expression of Ku70 S155D results in the arrest of cells in the G1 and G2 phases, 
this mutant alters the expression of cyclins known to regulate the progression through 
both the G1/S and G2/M checkpoints, and markedly upregulates the cell cycle inhibitor 
p21. 
3.3.3 Ku70 S155D induces a DNA damage response 
We previously determined that an alanine substitution at Ku70 S155 decreased 
activation of apoptosis via an ATF2-dependent DDR pathway following IR treatment 
(25). The altered proliferation of Ku70 S155 mutant-expressing MEFs however, was 
occurring in the absence of any DNA damaging agent, and it was not clear whether this 
phenotype was related to the DDR defect observed previously, or if it was a direct effect 
of Ku on the cell cycle. To test this, we examined the presence of active DNA damage 
response markers following the expression of Ku70 S155 mutants. Surprisingly, 
immunofluorescence (IF) analysis of Ku70 S155D-expressing MEFs showed 
significantly increased ϒ-H2AX and 53BP1 foci formation compared to both Ku70 WT 
and S155A-expressing MEFs, in the absence of any DNA damage treatment (Figure 3-
3A,B). Furthermore, western blot analysis for activated ATM, marked by an auto-
phosphorylation at serine 1981, showed increased levels (relative to WT) in untreated 
S155D MEFs, while S155A MEFs had very little activation of ATM after even IR 
(Figure 3-3C). Interestingly, pre-treatment of cells with the ATM inhibitor KU-55933 
prevented activation of ATM after IR in Ku70 WT and S155A MEFs, but had no impact 
on ATM activation in Ku70 S155D MEFs, suggesting that in these cells, ATM is 
constitutively phosphorylated at least to the same levels as those reached in response to 
10 Gy of IR (Figure 3-3C) (39). Overall, these observations suggest that expression of the 
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Figure 3-3 Ku70 S155D expression induces a DNA damage response in the absence 
of DNA damage.  
(A) Cells were analyzed by immunofluorescence with a Υ-­‐H2AX antibody with 
representative pictures shown (left). Foci-containing cells were quantified and shown as 
an average of three experiments with error bars indicating SEM (right) (**P<0.01, 
*P<0.05). Scale bars, 10 µm. Cells were scored positive when containing more than 5
foci.  (B) Same procedure as in A, but the analysis was performed with a 53BP1 
antibody. (C) Western blot analysis of p-S1981 ATM in Ku70 S155D, WT and S155A 
expressing MEFs. Samples were either left untreated (control), collected 30 minutes 
following 10 Gy of IR (IR), or collected 30 minutes after 10 Gy of IR following a 1 hour 
incubation with 10 µM ATM inhibitor (ATMi). Quantification of four separate 
experiments is shown (below) with error bars indicating SEM.  
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phosphomimetic Ku70 S155D constitutively activates an ATM-dependent DNA damage 
response pathway, in the absence of ectopically-induced DNA damage. 
3.3.4 Ku70 S155D vWA domain is sufficient to induce cell cycle 
arrest 
Ku is well characterized as a DNA binding protein functioning in both DNA 
repair via the NHEJ pathway and the protection of telomere ends (19). Although it 
appeared as though the Ku70 S155D mutation induced a constitutive signal for the DDR, 
the signaling mechanism was unclear. In order to test whether the DNA binding activity 
of Ku was needed to produce the DDR induced by Ku70 S155D, we generated truncated 
Ku70 Flag-tagged constructs containing only the vWA domain, either with the WT 
sequence or with the S155D substitution. The central ring domain is required for 
Ku70/Ku80 heterodimerization and DNA binding activity, so a truncated Ku70 construct 
containing only the vWA domain cannot fulfill either function (20). Similar to the full-
length (FL) Ku70 S155D construct, the expression of the S155D vWA domain in Ku70-/- 
MEFs significantly decreased proliferation, as by the fifth day the Ku70 S155D vWA 
MEFs had a 16.4-fold lower proliferation rate as compared to the Ku70-/- MEFs 
expressing Ku70 WT vWA domain control (Figure 3-4A). Also, consistent with what 
was observed previously with Ku70 S155D, western blot analysis demonstrated a marked 
upregulation of p21 levels in Ku70 S155D vWA MEFs compared to Ku70 WT vWA 
control cells (Figure 3-4C). This suggests that recruitment of the Ku70 S155D mutant to 
DNA is not required to induce a DDR. These results were obtained in a Ku70 null 
background, so we sought to determine whether the Ku70 S155D mutation would have a 
dominant effect in a cell line that had normal Ku70 expression. Expression of the  
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Figure 3-4 N-terminal Ku70 S155D domain is sufficient to induce a DDR and cell 
cycle arrest. 
(A) Growth rates of Ku70-/- MEFs expressing Ku70 WT or S155D vWA domain 
constructs were assessed for 5 days. Data represent percent growth relative to Day 1 of 
three independent experiments with error bars indicating SEM (*P<0.05 compared to 
WT).  (B) Growth rates of IMR-90 cells were assayed as described above, for 10 days. 
(C) Western blot analysis of p21 levels in IMR90 and Ku70-/- MEFs expressing either 
Ku70 WT or S155D vWA domain.  (D) IMR-90 cells expressing Ku70 WT or S155D 
vWA domain truncated constructs were stained with a solution containing X-gal (5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside). Senescence induced over expression 
of the β-galactosidase enzyme cleaves X-gal to produce a blue dye observed in bright 
field microscopy. The percentage of cells stained blue were quantified and shown as an 
average of three experiments with error bars representing SEM (*P<0.05). Scale bars, 10 
µm. 
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retroviral Ku70 vWA-only constructs in the human cell line IMR-90 produced similar 
results, with the Ku70 S155D vWA domain significantly reducing proliferation by 3-fold 
compared to the Ku70 WT vWA domain at the tenth day of culture (Figure 3-4B). Again, 
a marked upregulation of the p21 protein levels in the S155D vWA-expressing IMR-90 
cells was observed compared to WT vWA as measured by western blot (Figure 3-4C). 
Additionally, in this cell line, a senescence phenotype was observed (4), as a significantly 
increased level of beta-galactosidase activity was found in S155D expressing cells 
relative to WT (Figure 3-4D). Overall, the Ku70 S155D vWA domain does not require 
heterodimerization with Ku80 nor end-binding capabilities to induce cell cycle arrest and 
this phenotype is dominant to WT Ku. 
3.3.5 Ku70 S155D interacts with and inhibits Aurora B 
Given that the Ku70 S155D vWA domain lacking both its DNA binding domain 
and the ability to heterodimerize with Ku80 induced cell cycle arrest, we hypothesized 
that this domain was acting by binding to another factor(s) and either constitutively 
activating or inhibiting its activity. A general screen for interacting factors was performed 
using biotin-conjugated peptides of the loop region surrounding S155 (aa 145 to 163) and 
comparing factors that bound to peptides containing either an alanine or aspartic 
phosphomimetic mutant at the serine 155 position. S155A or S155D peptides were 
incubated with MEF nuclear extracts from cells that were either untreated or subjected to 
10 Gy of IR. Interacting factors were pulled down with streptavidin beads and identified 
by mass spectrometry.  
MS analysis identified Aurora B as a factor interacting with the S155D peptide in  
control and IR-treated extracts (Supplementary Figure 3-2). The interaction of Aurora 
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B with the S155D peptide was validated using pull-down of WT MEF extracts with S155 
A/D peptides followed by western blot analysis (Figure 3-5A). We then verified the 
interaction between Aurora B and full length Ku70 S155D. Ku70 was 
immunoprecipitated from nuclear extracts from Ku70-/- MEFs (used as a control), and 
Ku70-/- MEFs re-expressing WT Ku70 or Ku70 S155D. Endogenous Aurora B was 
efficiently co-immunoprecipitated with Ku70 S155D, indicating that Aurora B interacts 
with the phosphomimetic form of Ku70 (Figure 3-5B). However, very little Aurora B 
was observed in the WT Ku70 immunoprecipitates, suggesting that phosphorylation of 
S155 is needed for interaction between the two proteins. 
Aurora B, a member of the serine/threonine family of Aurora kinases, promotes 
the progression of the cell cycle through the G1/S, G2/M and mitotic checkpoints by the 
phosphorylation of several targets (5). Interestingly, studies examining the potential for 
Aurora B inhibitors in cancer therapy showed that chemical inhibition of Aurora B results 
in cell cycle arrest and the activation of several DDR markers, notably ϒ-H2AX and 
53BP1, ATM S1981 phosphorylation and upregulation of p21 (15, 16). Thus, the effects 
of Ku70 S155D expression appeared to be similar to those reported in response to Aurora 
B inhibition, suggesting the possibility that interaction between Ku70 S155D and Aurora 
B could inhibit Aurora B.   
First we investigated whether inhibition of Aurora B in Ku70 WT MEFs produced 
the same cellular response as that observed in MEFs expressing the Ku70 S155D mutant. 
Treatment of WT MEFs with 20 µM of the Aurora B selective inhibitor AZD-1152 (40) 
for 48 hours triggered a marked upregulation of the cell cycle inhibitor p21 relative to 
control (vehicle-treated) samples as measured by western blot analysis (Figure 3-6A).  
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Figure 3-5 Ku70 S155D interacts with Aurora B.  
(A) Aurora B interacts with a Ku70 S155D peptide. Biotin-conjugated peptides of the 15 
amino acids surrounding Ku70 S155 containing either a S155A or S155D substitution 
were used in a biotin-streptavidin pull-down with untreated WT Ku70 MEF extracts. 
Shown is a western blot analysis of Aurora B present in the samples pulled-down with 
the indicated peptides.  (B) Interaction of Aurora B with Ku70 S155D. Extracts from 
Ku70-/- MEFs stably expressing Ku70 WT, Ku70 S155D or empty vector were 
immunoprecipitated with a Ku70 antibody. The immunoprecipitates were analyzed by 
western blot with antibodies against Ku70 and Aurora B. 
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Figure 3-6 Aurora B chemical inhibition induces a DNA damage response. 
(A) Western blot analysis of p21 and p-S1981 ATM levels in WT Ku70 MEFs treated for 
48h with either 20 μM of the Aurora B inhibitor AZD-1152 (+) or the DMSO vehicle 
control (-). (B) RT-PCR analysis of Cyclin B, CDK6, Cyclin D and XAF-1 in WT Ku70 
MEFs treated with Aurora B inhibitor as described in A, normalized to the DMSO 
vehicle control (*P<0.05). (C) Immunofluorescence analysis of γ-­‐H2AX and 53BP1 foci 
formation in MEFs treated with either AZD-1152 or the DMSO vehicle control as 
described above. Cells were scored positive when containing more than 5 foci and the 
results shown are averaged from three experiments with error bars indicating SEM 
(*P<0.05). Scale bars, 10 µm. 
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Next, we looked at the effect of Aurora B inhibition on the expression of the 
genes that we found deregulated in cells expressing Ku70 S155D. RT-PCR analysis of 
RNA extracted from Ku70 WT-expressing MEFs treated with AZD-1152 revealed, 
similar to what was observed in Ku70 S155D-expressing cells, Cyclin B, Cyclin D and 
CDK6 expression was significantly downregulated relative to the vehicle control-treated 
cells (Figure 3-6B). Lastly, we investigated the effect of Aurora B inhibition on the 
activation of the DDR. Immunofluorescence analysis of ϒ-H2AX and 53BP1 foci 
formation revealed that treatment of Ku70 WT MEFs with AZD-1152 significantly 
increased both 53BP1 and ϒ-H2AX foci (Figure 3-6C). Western blot analysis also 
showed an increase in ATM activation in the AZD-1152-treated samples, as determined 
by the pS1981-ATM levels (Figure 3-6A). Thus, Aurora B inhibition induced a DNA 
damage response and transcriptional changes that mirrored those induced by Ku S155D 
expression.  
Since Ku70 S155D-expressing MEFs display cell cycle arrest and activation of a 
DNA damage response, a phenotype observed in Aurora B inhibitor-treated MEFs, we 
hypothesized that Ku70 S155D interaction with Aurora B could be inhibiting the activity 
of Aurora B. To explore the impact of Ku70 S155D expression on Aurora B kinase 
activity, we monitored phosphorylation of histone H3 on serine 10 (H3S10), which is 
catalyzed by Aurora B (9, 41, 42). Immunofluorescence analysis of phospho-H3S10 in 
MEFs expressing either WT or Ku70 S155D revealed that Ku70 S155D expression led to 
significantly decreased H3S10 phosphorylation compared to WT (11% of phospho-
H3S10 foci-containing cells versus 43% in S155D) (Figure 3-7A). However, although 
this result showed that the Ku70 S155D expression led to the loss of a specific Aurora B  
152 
152 
Figure 3-7 Ku70 S155D inhibits Aurora B kinase activity. 
(A) Immunofluorescence analysis of phospho-H3S10 foci formation in Ku70 WT and 
S155D-expressing MEFs. Foci-positive cells were counted as a percentage of total cells 
and shown is the average of three experiments with error bars indicating SEM (*P<0.05). 
Scale bars, 10 µm.  (B) Aurora B kinase activity assay. Ku70 WT or S155D-expressing 
MEF nuclear extracts were immunoprecipitated with an Aurora B antibody or IgG 
control. The immunoprecipitates were then incubated with 1 µg of purified Histone H3 
and 10 µM of ATP and analyzed by western blot with antibodies to phospho-H3S10, 
Aurora B and Ku70. Phospho-H3S10 western blot signal was quantified and shown as an 
average of three separate experiments with error bars indicating SEM (*P<0.05)  
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phosphorylation event, the loss of H3S10 phosphorylation would be expected to happen 
in cells experiencing prolonged cell cycle arrest and no longer undergoing mitosis. To 
show that this was not the result of cell arrest, but a direct effect of Ku70 S155D on 
Aurora B kinase activity, we carried out an in vitro assay in which endogenous Aurora B 
was immunoprecipitated from either Ku70 WT or S155D-expressing MEFs and 
incubated with purified histone H3. Western blot analysis using an antibody directed 
against phosphorylated H3S10 detected phosphorylation with Aurora B 
immunoprecipitates from Ku70 WT-expressing MEFs in this assay (Figure 3-7B). 
However, phosphorylation of H3S10 was significantly lower (2.9-fold) in 
immunoprecipitates from Ku70 S155D-expressing MEFs, suggesting that complex 
formation of Aurora B and Ku S155D has an inhibitory effect on Aurora B kinase 
activity (Figure 3-7B).  
3.3.6 Ku70 and Aurora B interact following DNA damage 
Thus far, our results indicated that Ku70 S155 was phosphorylated in response to 
IR and that Ku70 comprising the phosphomimetic substitution S155D interacted with and 
inhibited the activity of Aurora B. These data led us to speculate that in vivo, Ku70 
phosphorylation after IR could function to inhibit the activity of Aurora B and prevent 
cell cycle progression, potentially leading to the activation of cell cycle checkpoints and 
senescence. In order to test this model, we sought to determine if Ku70 and Aurora B 
interact following IR treatment. Since the localization of Ku to DSBs is difficult to 
observe directly by microscopy (43), we employed a proximity ligation assay (PLA), a 
method that was developed to monitor interactions of endogenous proteins directly in 
individual cells by immunofluorescence (44). Briefly, following incubation with primary 
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antibodies against the two proteins of interest, cells are incubated with secondary 
antibodies linked to short DNA oligonucleotides, called PLA probes. When two PLA 
probes come into close proximity, (within 40nm) they serve as a template for rolling-
circle DNA synthesis, resulting in a PLA signal in the form of a dot by fluorescence 
microscopy analysis. Each protein-protein interaction is represented as a fluorescent dot 
which can be visualized by fluorescence microscopy. PLA was performed in Ku70-/- 
MEFs re-expressing either Ku70 WT or Ku70 S155A with antibodies directed against 
both Ku70 and Aurora B (Figure 3-8A). In untreated samples, few dots were detected in 
either the Ku70 WT or S155A-expressing cells. However, in cells treated with 10 Gy of 
IR, a significant increase in the number of dots was observed in the Ku70 WT-expressing 
MEFs, while no change was detected in the Ku70 S155A-expressing MEFs. These results 
suggest that while Ku70 and Aurora B do not associate in normally proliferating cells, a 
complex is formed following the introduction of DNA damage. This interaction is 
dependent upon the phosphorylation of Ku70 at S155, as it is not observed in the S155A 
samples, where the residue is not phosphorylated.  
We next investigated the effect of Ku70 S155 mutations on Aurora B activity 
following IR, as measured by phospho-H3S10 foci formation. In Ku70 WT-expressing 
MEFs, a decrease in H3S10 phosphorylation was observed 2 hours following IR 
treatment (36% of foci-containing cells down to 21%) suggesting a decrease in Aurora B 
activity (Figure 3-8B). In Ku70 S155A-expressing MEFs, however, no significant 
difference in the phospho-H3S10 levels was not detected between control and irradiated 
(2h) samples suggesting that Aurora B activity was not reduced in these cells. This 
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suggests that Ku phosphorylation on Ku70 S155 in response to DNA damage functions to 
promote its interaction with Aurora B and inhibits its kinase activity.  
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Figure 3-8 Ku70 interacts with Aurora B after IR and Aurora B inhibition after IR 
is dependent on Ku70 S155 phosphorylation.  
(A) Interaction of Aurora B and Ku after DNA damage using Proximity Ligation Assay 
(PLA). Ku70 WT and S155A expressing MEFs were left untreated or were treated with 
10 Gy of IR and fixed after a 30-minute incubation. Cells were incubated with antibodies 
to Ku70 and Aurora B and processed for PLA analysis. Shown are representative 
immunofluorescent images. Green dots represent the PLA signal, the nuclei are stained 
with DAPI. Interactions were quantified by pixel density and shown as an average of 
three experiments with error bars indicating SEM. (*P<0.05). Scale bars, 10 µm. (B) 
Immunofluorescence analysis of phospho-H3S10 in Ku70 WT and S155A-expressing 
MEFs that were either left untreated, or were treated with 10 Gy of IR and incubated for 
2 hours. Foci-positive cells were counted as a percentage of total cells and results are 
shown as an average of three experiments with error bars indicating SEM (*P<0.05). 
Scale bars, 10 µm. 
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3.4 Discussion 
This study identifies serine 155 of Ku70, as a novel phosphorylation site 
following DNA damage. Through expression of a phosphomimetic S155D mutant, we 
demonstrated that this phosphorylation event induces a DDR and cell cycle arrest. We 
found that Ku phosphorylated at Ku70 S155 interacts with the Aurora B kinase and 
inhibits its activity, suggesting that the DNA damage signaling events activated by Ku70 
S155D occur through Ku’s modulation of Aurora B kinase activity. 
Expression of a phosphomimetic substitution at the serine 155 site into Ku70-/- 
MEFs induces a potent DDR leading to cell cycle arrest and senescence. This is in 
contrast to what is observed with cells expressing Ku70 with an alanine substitution at the 
S155 site, which exhibit increased growth rate, increased survival and decreased 
activation of DNA damage markers after IR. These opposing phenotypes led us to 
hypothesize that S155 is modified and that the alanine substitution prevents a 
phosphorylation event that dictates cell survival following DNA damage. Phosphorylated 
Ku has been observed in large scale and in vitro proteomic studies, in a number of 
different contexts and cell types. These include human Hela and K562 cancer cell lines, 
and upon mTOR-dependent signaling, stem cell differentiation and, interestingly, mitotic 
kinase inhibition (45-49). However in many cases functional significance of this 
phosphorylation could not be demonstrated. For example, alanine substitutions of several 
residues phosphorylated by DNA-PK in vitro had no impact on NHEJ efficiency (50, 51). 
Interestingly, some of these same residues, located in the Ku70 N-terminus, were deemed 
essential for apoptotic activation in neurons (52). Here, we demonstrate that 
phosphorylation of Ku70 on serine 155 is a DNA damage-induced event that modulates 
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cell fate decisions. The fact that S155 phosphorylation was not detected in previous 
proteomic studies could be due to low abundance of the pS155 peptide. We propose that 
S155 phosphorylation occurs on those Ku molecules actively involved in NHEJ at the 
break, and in the event of overwhelming damage that requires the activation of apoptosis 
or prolonged cell cycle arrest. This would result in very few phosphorylated Ku 
molecules relative to the total amount of this highly abundant protein, and would only 
occur under very specific conditions. We optimized detection of this residue by treating 
cells with a high dose of IR and immunoprecipitating Ku70, but still observed the 
phosphorylated peptide in low abundance. Furthermore, the previous proteomics studies 
employed proteolytic enzymes other than chymotrypsin and could have been producing 
pS155 peptides without a composition favorable for MS detection. It should be noted that 
our results also indicate a probable phosphorylation at the S162 position, a site that has 
not been reported in these large-scale studies.  
It remains to be determined which kinase is responsible for phosphorylating S155 
as it does not fall within any canonical kinase motif. Possible candidates include ATM 
and DNA-PKCS, which have a loose consensus motif that includes S/TXXQ sequences, 
satisfied by the SDVQ sequence of Ku70 (53). Many other possibilities exist however, 
due to the abundance of serine/threonine kinases involved in the DDR. Indeed, proteomic 
data have implicated the kinases Chk1, CDK2 and Polo-like in Ku phosphorylation (47, 
54, 55).  
The expression of Ku70 S155D induced a DDR marked by H2AX 
phosphorylation, 53BP1 foci accumulation and activation of ATM. This phenotype 
correlates with the phenotypes observed in cells treated with Aurora B inhibitors and 
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suggests that the effects of Ku S155D are conferred, at least in part, through its inhibition 
of Aurora B activity. Studies using the broad Aurora kinase family inhibitors MLN8054, 
MK-0457, and VE-465, as well as our own study employing the specific Aurora B 
inhibitor AZD-1152, observed γ-H2AX and 53BP1 foci formation, and the activation of 
ATM signaling, as measured by ATM phosphorylation (15, 16). AZD-1552 treatment has 
been further shown to slow growth rate, induce cell cycle arrest and senescence, and 
increase sensitivity to IR, all phenotypes observed following Ku70 S155D expression 
(12-14, 56). We also observed some enlarged nuclei in Ku70 S155D-expressing MEFs 
(Figure 3-3A), a phenomenon indicative of failed cytokinesis and polyploidy, another 
common consequence of Aurora B inhibition (57).  
Perhaps the most striking effect of Ku S155D expression is its ability to strongly 
activate p21. p21 gene (Cdkn1a) expression was increased in S155D cells (Supplemental 
Table 3-1) and p21 protein levels were markedly upregulated. In contrast, in cells 
expressing Ku70 S155A, p21 induction was severely attenuated in response to DNA 
damage. Aurora B has been suggested to repress p21 expression and Aurora B 
downregulation or inhibition was shown to result in p21 upregulation (58, 59). Again, 
this is consistent with an inhibitory role for Ku70 S155D on Aurora B activity leading to 
p21 activation, and with a lack of repression of Aurora B in Ku70 S155A cells, 
preventing p21 induction in response to DNA damage. Interestingly, Kumari et al. 
revealed that Aurora B inhibition activates p38 MAP kinase, which in turns promotes p21 
induction by promoting transcriptional elongation of p21 transcripts (60). p38 is known 
to activate the transcription factor ATF2, which is also found strongly activated in Ku 
S155D MEFs (25). In addition, the expression of ATF3, a downstream target of ATF2 
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that is upregulated in the Ku70 S155D-expressing cells (Supplemental Table 3-1) is 
increased through Aurora B inhibition in a p38-dependent manner (61, 62). Altogether, 
the similarities between the effects caused by Aurora B inhibition and Ku70 S155D 
expression are consistent with the inhibition of Aurora B by Ku70 S155D. 
Expression of a truncated Ku70 S155D comprising only the vWA domain 
triggered a similar growth defect in both Ku70-/- MEFs and in the cell line IMR90 which 
are non-transformed human lung cells that express normal levels of Ku. This 
demonstrates that the Ku70 S155D substitution exerts a dominant-negative effect, and 
that Ku70 S155 regulation is not specific to a particular cell line, although the amplitude 
of the response may vary depending on cell type. Moreover, it suggests that Ku70 S155D 
can exert its effects in absence of DNA binding. Indeed, the Ku70 vWA peptide lacks 
both heterodimerization and end-binding activities. However, we cannot exclude that it 
interacts with telomeres. How Ku binds to telomeres, whether it is through direct binding 
to telomeric DNA or through telomere protein interactions is still a matter of debate (19). 
Interestingly, residues in Ku70 vWA domain Helix 5 have been suggested to interact with 
the shelterin protein TRF2, however, whether this interaction is sufficient to recruit Ku to 
telomeres has not been investigated (26).  
The interaction between Aurora B and Ku was dependent on phosphorylation at 
S155. We showed that while Ku70 and Aurora B do not interact in normally proliferating 
cells, Aurora B does associate with the phospho-form of Ku70, and they form a complex 
following DNA damage. Importantly, we found that Aurora B inhibition was dependent 
on Ku70 S155 phosphorylation, which suggests that the interaction of Ku pS155 with 
Aurora B is required for its inhibition. The full activation of Aurora B is achieved 
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through conformational changes induced by the binding of protein cofactors (63). There 
are a number of known activators of Aurora B, well characterized examples being the 
members of the chromosomal passenger complex (CPC), and this diversity allows for the 
specific targeting and local activation of Aurora B to different chromosomal structures 
(64). Similarly, inhibition of Aurora B is mediated through protein-protein interactions, 
including phosphatases PP1, PP2A and the checkpoint protein BubR1 (64). We propose 
that Ku, interacting with Aurora B through its Ku70 vWA domain, is an inhibitory 
cofactor following DNA damage. Thereby, the phosphomimetic S155D Ku70 mutant acts 
as a dominant negative, by constitutively binding and inhibiting Aurora B, either through 
direct hindrance of its catalytic activity or by precluding the interactions with other 
activating cofactors. 
There is a body of evidence linking DNA repair proteins to the inhibition of 
Aurora B kinase activity. Similar to what we observed with Ku70 S155D, the alternative 
end-joining DSB repair protein PARP-1, was demonstrated to interact with and inhibit 
Aurora B kinase activity, in this case as a result of direct ribosylation of Aurora B (65). 
The HR proteins BRCA2/BARD1 were also shown to negatively regulate Aurora B by 
promoting its degradation (66). Together with our results, this suggests that several 
mechanisms involving factors from the three different DSB repair pathways converge to 
inhibit Aurora B activity in response to DNA damage.  
Overall, our results suggest that upon the introduction of DNA damage, 
unphosphorylated Ku is recruited to DNA breaks where it promotes the assembly of the 
NHEJ DNA repair complex. We propose that Ku is phosphorylated at S155 under 
conditions of overwhelming damage or when the DNA break is too complex for proper 
164 
164 
repair. This event ensures the sustained activation of the DDR and Aurora B inhibition to 
reinforce cell cycle arrest, providing time to complete DNA repair. If repair cannot be 
completed, the persistence of Ku70 S155 phosphorylation could contribute to senescence 
or activation of apoptotic pathways. Our model implies that Aurora B is recruited to 
DNA breaks, which remains to be confirmed. The role of Aurora B in the DDR is still 
poorly understood, however, it has previously been linked to prominent regulators of the 
DDR, such as the Repo-Man/PP1 complex and ATM (67-69). Our data provide 
additional evidence that Aurora B plays an important role in the response of cells to DNA 
damage. Our study also reinforces the notion that Ku’s presence at the DNA break not 
only serves to recruit the NHEJ machinery, but also functions to relay signals to the DDR 
to modulate cellular responses, presumably as a function of DNA repair completion.  
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3.6 Supplementary materials 
Supplementary Figure 3-1 Identification of S155 phosphorylation. 
(A) Theoretical chymotryptic digest of Ku70 amino acids 68-300 obtained from MS-
Digest (UC San Francisco). Parameters allow 6 missed cleavages and consider oxidation 
and serine/threonine phosphorylation. (B) Experimental masses obtained from MALDI 
analysis of Ku70 immunoprecipitated from both unirradiated and 30 minutes following a 
40 Gy IR treatment WT Ku70 MEF samples were matched to theoretical masses obtained 
from MS-Digest. Peptides including Serine 155 highlighted in yellow with amino acid 
modifications indicated. (C) Analysis as in B, with MEFs expressing Ku70 S155A. D. 
Analysis as in B, with MEFs expressing Ku70 S162A.  
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Supplementary Table 3-1 S155D Ku70 induces expression changes in genes 
regulating cell cycle and apoptosis. 
Samples from WT and S155D Ku70 expressing MEFs were subjected to microarray 
analysis using a GeneChip Mouse Gene 1.0 ST Array (Affymetrics, Santa Clara, CA). 
GeneChips were processed at the London Regional Genomics Centre (Robarts Research 
Institute, London, ON; http://www.lrgc.ca). Shown is the list of genes, organized by 
cellular process, identified as differentially expressed in S155D Ku70 MEFs compared to 
the WT Ku70 control, with the fold expression change indicated for two separate 
experiments.  
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Supplementary Figure 3-2 Pulldown of proteins interacting with biotin-conjugated 
Ku70 peptides. 
(A) Silver stained gel of streptavidin-biotin pulldown of proteins interacting with Ku70 
peptide containing either an alanine or aspartic acid substitution at the S155 position. Pull 
down was performed in MEF extracts that were either untreated or treated with 10 Gy of 
IR and incubated for 30 minutes. Band boxed in red was identified by MS/MS as being 
Aurora B. (B) Proteins were subjected to trypsin digestion and peptide masses obtained 
from MS/MS analysis. MASCOT (Matrix Science) database results for boxed band with 
parameters indicated. 
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Supplementary Table 3-2 Primers used in this study. 
RT-PCR primer sequences. 
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Chapter 4 
4 General Discussion 
4.1 Summary of findings 
Prior to the start of this investigation, there was little known about the 
contribution of Ku’s vWA domain to the execution of NHEJ. This domain, named after 
the prototypic member, the von Willebrand factor A, frequently functions to mediate 
protein-protein interactions. We aimed to identify a possible role for this domain in 
response to IR by producing a series of alanine mutants at different positions throughout 
the vWA domain. Our hypothesis was that this domain could be mediating interactions 
with Ku and other NHEJ factors, so we chose residues that were more likely to 
participate in interactions, such as those that were present on the solvent exposed surface 
and showed some degree of conservation amongst Ku homologs.  
Through this investigation, we identified two important regions of the Ku70 vWA 
domain in response to IR (Chapter 2). Firstly, helix 5, particularly residues D192/D195, 
is required for efficient completion of NHEJ. Mutation of these residues to alanine results 
in severely compromised survival in response to IR. The analysis of DNA repair 
efficiency demonstrated that this mutation greatly decreases DNA repair capacity relative 
to WT, indicating that the survival defect was due to a loss of NHEJ capability. Next, the 
mutation of S155 to alanine produced a surprising phenotype. Unlike what would be 
expected of a mutation impairing DNA repair, alanine substitution of this residue resulted 
in increased survival in response to IR. There was decreased activation of the ATF2 
dependent DDR cascade that resulted in decreased activation of apoptosis. Given the 
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prevalence of serine phosphorylation in the DDR, we hypothesized that this alanine 
substitution was preventing a phosphorylation event at this residue that is required for the 
DDR activation of apoptosis in the event of unsuccessful repair. We went on to confirm 
this phosphorylation (Chapter 3) event and utilized a phosphomimetic mutant (S155D) to 
demonstrate that this modification after IR is required for the interaction and inhibition of 
the kinase Aurora B. Expression of the phosphomimetic mutant induces a profound 
phenotype, marked by constitutive activation of DDR and cell cycle arrest in the absence 
of damage. These results suggested that phosphorylation of S155 occurred after IR, 
perhaps in the case of overwhelming damage, in order to mediate the inhibition of Aurora 
B and induce cell cycle arrest or activation of apoptosis.  
4.2 Ku70 vWA domain in DNA repair 
Our work has identified helix 5 of the Ku70 vWA domain has being essential for 
DNA repair in MEFs (1). The requirement for these residues appears to be conserved 
amongst eukaryotes as it has also been shown to be required for DNA repair in yeast. A 
previous study by Ribes-Zamora et al., using S. cerevisiae as an experimental system, 
investigated the requirement for certain residues in DNA repair by performing random 
mutagenesis across the entire Ku heterodimer followed by in vitro plasmid repair assay 
(2). They identified the mutation of residues R189A/D192A/D195R in helix 5 the Ku70 
vWA domain as conferring a DNA repair defect. They later confirmed our results in a 
mammalian system, demonstrating that the transfection of a Ku70 D192A/D195R mutant 
into human cell lines resulted in significantly decreased survival in response to IR 
compared to the WT control (3). 
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Despite the evidence that the Ku70 vWA helix 5 is required for efficient NHEJ in 
response to IR, we have yet to elucidate the exact role of these residues. As a protein-
protein interaction domain, we hypothesize that this region mediates the recruitment of 
NHEJ factors to the break and the mutation is preventing this recruitment and therefore 
hindering completion of break repair. There are numerous possibilities given number of 
proteins involved in processing and ligation of a DSB, however making some 
assumptions based on the data available can reasonably narrow the pool of candidates. 
Firstly, this mutation inhibits the repair of relatively simple DSBs generated from 
endonucleases in a plasmid repair assay (2, 4) as well as confers a dramatic survival 
defect after IR, which produces a variety of complex DSBs (5-7). Thus, it seems unlikely 
that it would be recruiting an accessory processing factor but instead a member of the 
core NHEJ machinery required to ligate even basic DSBs (8). Secondly, although the 
mechanism of NHEJ is a fairly conserved process amongst eukaryotes, there are several 
participants in mammalian NHEJ that are not present in yeast. For example, there is no 
obvious yeast homolog for DNA-PKCS, so it is unlikely that this helix is required for 
recruitment and formation of the DNA-PK complex. Instead the focus should be placed 
on proteins that have homologs across eukaryotic organisms, such as ligase IV and 
XRCC4, which have direct homologs in yeast (9).  
This question would be best addressed using a system to monitor DSBs in an in 
vivo setting, such as laser microirradiation (micro-IR). This technique utilizes high-
powered lasers from confocal microscopy to generate a dense cluster of DNA damage in 
discrete locations in the nucleus (10, 11). This method allows for the visualization of 
NHEJ proteins at the site of damage due to their concentration at a specific location, 
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unlike conventional DNA damaging agents that produce uniform damage throughout the 
nucleus, and therefore a diffuse localization of proteins (10, 11). Through this system, 
one can monitor the accumulation of NHEJ factors at the break and determine if the 
mutation of D192A/D195R is preventing the recruitment of a factor essential for the 
completion of NHEJ.  
Interestingly, Ribes-Zamora et al. propose that this helix 5 is required to mediate 
heterotetramerization of two Ku dimers (3). They suggest that after Ku molecules load 
onto the ends, this region mediates the bridging of the DNA. Their results did indeed 
demonstrate that mutation of helix 5 decreased co-immunoprecipitation between 
transfected Ku molecules relative to their WT counterparts. However, these experiments 
were performed in the absence of DNA and in DNA-PKCS deficient cells and therefore do 
not accurately represent the conditions of in vivo NHEJ, and does not definitively prove 
that this helix is required for DNA end bridging. Previously, an in vitro DNA end 
bridging assay demonstrated that the presence of Ku promoted the association of two 
DNA molecules (12). Instead of testing the ability of Ku70 D192A/D195R mutants to 
associate with each other, a DNA end-bridging assay may be more informative regarding 
whether this mutation impairs the ability of Ku to bring two DNA molecules together.  
4.3 Ku70 vWA in DNA damage signaling 
The coordination between DNA repair and the cell cycle and apoptotic machinery 
is an essential part of the DDR. This is required to relay the signal of completed repair to 
terminate cell cycle checkpoints, or perhaps in the case of complicated or unsuccessful 
repair, to induce prolonged cell cycle arrest and the activation of apoptosis. We propose 
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that the phosphorylation of S155 on Ku70 acts as one of these coordinating signals 
between NHEJ and the DDR. 
Our initial observations suggested a role for S155 distinct from DNA repair. 
S155A expressing MEFs demonstrated increased survival and decreased activation of 
apoptosis in response to IR treatment. This mutant also displays decreased activation of 
several DDR markers after IR, including ATM and the ATF2-dependent signaling 
pathway. Interestingly, we confirmed that this residue does not appear to play a role in 
NHEJ, as the mutation had no impact on DNA repair efficiency, and was even able to 
rescue survival when introduced in conjunction with our established DNA repair mutant 
(D192A/D195R). Therefore, we hypothesize that this residue is required for the 
activation of cell cycle checkpoints and apoptosis in response to IR, likely in the event of 
unsuccessful repair and persistent DSBs. Indeed, we observed the prolonged presence of ϒ-H2AX foci in S155A MEFs after IR, a phenotype previously observed in cells 
surviving with unrepaired breaks (13), indicative of the cells not properly activating 
apoptosis in response to irreparable damage. This notion is further supported by the 
phenotype of our phosphomimetic mutant (S155D), which we hypothesize would act as 
constitutive signal for unrepaired breaks. This mutation confers extremely low survival in 
response to IR, and the constitutive activation of DDR markers and cell cycle checkpoints 
in the absence of any ectopic DNA damage. In contrast, the alanine substitution mimics a 
constitutively unphosphorylated residue and is able to bypass cell cycle arrest and 
apoptosis despite persistent DNA damage.  
An important consequence of S155 phosphorylation that we have uncovered is the 
modulation of Aurora B activity. We observed an interaction between the Ku70 S155D 
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mutant and an inhibition of Aurora B activity in S155D expressing MEFs. Furthermore, 
the phenotype of cells treated with an Aurora B chemical inhibitor closely mimics that of 
our S155D mutant. We hypothesize that following Ku recruitment to the DSB, Ku70 
S155 is phosphorylated, and this promotes interaction with Aurora B to inhibit its kinase 
activity. We postulate that this event occurs in response to overwhelming or complicated 
damage in order to induce cell cycle arrest. Indeed, we observed an interaction between 
endogenous WT Ku70 and Aurora B after the introduction of DNA damage but not in 
control (untreated) cells. Aurora B activity was also inhibited following IR treatment in 
WT Ku70 cells, but this inhibition was blocked by the S155A mutation, confirming that 
the phosphorylation is required for Aurora B inhibition.  
In order to fully understand the mechanism of inhibition of pS155 Ku70 on 
Aurora B, it is important to elucidate the spatio-temporal control of both Ku70 
phosphorylation and the inhibition of Aurora B activity. If Ku70 phosphorylation is used 
as a signal of delayed or unsuccessful repair, then this would be an event that occurs at a 
small subset of breaks, and would likely not appear until after the first 30 minutes, when 
the vast majority of simple breaks are resolved and NHEJ complexes dissociated (8). It 
remains to be determined which kinase is responsible for the phosphorylation of S155 as 
there is a large array of serine/threonine kinases involved in the DDR. The use of 
bioinformatics tools designed to predict phosphorylation based on the known consensus 
motifs of various kinases did not pinpoint any in particular with a strong likelihood (14, 
15). While there are many possibilities, a strong candidate is ATM. ATM activity is often 
dispensable for simple NHEJ repair, but it is required for the completion of lengthy 
repair, reactions that would often induce prolonged cell cycle arrest as observed in the 
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S155D MEFs (8, 16). Furthermore, ATM is involved in promoting its own positive 
feedback loop that amplifies its signal and maintains the prolonged signaling cascade 
required to sustain cell cycle arrest (17, 18). Since S155 phosphorylation controls the 
activation of ATM after IR, it could be yet another mechanism by which ATM 
propagates its own signaling cascade.  
Unfortunately, addressing these questions has proved challenging thus far. We 
were able to observe S155 phosphorylation after IR by utilizing MALDI-TOF MS/MS, 
however this technique is not conducive to the finite monitoring of the phosphorylation 
and dephosphorylation of S155 due to the method’s insensitivity and large abundance of 
material required. The kinetics of Ku phosphorylation after IR in vivo would be best 
analyzed by western blot or immunofluorescence. We attempted to generate a phospho-
specific antibody directed against this site, but this antibody cross-reacted with other 
proteins and could not be utilized for further studies. The successful generation of a 
phospho-S155 antibody would be an invaluable tool for understanding the timing and 
necessary kinase activity for Ku phosphorylation. 
While we have established that an interaction between Aurora B and pS155-Ku70 
mediates the inhibition of Aurora following DNA, we now need to establish the nature of 
this interaction. The regulation of Aurora B is achieved through the binding of a variety 
of different cofactors. Aurora B, for example, is most well known for its participation in 
the chromosomal passenger complex, where it interacts with subunits INCENP, Survivin 
and Borealin that stimulate its kinase activity towards several substrates in mitosis (19). 
Aurora B only makes direct contact with INCENP, with its N-terminal regulatory and 
catalytic domains of Aurora B interacting with the IN box motif of INCENP, a 
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requirement for basal kinase activity at the kinetochore (20, 21). The other subunits do 
not interact directly but are involved in the correct localization and clustering of Aurora B 
molecules that are essential for full activity (22). Therefore, it is possible that Ku is 
directly modulating kinase by binding and hindrance of the catalytic domain, binding the 
regulatory region to induce unfavorable conformational changes or precluding the 
interactions with activator subunits. It is also possible that Ku and Aurora B do not 
interact directly and their association is mediated by another factor.  
The role of Aurora B following DNA damage is not well understood. Aurora B 
kinase activity has been shown by us and others to be inhibited following DNA damage 
(23), but whether Aurora B is recruited to DSBs has never been demonstrated. This is not 
entirely surprising if its recruitment is dependent upon an interaction with Ku however, 
since Ku does not assemble at a break in large enough numbers to be visible by 
conventional microscopy. Similar to what is utilized to visualize NHEJ factors at the 
break, micro-IR would be an excellent tool for observing the localization of Aurora B to 
DSBs and determine the time course of its interaction with Ku. Another unknown is the 
link between inhibition of Aurora B and the activation of ATM signaling. Aurora B has 
actually been shown to activate ATM by phosphorylating serine 1403, but this event was 
shown to specifically mediate the spindle assembly checkpoint in mitosis (24). Our 
results point to DNA damage specific role for Aurora B regulation of ATM, not 
dependent upon any particular cell cycle phase, and this remains to be clarified. There are 
some indirect connections between Aurora B and ATM, with an interesting one involving 
the protein Repo-man. During mitosis, Repo-man is required for correct Aurora B 
localization but also counteracts Aurora B activity by dephosphorylating several of its 
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substrates (25, 26).  Repo-man has also been shown to localize with inhibit ATM activity, 
only to be released from chromatin after DNA damage to allow ATM activation (27). It is 
possible that following DNA damage, Repo-man is released from ATM and complexes 
with Ku70 and Aurora B to inhibit its activity, but this remains to be investigated.  
It is currently unclear whether the effects of the S155 mutants can all be attributed 
to Aurora B activity, or whether there are additional signaling events occurring following 
Ku70 S155 phosphorylation. In Chapter 2, we describe the expression of S155A 
repressing the activation of an ATF2 dependent DDR, resulting in the deregulation of 
several ATF2 transcriptional targets such as ATF3 and CHOP (28). While this could be a 
distinct signaling pathway regulated by S155 phosphorylation, there have been studies 
demonstrating that many of the effects of Aurora B inhibition are dependent upon the 
activation of the p38 kinase pathway, a kinase that is the main regulator of ATF2 (29-31). 
The repression of ATF2 signaling after IR in S155A cells could be explained by a loss of 
Aurora B inhibition and subsequent lack of p38 pathway activation. If the gene 
expression changes observed after S155D expression are due to the Aurora B dependent 
activation of the p38 pathway, it would be interesting to test whether the use of a p38 
inhibitor could rescue its dramatic phenotype. However, there are other gene expression 
changes that cannot be explained by Aurora B inhibition. In an examination of the 
microarray data obtained from S155D expressing MEFs relative to WT (Supplementary 
Table 3-1), it is interesting to note that a large number of phosphatases are found 
downregulated following S155D expression. This is consistent with a constitutively 
active DDR and cell cycle arrest, as phosphatases are required to resolve checkpoints and 
resume normal cycling after the repair of damage (32, 33). Yet, the downregulation and 
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inhibition of phosphatases has been demonstrated to increase Aurora kinase activity, 
which is in clear opposition of our findings (34, 35). This apparent contradiction could be 
due to additional factors or pathways being modulated by S155 phosphorylation that are 
independent of Aurora B activity.   
4.4 Conclusion 
In summary, this work has contributed to the broader understanding of the Ku70 
vWA domain function in response to DSBs on two fronts: demonstrating the requirement 
for helix 5 for proper DSB repair in mammalian cells, and identifying a novel 
phosphorylation site that signals to the DDR to modulate cell fate decisions. We propose 
a model for the function of the Ku70 vWA domain in NHEJ (Figure 4-1) where Ku is 
rapidly recruited to a DSB, and helix 5 participates in the completion of NHEJ by either 
mediating the recruitment of another essential NHEJ factor, or the interaction with 
another Ku heterodimer at the break. If repair cannot be completed, S155 is 
phosphorylated, and this results in the inhibition of Aurora B activity, thereby inducing 
prolonged cell cycle arrest or the activation of apoptosis.  
A thorough understanding of DNA repair and the DDR has broad implications for 
human health as genome instability is a hallmark of cancer (36). We now understand that 
Ku not only is involved in the repair of breaks, but also through the phosphorylation of 
S155, is essential for the elimination of cells damaged beyond repair. The loss of this 
regulation would lead to the proliferation of unstable cells, potentially resulting in 
genomic instability and cancer. It would be interesting to investigate the consequences of 
a S155 alanine substitution at the organismal level, and whether the loss of this 
phosphorylation has oncogenic potential. On the contrary, we have observed that the 
194 
194 
Figure 4-1 Model for the function of the Ku70 vWA domain in response to DSBs. 
(A) Following recruitment of the Ku heterodimer to the break, the Ku70 α-helix 5 is 
positioned inwards towards the DNA end. This helix is required for NHEJ and cell 
survival in response to DSBs, and there are currently two hypotheses to explain its role: 
(i) protein-protein interaction surface utilized in the recruitment of an essential NHEJ 
factor, (ii) interaction surface between two Ku70 molecules to mediate 
heterotetramerization of Ku in order to bridge DNA ends at the break. (B) (i) Ku attempts 
repair by NHEJ (ii) Following unsuccessful or prolonged repair, an unknown kinase 
phosphorylates Ku70 on residue serine 155. (iii) Ku70 pS155 interacts with Aurora B 
kinase, either directly or indirectly, in order to inhibit Aurora B kinase activity. (iv) 
Inhibition of Aurora B kinase results in increased activity of ATM and ATF2 and 
upregulation of p21, leading to the activitation of cell cycle checkpoints, senescence and 
apoptosis.  
195 
190 
196 
196 
transfection of the S155D vWA had a profound effect on both mouse and human cell 
lines, inducing cell cycle arrest and senescence, through a modulation of Aurora B 
activity. Given the prevalence of small molecules being generated against the Aurora 
kinases for the treatment of cancer, it raises the possibility of whether this 
phosphomimetic peptide of Ku has therapeutic potential.  
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